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Advances in nanotechnology have given rise to the rapid development of many novel applications in the 
biomedical field. Therefore, there is a need to elucidate the safety and health risks of these nanomaterials. 
The hypothesis in this study is that gold nanoparticles (AuNPs) exert both cytotoxic and genotoxic effects 
in lung cells in vitro and in vivo. This thesis aims to evaluate the biological effects of AuNPs in human 
lung cell lines (small airway epithelial cells and MRC5 lung fibroblasts) and rat lung tissues. The 
methodologies covered in this study include characterization of the AuNPs, cellular uptake of AuNPs, 
cytotoxic and genotoxic studies, transcriptomic, epigenetic and advanced proteomic approaches. 
Verification of internalization of AuNPs in human lung cells were performed by light microscopy, 
transmission electron microscopy, focused ion beam-scanning electron microscopy and inductively 
coupled plasma mass spectrometry. Clathrin-mediated endocytosis was observed to be the pathway 
responsible for their uptake into the cells. Lipid hydroperoxide (LPO) assays revealed that AuNPs were 
able to induce oxidative stress in lung cells concomitant with an increased in anti-oxidant gene expression. 
Following oxidative stress, AuNP treatment caused increased lactate dehydrogenase (LDH) leakage and 
non-viability of the cells. Comet assay revealed DNA fragmentation after 72 h AuNP exposure in SAECs, 
concomitant with up-regulation of DNA repair Xeroderma pigmentosum gene. 
A genome wide microarray study was conducted and a total of 42 and 19 genes were found to be 
differentially expressed in SAECs and MRC5 fibroblasts respectively. These altered genes included up-
regulation of serum amyloid A-1 (SAA1) and toll-like receptor 2 (TLR2) in SAECs as well as up-
regulation of miR-155 with down-regulation of protein S alpha 1 (PROS1) in MRC5 lung fibroblasts. The 
four differentially expressed genes were selected for down-stream analysis as they were postulated to be 





As SAA1 is known to interact with TLR-2 to trigger nuclear factor kB (NFkB) activation, a co-
immunoprecipitation assay was performed with TLR2-SAA1 in SAECs, with positive results. TLR2-
SAA1 protein-protein interaction was also verified by in silico modeling. There was also concomitant 
activation of NFkB activity, suggesting that SAA1-TLR2 interaction could activate NFkB. 
The epigenetic studies suggest that miR-155 and histone deacetylases (HDAC) activity could regulate 
expression of PROS1, but not DNA methylation in AuNP-treated MRC5 lung fibroblasts. Silencing of 
miR-155 established the PROS1 gene as a putative target gene, together with the observation of nuclear 
chromatin condensation and re-organization at the ultrastructural level. 
To mimic the physiological condition in the lung, a co-culture of lung epithelial cells and lung fibroblasts 
was performed. Proteome analysis using the stable isotope labeling by amino acids in cell culture (SILAC) 
-mass spectrometry (MS) based approach, revealed a significant perturbation of cell motility and 
extracellular network in the underlying lung fibroblasts which were co-cultured with lung epithelial cells 
pre-exposed to AuNPs. There was associated up-regulation of Paxillin (PXN), breast cancer anti-estrogen 
resistance 1 (BCAR1) and Caveolin-1 (Cav-1) protein expression, which led to disruption in focal 
adhesion (FA) formation and an increase in vinculin binding sites. In addition, there was a significant 
increase in cell adhesion towards fibronectin as well as Collagen I. These results demonstrate that AuNP 
treatment could induce by-stander effects in neighboring unexposed fibroblasts, possibly via cell-cell 
crosstalk. 
Finally, a proof of concept study was performed in rats injected with AuNPs intravenously. 
Biodistribution analysis confirmed the accumulation of AuNPs in the rat lungs. Systemic inflammation 
was observed as evidenced by the increase in serum Transforming growth factor beta (TGF-β), 
interleukin 6 (IL-6) and IL-1α. Prolonged blood coagulation time was observed in the AuNP-treated rats, 
implying that AuNP exposure could potentially lead to bleeding diathesis. Moreover, there was also 





infiltration, influx of macrophages and increased IL-1α expression in the tissues. A miRNA expression 
profiling study using real-time PCR showed that expression of miR-327 was significantly decreased in 
single dose of AuNP exposure. 
In sum, the presence of AuNPs is likely to induce biological effects in the lung through the generation of 
oxidative stress, leading to cellular damage and inflammation. The results from this nanotoxicological 
study has provided data that will help to address the health concerns associated with AuNPs, and the safer 
use of AuNPs for biomedical applications and the industry. 
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1.1 Nanotechnology and Nanomaterials (NMs) 
The rapid development of nanotechnology worldwide has enabled nano-sized materials to be used across 
various fields such as for biomedicine, industrial and commercial applications. An example of the use of 



























Figure 1.1: Schematic diagram showing nanoparticles and their applications in both diagnosis and therapy 
for breast cancer. 
 
 
Engineered nanomaterials (NMs), including NPs, are defined as the creation and production of materials 
with the size range within 100 nm in at least one of its dimension (in length or diameter) (Warheit et al., 




 nm) innovations possess properties which differ distinctively 





surface area to volume ratio, NMs exhibit high reactivity and attractive physicochemical properties. 
Depending on their size, charge, surface properties and shape, engineered NMs possess unique optical, 
magnetic and electronic properties which hold the key to unlock a wealth of opportunities in the global 
market (Wolfgang, 2004). Nanotechnology has emerged as an important sector in the global economy, 
and estimated to contribute to USD 3.3 trillion worth of investment by 2018 (Global-Industry-Analysts, 
2012). 
The U.S Environmental Protection Agency (USEPA) has classified engineered NMs based on 
chemical constituent and physical structure into 4 main classes as below: 
1) carbon-based NMs, for example, fullerenes and carbon nanotubes 
2) metal-/metal oxide based NMs, for example, gold (Au) and silver nanoparticles (AgNPs) 
3) dendrimers 
4) composites (USEPA, 2007) 
 
1.2 Au and AuNPs 
Gold nanoparticles (AuNPs) have been selected out of a vast variety of available NMs as a model of 
engineered NMs for further study in this thesis. Au, being a noble and inert d-block element in its bulk 
form, has been used for medicinal purpose as early as 2500 B.C. Colloidal Au was regarded as the magic 
potion for longevity in ancient Chinese society (Higby, 1982). Moreover, in the country of India, colloidal 
Au has served as a medicine or elixir of youth, which helps in rejuvenation (Richards et al., 2002). 
Nowadays, Auronofin and Aurasol, a gold complex have been recognized as modalities of treatment for  
rheumatoid arthritis (Tsai et al., 2007; Dykman and Khlebtsov, 2011) and tuberculosis (Kean et al., 1985); 
while CYT-6091, 27-nm citrate-coated GNPs conjugated with PEG-thiol and tumour necrosis factor-α 
(TNF-α) (Aurimmune) have entered a phase I clinical trial (Libutti et al., 2010). Other than exposure to 
Au mediated through medications, dermal contact to Au (in the form of jewellery and dental restoration) 





AuNPs possess unique surface plasmon resonance and optical properties which lead to their 
applications as a drug carrier, bio-imager and bio-sensor (Jain et al., 2006; Tsyusko et al., 2012). 
Furthermore, being a d-block element, AuNPs are able to excite the electrons in the conduction band, 
resulting in the loss of energy in the form of heat, making them a suitable candidate as a photothermal 
agent in cancer therapy (Jain et al., 2008). Other than their medicinal values, AuNP innovations have 
infiltrated commercial products and the industrial settings, including solar cells, automobiles, cosmetics 
(as anti-aging agent) and conductive ink (Keel T; Sung et al., 2011a). The top 6 nanotechnology-based 
products are nano-Au-based, and hence make AuNP a relevant candidate for toxicological evaluation. 
 
1.3 Cellular uptake of NPs 
Understanding the mechanism of NP internalization into cells is important for determining the 
intracellular delivery and fate of NPs. In addition, optimization of parameters affecting the NP uptake into 
cells will aid in the design of smart NP carriers for better applications in the biomedical setting. 
 
(A) Cellular uptake mechanism of NPs 
Endocytosis has been recognized as one of the major pathways that account for intracellular uptake of 
NPs. Endocytosis comprises several pathways including macropinocytosis, caveolae dependent and 
independent, and clathrin dependent and independent pathway (Hao et al., 2012; Munoz and Costa, 2012). 
In particular, receptor-mediated endocytosis (RME) which is mediated through interaction between the 
adsorption of serum proteins onto NPs and receptors present on the cell membrane, has been identified as 
a major uptake pathway for AuNPs (Chithrani, 2010). RME is an ATP-dependent process which involves 
membrane invagination around the NPs through clathrin, caveolae and other lesser-known pathways. To 
confirm if uptake of NPs occur via endocytosis, a lower temperature (4 
o
C) or sodium azide (an ATPase 
inhibitor) has been used to compare with uptake at 37
 o
C. As there is energy depletion at 4
 o
C or in the 
presence of the inhibitor, RME is therefore not possible (Xiang et al., 2012). Upon internalization of NPs 





endsosomes, followed by delivery of the NPs to lysosomes subsequently for degradation (also known as 
the classical endocytic pathway) (Rejman et al., 2004; Johnston et al., 2010a). 
Clathrin-mediated endocytosis (CME) occurs via five key assembly and maturation steps which 
are: nucleation, cargo selection, coat assembly, followed by scission and lastly uncoating (Munoz and 
Costa, 2012). The clathrin-coated pit, which originates from plasma membrane, has varying sizes in a 
species dependent manner, but do not exceed 200 nm in general. The invagination of clathrin pits 
continue till vesicle fission is formed (Xiang et al., 2012). Adaptor protein 2 (AP 2) is one of the adaptors 
which assists in pit formation. As CME is lipid raft-mediated, depletion of cholesterol is known to disrupt 
the vesicle formation by preventing pit detachment from the plasma membrane. 
Caveolae-mediated endocytosis (CvME) is also a receptor mediated and ATP-dependent process. 
GTPase dynamin mediates the fission of caveolae at its neck; while receptors located in caveolae 
(including epidermal growth factor and insulin receptor) are known to mediate CvME too (Xiang et al., 
2012). Similar to CME, Cvme is also cholesterol-dependent; and what differs between these two 
pathways is that CvME is a non-digestive route, bypassing lysosomal degradation and the classical 
endocytic pathway (Bengali et al., 2007). However, this notion still remains debatable. 
 
(B) Pharmalogical inhibitors as tools for mechanistic studies of uptake 
Inhibitors are widely used to block a specific endocytic pathway. Pharmacological inhibitors exert 
homogenous effects on cells and require little time to achieve an inhibitory effect, making them useful for 
this purpose. However, the lack of specificity and possible side effects associated with their use are 
frequently encountered (Ivanov, 2008). Moreover, these inhibitors may results in cell type variations, thus 
warranting an unbiased view of these disadvantages. 
To study CME, chlorpromazine is employed to disrupt the formation of clathrin pits. 
Chlorpromazine is a cationic amphipathic inhibitor, which reversibly inhibit AP2 adaptor complex and 
clathrin from translocation at the cell surface (Ivanov, 2008). In addition, chlorpromazine alters the 





formation of clathrin coated pits (Ogiso et al., 1981). Other than chlorpromazine, Concanavalin A (ConA) 
is also an inhibitor for CME which blocks the internalization of receptors on the cell surface through 
agglutination of receptors (Markelc et al., 2014). 
CvME, being cholesterol-dependent for caveolae synthesis, can be inhibited by blocking 
cholesterol biosynthesis. One such inhibitor is nystatin, which creates large aggregates in the cholesterol-
rich membrane, causing cholesterol to be sequestered from the cell membrane, and inducing distortion in 
caveolar shape and lipid raft ligand internalization (Ros-Baro et al., 2001). 
 
(C) Physicochemical properties affect cellular uptake of NPs 
The size, shape and surface functionalization of NPs influence the amount and type of pathways for their 
internalization. Energetic and kinetic models have elucidated a size-dependent uptake of NPs, in which  
50 nm NPs possessed the highest uptake while NPs smaller than 50 nm showed lesser uptake due to 
prohibitive thermodynamic barriers as they are too small to be recognised, hence restricting their uptake 
(Chithrani and Chan, 2007; Jin et al., 2009). Other than size, Chithrani et al (2007) also investigated the 
effect of shape on uptake of NPs. Uptake of rod-shaped NPs (with a higher surface area as compared with 
spherical shape) is found to be lesser than spherical NPs of the same surface coating; and it is speculated 
that nanorod requires a longer wrapping time by the membrane, resulting in lower uptake. 
The presence of surface modification affects the uptake of NPs as well as protein adsorption onto 
the NPs. While clathrin-mediated endocytosis is responsible for the uptake of transferrin-coated AuNPs 
(Chithrani and Chan, 2007), both clathrin- and caveolae-mediated endocytosis are involved in the uptake 
of PEG-modified AuNPs (Nativo et al., 2008). External factors such as the extent of protein adsorption 
onto the NP affect its uptake. Unbound or naked NPs are able to compete with protein-adsorbed NPs at 
the receptor binding sites (Johnston et al., 2010a). On the other hand, Cetyl trimethylammonium (CTAB)-
coated NPs can inhibit the amount of adsorbed proteins onto the surface of NPs, resulting in lesser 
binding and interaction of NPs with receptors, thereby influencing uptake (Chithrani, 2010). These 





the uptake of NPs. As such, uptake efficacy of NPs can be manipulated through this ligand-receptor 
conjugation relationship. 
Studies have shown that the surface charge carried by NPs affects the uptake of NPs. In general, 
cationic NPs exhibit greater uptake into cells due to interaction with the negatively charged plasma 
membrane; while anionic NPs would be repelled during such an interaction (Chithrani, 2010). 
Furthermore, the different surface charge possessed by NPs will affect the degree of protein denaturation, 
affecting protein structure and function (Aubin-Tam and Hamad-Schifferli, 2008). The findings from 
these in vitro studies have highlighted the need to consider these physicochemical effects during the 
design of NP-based carriers for in vivo experiments. 
 
1.4 Nanotoxicology 
Human exposure to engineered NMs can occur intentionally or unintentionally. Intentional exposure 
includes medical application where NMs are introduced into body via for example, an intravenous 
injection (IV) route, for diagnostic or the therapeutic purpose or both. Unintentional (or accidental) 
exposure includes occupational exposure to NMs by workers (such as by inhalation and dermal contact 
routes) at the workplace or manufacturing plant (Oberdorster et al., 2005). Regardless of how NMs enter 
the body, they will be systemically distributed throughout the body and accumulate in various organs, if 
they are not removed by the first pass effect or by phagocytic processes. 
Emergence of engineered NM-related products has generated a great concern for health issues, 
due to the increasing risks of exposure. As NMs has high surface reactivity (i.e., redox ability), they are 
bio-reactive and can interact with intracellular organelles and biomolecules of a similar size scale, thereby 
altering their structures and triggering undesired effects such as oxidative stress, autophagy, inflammation 
and cellular injury (Krpetic et al., 2014). Therefore, understanding the uptake mechanism, biodistribution 
and potential adverse effects of these NMs upon entering into human body is of the upmost importance. 
Besides, target specific study such as effects of NMs at secondary organs is fundamental in the 





It has been demonstrated that the toxicity of metal NPs is greater than the toxicity of 
microparticles of the same parent chemical. Owing to their small sizes, the NPs are shown to be more 
reactive and possess higher penetrative efficiency and cellular uptake than microparticles (Desai et al., 
1996)). NPs were also reported to be more toxic than microparticles both in vitro and in vivo (Jiang et al., 
2009; Lin et al., 2009; Moos et al., 2010; Nair et al., 2009; Gaiser et al., 2011). 
With the increased production and utilization of engineered NMs and their related products 
worldwide, the likelihood of releasing and exposure to NMs in human also increased. Thus, there is a 
need to institute appropriate guidelines on handling engineered NMs and evaluate their potential effects 
on human and environment. Information gleaned from the toxicity studies will aid in risk assessment and 
help to set safe exposure limits. Hence, knowledge of proper characterization of each engineered NM 
becomes crucial in determining their properties and understanding their behaviour under different 
environmental conditions (such as exposure route, duration and dosage). Although the literature on 
nanotoxicology of AuNPs is widely available, there are still questions that remain to be addressed with 
regard to AuNP-associated health risks. 
 
1.4.1 The lung as a model for nanotoxicology 
The lung is a respiratory organ which is in first line and high contact with atmospheric exposure to 
pollutants. Being an organ with large surface area, comprising approximately 2300 km long of airways 
and 300 million alveoli, the lung could be exposed to variety of airborne particles (Li et al., 2010a). 
Although the presence of nasal cilia could help in getting rid of these particles, NPs are likely to evade the 
mechanism responsible for their clearance due to their small size, leading to biopersistence. As such, the 
lung is vulnerable for NP invasion and accumulation in the deep regions, making the lung particularly 






























Figure 1.2. NP invasion and penetration into the deep regions of the lung, and enter the alveolus capillary 
into pulmonary circulation. 
 
 
Occupational exposure to NMs mediated via inhalation allows accumulation of NMs in lungs. Assessing 
pulmonary toxicity using epithelial cells lining the alveoli; or lung fibroblasts which constitute the major 
stromal component, is appropriate as these two cell types have the highest risk from exposure to NMs. 
Hence, the lung has been used as a model of study in vitro and in vivo to understand the potential impacts 
of NMs through the inhalation and injection routes. Lung cell lines which have been used for pulmonary 
toxicity of metal NPs include normal human lung fibroblast cells (IMR-90), human alveolar macrophage 
cell line (THB-1) and human epithelial cell line (A549) (Johnston et al., 2010a). From these studies, it 
would appear that different cell types possess varying degree of sensitivity towards the same type of NPs, 
implying the need to use two different cell types for better comparison and evaluation of toxicity. 
Based on the literature search (as summarized above), human exposure to AuNPs is likely to 





differences in the routes of exposure, Au has been found to enter the body, translocate to other secondary 
target sites or to developing embryos/fetus (Myllynen, 2009) and accumulate at varying amount at 
different organs. Among these organs, the lung is found to be one of the target sites for Au accumulation. 
Several possible clearance pathways including mucociliary clearance and pulmonary surfactant 
protein D modulated clearance (Yu et al., 2007; Semmler-Behnke et al., 2008; Schleh et al., 2013), and 
alveolar elimination by macrophages in the alveolar region (which does not apply to large agglomerates) 
(Takenaka et al., 2012) are available, but this process is often size dependent. Moreover, the lung is only 
protected by a poor barrier of 500 nm thickness made up by a single-cell layer from the blood capillaries 
(Hoet et al., 2004; Li et al., 2010a). Chen et al (2009) reported that AuNPs accumulated in mouse lung 
following IP injection, resulting in loss of structural integrity in lungs. Likewise, subchronic exposure to 
AuNPs via inhalation caused pathological signs including inflammatory infiltrate of mixed cell type 
(lymphocyte/neutrophil/macrophage) in male and female AuNP-exposed rats (Sung et al., 2011a). 
Previous studies by Balasubramaniam and colleagues have shown accumulation of 20 nm AuNPs 
in rat lung following both inhalation and IV injection studies (Yu et al., 2007; Balasubramanian et al., 
2010a). However, as the major reservoirs for Au accumulation have been reported to be in the liver and 
spleen, the effects of AuNPs on the lung after IV injection have received little attention. 
 
1.4.2 Nanotoxicity of AuNPs 
Biodistribution studies have demonstrated translocation of AuNPs to the lung via the blood circulation. 
Studying the effects of AuNPs in lung may provide additional insights into the pulmonary toxicity of 
AuNPs. However, previous in vitro and in vivo studies showed contradictory results for AuNP-related 
toxicity due to inconsistency in the parameters (Khlebtsov and Dykman, 2011). Furthermore, 
extrapolation of in vitro results to in vivo settings is not possible, due to the complexity of the biology of 
the whole organism (Tsyusko et al., 2012). Various factors have been identified to influence the toxicity 
of AuNPs. Physicochemical properties such as size, shape, surface modification and surface charge 





The animal model is a preferred system for toxicity evaluation. Other than animal models, three-
dimensional (3D) system and co-culture system are emerging platforms that simulate physiological 
conditions which are lacking in 2D cell culture system (Lee et al., 2009; Herzog et al., 2014). A tissue is 
made up of a collection of different cell types, and each cell type responds differently to NM exposure, as 
evidenced by cell-type specific effects. Moreover, as NM-induced toxic effects may be enhanced through 
cellular crosstalk, these aspects would deserve consideration when designing a model for NM toxicology 
(Johnston et al., 2010a). 
 
1.4.2.1 In vitro toxicity of AuNPs 
(A) Cytotoxicity 
Toxicity profiles of AuNPs have become widely available. AuNP-toxicity studies have been conducted 
with different surface properties, sizes and functionalization, implying that the toxic effects may not be 
caused by AuNPs alone, but due to combinatorial effects. Many studies have attributed the exposure of 
AuNPs to induce toxicity through disturbance to cell cytoskeleton, breakdown of the cellular permeability 
barrier, reduction of cell survival, apoptosis and activation of signaling pathways which are highlighted 
below. 
Uptake of AuNPs cause decreased cell proliferation and autophagy in MRC5 lung fibroblasts as 
reported previously (Li et al., 2008; Li et al., 2010a). Upon entry into human dermal fibroblasts, AuNPs 
were found to disrupt cytoskeleton filaments, causing decreased cell motility (Mironava et al., 2010). In 
addition to size, surface charge has been reported to be associated with toxicity. Cationic AuNPs are 
reported to be more toxic and has the ability to disrupt the integrity of plasma membrane, compared to 
neutral or anionic AuNPs (Goodman et al., 2004). A detailed study has revealed that cationic AuNPs 
caused more disruption to the negatively charged lipid-bilayered plasma membrane; while anionic AuNPs 
impeded such an effect (Tatur et al., 2013). 
Particle size influences the cytotoxicity, with smaller size of AuNPs observed to exhibit a greater 





apoptosis (Pan et al., 2007) while Pan et al showed that 1.4 nm AuNPs are much more cytotoxic than     
15 nm AuNPs of the same chemical constituents (Pan et al., 2009), causing necrosis through oxidative 
damage. Moreover, it appears that different sizes of AuNPs (1.2 nm vs 1.4 nm) induced cell death via 
different mechanism (apoptosis vs necrosis). 
Other than particle size, studies using different surface-modified AuNPs have been performed.  
20 nm AuNPs have been observed to inhibit cell proliferation, concomitant with down-regulation of cell 
cycle related genes (Li et al., 2008). Imidazole-stabilized AuNPs have been reported to induce neuronal 
death by apoptosis both in vitro and in vivo (Imperatore et al., 2014). Sodium-citrate capped AuNPs were 
observed to reduce cell viability, proliferation and induce leakage of lactate dehydrogenase (LDH) 
through the plasma membrane in human alveolar type-II cells in vitro (Uboldi et al., 2009). 
Moreover, opsonization of proteins which form the protein corona, has been shown to facilitate 
the uptake of NPs into cells by promoting the interaction with cellular receptors (Nativo et al., 2008). 
Upon entering the human body, NPs will be opsonized with biomolecules (e.g., serum proteins) and this 
may modify the behavior of the NPs. Also, formation of protein corona on NPs could potentially alter the 
protein conformation and function, adding confounding factors to toxicity studies (Johnston et al., 2010a). 
Binding of FBS as protein corona to the surfaces of AuNPs, has been shown to possess lesser non-
specific affinity to cell surface and reduced toxicity, as compared with naked AuNPs (Tenzer et al., 2013). 
Likewise, coating of AuNPs with bovine serum albumin has been observed to be non-toxic in MRC5 
fibroblasts (Das et al., 2012). Hence, such effects have to be considered when interpreting toxicity data. 
 
(B) Oxidative stress 
Other than cytotoxicity, oxidative stress is an important molecular mechanism in toxicity studies as 
heightened or uncontrolled oxidative stress may lead to unwanted effects such as fibrosis (Cheresh et al., 
2013) and DNA damage (Pizarro et al., 2009). The small size and bioreactivity of NPs aid in free radical 
generation and hence, oxidative stress induction (Yao et al., 2013). Oxidative stress has been 





diameter, were found to trigger oxidative stress (Jia et al., 2009; Li et al., 2010a), by releasing nitric oxide 
(NO) and up-regulating stress-responsive genes such as cyclooxygenase (Cox-2). Jia et al (2009) 
monitored AuNP-induced production of NO in a dose-dependent manner using a NO microsensor, which 
was possibly due to the catalytic effect of AuNPs on NO generation from endogenous S-nitroso adducts 
with the thiol (-SH) group. 
Mitochondrial stress test conducted in the human keratinocyte cell line suggest that both cationic 
and anionic AuNPs triggered oxidative stress through generation of reactive oxygen species (ROS), which 
then elevates superoxide dismutase (SOD) production (Schaeublin et al., 2011). Another study 
demonstrated a cell-line dependent dysregulation of SOD activity following increased ROS production in 
human leukemia and HepG2 cell lines, and concluded that cytotoxicity of AuNPs could be attributed to 
oxidative stress (Mateo et al., 2014). It is also acknowledged that AuNPs have strong binding affinity to 
the -SH group, which is a common functional group present in SOD. Therefore, the interaction between 
AuNPs and -SH group may also account for the accumulation of ROS (Johnston et al., 2010a). 
PEGylated AuNPs was observed to disturb the membrane integrity of erythrocytes, and induce 
oxidative stress accompanied by increased malonaldehyde (MDA) levels in the cells (He et al., 2014). 
Surface functionalization of AuNPs with CTAB is found to be more toxic than naked AuNPs (Connor et 
al., 2005); while AuNPs conjugated to -SH peptides do not enhance ROS formation. It has been 
previously reported that ~15 nm size citrate-capped AuNPs without surface functionalization, can trigger 
an increase in ROS, due to Au-S bonding interactions with intracellular proteins, such as, glutathione and 
–SH group containing proteins (Tedesco et al., 2010a). On the other hand, AuNPs conjugated to thiol 
peptides do not enhance ROS formation, as such interactions are deterred by the chain length and steric 
effect of the conjugated-peptide system through Au-S bonds (Morales-Avila et al., 2012). 
 
(C) Genotoxicity 
Genotoxicity refers to DNA damage, which may or may not result in mutation (Yao et al., 2013). 





expressed. Proposed mechanisms which may lead to NP-induced genotoxicity include direct binding of 
NPs to DNA; direct binding of NPs to DNA associated proteins and indirect cellular response such as 
oxidative stress (Yao et al., 2013). Genotoxic studies using the Salmonella typhimurium bacteria, 
demonstrated that AuNPs induced photomutagenicity, which was postulated to be caused by both citrate 
and Au³⁺ (or auric compounds) due to the formation of free radicals (Wang et al., 2011). In previous 
studies, AuNPs were found to induce genomic instability without causing massive cell death in MRC5 
fibroblasts. Comet and FISH assays revealed DNA damage and chromosomal breaks, coupled with 
dysregulation of DNA repair genes, thereby, leading to persistent DNA damage (Li et al., 2008; Li et al., 
2011a). While DNA damage could be rescued through DNA-repair mechanism, such repair is rendered 
impossible as NPs have altered the function of DNA repair genes. Citrate-capped 20 nm AuNPs have 
been reported to cause genotoxicity in human liver HepG2 cells using the comet assay. This phenomenon 
was not observed when AuNPs were functionalized with 11-mercaptoundecanoic acid (11-MUA), 
highlighting the effects of surface properties on the genotoxic effects observed (Fraga et al., 2013). 
 
1.4.2.2 In vivo toxicity of AuNPs 
Biodistribution and toxicity studies of AuNPs have been performed in several animal models including 
Caenorhabditis elegans (C. elegans), zebrafish, Drosophila fly and rodents. The parameters that were 
examined include size of AuNPs, surface modification, route of exposure and dose on the biodistribution 
and toxicity of AuNPs. 
Genome-wide analysis of AuNP-exposed C. elegans revealed accumulation of AuNPs and 
activation of biological pathways associated with protective mechanism against AuNPs (Tsyusko et al., 
2012). A study of AuNPs functionalized with N,N,N-trimethylammoniumethanethiol (TMAT-AuNPs), a 
cationic ligand, revealed a smaller malpigmented eyes coupled with cell death in eye using embryonic 
zebrafish model (Kim et al., 2013). This effect has also been extended to other toxicity-related health 
issues such as behavioral and neuronal damage in zebra fish at the developmental stage. Using the same 





toxicity which caused abnormalities to the larval and adult behavior. Citrate-capped 15 nm AuNPs, 
formulated into the diet of Drosophila flies, are known to cause genotoxic and mutagenic effects in the 
fruit flies, accompanied by impaired fecundity, fertility and morphological defects on the wings and eyes 
(Vecchio et al., 2012). 
Smaller size AuNPs were reported to have a better biodistribution, leading to a greater amount of 
accumulation in various organs (Zhang et al., 2010; Glazer et al., 2011). For example, a size distribution 
study in mice after IV injection, revealed a wide-spread organ distribution for 15 nm AuNPs as compared 
to 200 nm AuNPs. Furthermore, 15 nm and 20 nm AuNPs were found to translocate to the brain, 
indicating the ability of these AuNPs to pass through blood brain barrier (BBB). Besides, the highest 
accumulation of Au after IV injection was observed to be predominantly in the liver and spleen 
(Sonavane et al., 2008; Wojnicki et al., 2013), accompanied by gene expression changes 
(Balasubramanian et al., 2010a). Other than distribution in various organs, a study has investigated size-
dependent passage of AuNPs across different types of barriers from the respiratory tract to the blood. 
Intratracheal instillation of 1.4 nm radiolabelled AuNPs in rats demonstrated increased translocation of 
AuNPs to secondary targets, in comparison with 18 nm AuNPs where a majority of AuNPs (99.8%) were 
retained within the lung. This finding indicates that smaller size of AuNPs are not only able to pass 
through BBB effectively, but also able to penetrate the air-blood barrier of the lungs (Semmler-Behnke et 
al., 2008). Overall, AuNPs are able to translocate from the primary site and smaller sizes result in wider 
organ distribution, with liver and spleen as preferential sites. 
Surface modification of AuNPs study using 13 nm PEG-coated AuNPs have a longer half life, 
resulting in greater retention in blood after single IV injection in mice, concomitant with the induction of 
acute inflammation and apoptosis in liver (Cho et al., 2009), which is similar to that reported by Hwang et 
al (2012). In addition, inflammation in the liver, influx of neutrophils and increased expression of 
cytokines and cell adhesion molecules were also observed Another study showed that 10 nm naked 
AuNPs induced  oxidative damage such as lipid peroxidation in rat liver tissues (Khan et al., 2012). 





induction of pro-inflammatory cytokines in liver and kidney (Khan et al., 2013). However, conjugation of 
immunogenic peptides onto the surface of the AuNPs reduced their toxicity (Chen et al., 2009). The 
propensity of AuNPs to trigger inflammation is worthy of consideration for further investigations. 
Other than physicochemical properties of AuNPs, different routes of exposure have been reported 
to possess varying degrees of toxicity to the animal studied. In a study tracing administration routes of 
AuNPs in mice, Zhang et al found that tail vein injection was less toxic than the oral and intraperitoneal 
injection (Zhang et al., 2010). While exposure routes has been shown to pose effects when interpreting 
toxicity results, the experimental model used and the consequent bioavailability of AuNPs are dependent 
on the exposure route too. For example, pulmonary toxicity study using IV injection as the route of 
exposure, resulted in accumulation of <0.7% of Au in the lung. On the other hand, instillation of AuNPs 
resulted in accumulation of >91% of Au in the lung (Semmler-Behnke et al., 2008). These findings 
suggest that tissue distribution of Au is dependent on exposure routes, highlighting the importance of 
choosing an appropriate route of exposure for toxicity studies in a specific target organ. 
Besides physicochemical properties and exposure routes of AuNPs, the treatment dose remains 
one of the major factors which has lead to vast ambiguity in toxicity findings related to AuNPs. For 
example, 8 mg/kg of Au injected intraperitoneally (IP) into mice caused toxicity in one study (Chen et al., 
2009) while 400 µg/kg of Au did not cause toxicity in another study (Lasagna-Reeves et al., 2010). 
Administration of a physiologically relevant dose for both in vitro and in vivo studies has been 
challenging. There has been a lack of consensus on the dose metrics especially for in vitro studies (Joris et 
al., 2013). Relatively high doses applied in in vitro studies have raised questions on the relevance of the 
findings in the in vivo environment (Oberdorster et al., 2005). It has been advocated that the dose 
administered should be comparable in the different settings (Johnston et al., 2010a), especially for 





1.5 Epigenetics and nanotoxicology 
The prefix “Epi” means “above” (in Greek) and hence epigenetic refer to the changes in gene expression 
pattern and phenotypes, which is often reversible and heritable, without a change in the primary gene 
sequence (Goldberg et al., 2007; Lopez-Otin et al., 2013). There are three main mechanisms involved in 
regulating such changes, namely microRNA (miRNA), DNA methylation and posttranslational 
modification of histone tails. Epigenetic studies on NP-related toxicity have been under-explored; but 
some NPs have already been reported to impose epigenetic effects associated with health risks (Table 1.1). 
As such, epigenetic factors should be included as they may in part, hold the key in the understanding the 
toxicity of engineered NMs. 
Table 1.1: Epigenetic studies of NPs. 




Mouse AuNPs miR-183 and Let-7a alteration and AuNP-
induced transplacental clastogenic effects 
(Balansky et al., 
2013) 
Rat AuNPs miRNA expression dysregulation in blood 
serum; potential use of miRNA as biomarker 
(Chew et al., 
2012) 
Jurkat cells AgNPs and Ag 
ions 
Epigenetic-regulated differential cell 
sensitivity towards AgNPs and Ag ions 
(Eom et al., 2014) 
Mouse TiO2NPs Regulation of inflammation and acute phase 
response genes by miRNAs 
(Halappanavar et 
al., 2011) 
NIH/3T3 Fe2O3 NPs, 
CdTe QDs and 
MW-CNTs 
Sequencing-based total miRNA profiling 
pattern revealed alteration of miRNAs induced 
by these ENMs 
(Li et al., 2011b; 
Li et al., 2011c) 
DNA methylation 
MCF-7 cells QD Decrease in DNA methylation (Choi et al., 
2008) 
HaCaT cells SiO2 Global genomic DNA hypomethylation (Gong et al., 
2010) 
HaCaT SiO2 Hypermethylation of PARP-1 (Gong et al., 
2012) 
Histone modification 
Ex vivo AuNPs AuNPs bind strongly to histone deacetylase 8, 
exhibit inhibitory effects 
(Sule et al., 2008) 
HeLa cells AuNPs NPs act as epigenetic agents (Mazumder and 
Shivashankar, 
2007) 








miRNAs, which belong to the family of small, non-coding RNA, mediate gene silencing at either 
transcription or translational level (Bhattacharyya et al., 2011), based on the degree of seed region (6-8 
mers) complementarity between the miRNA and its putative targets. mRNA of the target gene will be 
degraded, resulting in gene transcription suppression if there is high complementarity. On the other hand, 
translational repression or inhibition on protein translation will occur in the case of partial 
complementarity (Eulalio et al., 2008; Bartel, 2009). miRNAs are ubiquitously expressed and each 
miRNA may have multiple mRNA targets and vice versa (Miranda et al., 2006). 
There are a few reports on the involvement of miRNAs in relation to AuNP-induced effects. 
Maternal exposure to AuNPs is reported to induce alteration of miRNA expressions (miR-183 and Let-7a) 
in the lung and liver of the fetus that was not directly exposed to AuNPs (Balansky et al., 2013). This is 
also the first report thus far, reporting on the transplacental clastogenic effects of AuNPs in mouse fetus, 
together with miRNA regulation. Furthermore, miRNA expression changes in rat blood has been 
investigated and it was observed that there were 23 dysregulated miRNAs and 45 dysregulated miRNAs 
in rat exposed to AuNPs following IV injection after 1 week and 2 months respectively (Chew et al., 
2012). Although the targets and functions of the dysregulated miRNAs in both studies remain unknown, 
understanding the interplay between miRNA and NPs will definitely aid in bridging gaps that exist in NP-
related toxicity studies. 
Other than AuNPs, a recent study compared the difference in miRNA expression in Jurkat cells 
after treatment with AgNPs and Ag ions. A correlation analysis between mRNA and miRNA expression 
revealed involvement of epigenetic mechanism in regulating the cell sensitivity towards AgNPs and Ag 
ions (Eom et al., 2014). A mouse model study to examine the epigenetic effects was performed by 
Halappanavar et al (2011) using titanium dioxide NPs (TiO2NPs). 53 genes associated with inflammation 
and acute phase response were found to be dysregulated in mouse lung exposed to TiO2NPs. As there was 
no correlation between the transcriptomic and protein expression level, the investigators ruled out the 





Sequencing-based miRNAs expression profiling was performed in NIH/3T3 cells using three 
different types of ENMs including iron oxide NPs, cadmium telluride quantum dots (CdTeQDs) and 
multi-walled carbon nanotubes (MWCNTs). A high-throughput deep sequencing method (SOLiD 
sequencing) was employed to detect low coverage miRNAs and revealed dsyregulation of miRNAs post 
ENM exposure. Among the dysregulated miRNAs, those which are co-regulated have been identified to 
exert similar cytotoxic effects common among ENMs (Li et al., 2011b). A previous study by the same 
group of researchers analyzed the global miRNA expression pattern using the same sequencing method 
using CdTeQD treated cells and observed an association between apoptosis-like death and miRNA 
expression pattern (Li et al., 2011b). 
 
(B) DNA methylation 
CpG islands are located at the promoter region of a gene and are normally unmethylated (Deaton and Bird, 
2011). The cytosine residue on CpG islands is subjected to modification such as the addition of methyl 
group catalyzed by DNA methyltransferase to its fifth position, forming 5’methylated cytosine. Excessive 
methylation of cytosines and their interactions with methyl-CpG binding proteins will impede the access 
of the transcription initiator, resulting in alteration of gene expression (Edwards and Ferguson-Smith, 
2007). Hypermethylation at the promoter region of a gene will lead to gene silencing and vice versa, but 
with few exceptions (Yao et al., 2013). DNA methylation occurs not only at the promoter regions, as 
intragenic regions are also subjected to methylation (Ball et al., 2009). 
The first report on the DNA methylation study after NP treatment was initiated by Choi et al 
(2008) using QDs in MCF7 breast cancer cells. There was a decreased in DNA methylation post NP 
treatment, which is in concordance with the gene expression changes observed. Moreover, global 
genomic DNA hypomethylation in silicon dioxide (SiO2) NP-treated human HaCaT cells was observed, 
implying epigenomic response induced by NPs occurred through DNA methyltransferase (Gong et al., 





poly-ADP-ribose polymerase-1 (PARP-1), concomitant with promoter hypermethylation of PARP-1 in 
the same cell line. This inhibitory effect was abrogated after DNMT1 silencing (Gong et al., 2012). 
Although there have been no studies performed on AuNP-induced hypo- or hypermethylation, 
epigenetic changes may impose a long term effect on future gene expression profiles and in the case of 
persistent changes through cell division, the effect would be heritable (Yao et al., 2013). 
 
(C) Histone modification 
Chromatin packs the DNA which is wrapped around histone proteins, enabling tight packaging of the 
whole human genome content into the nucleus of the cell. Histone proteins are subjected to post-
translational modification through enzymatic reaction which in turn, results in gene expression regulation 
(Kouzarides, 2007). Depending on the types of modification, chromatin may present in compact structure 
(heterochromatin) or in non-condensed structure (euchromatin). 
There are only a few reports with regard to NPs and histone modification. As AuNP binds 
strongly to the thiol group present on histone deacetylase 8 (HDAC 8), a study has shown that the 
catalytic function of this enzyme is impaired. This enzymatic inhibitory effect is almost as potent as the 
use of Trichostatin A (TSA), an inhibitor for HDAC (Sule et al., 2008). A similar finding has shown the 
possibility of NPs as epigenetic agents due to their ability to modulate heterochromatin assembly 
(Mazumder and Shivashankar, 2007). In a similar study by Choi et al (2008), QD treatment was found to 
result in dose-dependent global hypoacetylation of histone 3 in MCF-7 cells, and this effect was 
reversible by the use of an inhibitor. This finding suggests the involvement of histone modifying enzymes 
in QD-induced histone modification and regulating cell death. Although these studies have explored the 
effects of NP exposure on histone acetylation and deacetylation status, other types of histone post-







Figure 1.3 summarizes the possible epigenetic pathways of NP-induced toxicity based on information 
available in the literature. 
 
 






1.6 Scope of study 
Advances in nanotechnology have given rise to a rapid development of many novel applications in the 
biomedical field. Hence, studies into the risks and health safety of these nanomaterials are essential. The 
findings gleaned from this study will provide a better insight into molecular mechanisms underlying gold 
nanotoxicity induced by AuNPs. Biodistribution studies have identified the lung as one of the target sites 
of accumulation for AuNPs, necessitating further studies into nanotoxicological effects in the lung. 
The hypothesis of this study is that AuNPs exert cytotoxic, genotoxic and epigenetic effects in lung 
cells in vitro and in vivo. 
The objectives of this study are: 
1) Investigating the intracellular localization of AuNPs in lung cells and morphological effects using 
various microscopic methods so as to determine the route of uptake. 
2) Determining the in vitro effects of AuNPs on the cytotoxicity and genotoxicity of lung cells. 
3) Performing genomic, proteomic and epigenetic analysis in AuNP-treated lung cells. 
4) Analyzing study cell-cell interaction post AuNP exposure using a co-culture system. 
5) Evaluating toxicity associated with AuNP exposure in male Wistar-Kyoto rats via IV injection in vivo. 
 
A flow chart of the experiments performed as related to the specific objectives in this study is illustrated 
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2 MATERIALS AND METHODS 
2.1 AuNP synthesis 
AuNPs (20 nm, 2 nM in concentration) used in this study were synthesized in colloidal 
form by citrate reduction of gold salts from Au
+3
 (HAuCl4) to Au
0
 following the 
Turkevich method as previously described (Li et al., 2010a). Briefly, 95 ml of 
tetrachloroauric acid (HAuCl4) solution consisting of 5 mg of Au was boiled and stirred 
vigorously, with addition of 5 ml of 1% sodium citrate solution for reduction of Au ions 
to take place. Stirring was continued till a wine red colored solution was formed. The 
AuNP solution was then concentrated via centrifugation following the published protocol 
of Balasubramanian et al (2010b), before functionalization with fetal bovine serum (FBS) 
in a water bath at 37°C. After FBS adsorption for 5 h, AuNPs were washed with 
phosphate buffer saline (PBS) and finally reconstituted to 10 nM NP solution. The AuNP 
colloidal solution was then filtered with a 0.2 µm filter before using for experimentation. 
 
2.2 Characterization of AuNPs 
Transmission electron microscopy (TEM) was performed using the CM120 BioTWIN 
transmission electron microscope. The NanoDrop ND-1000 UV-Vis Spectrophotometer 
(NanoDrop Technologies
 
Inc., USA) was used to analyze the absorption spectrum of 
AuNPs. In addition, dynamic light scattering (DLS) and zeta potential (Zetasizer Nano 
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2.3 In vitro AuNP experimentation 
2.3.1 Cell culture 
SAEC cells, a human small airway epithelial cell line (CC-2547S), purchased from Lonza 
were grown in SAGM supplemented with BulletKit (CC-3119). Human MRC5 fetal lung 
fibroblasts (ATCC® CCL-171™), were cultured in Roswell Park Memorial Institute 
(RPMI 1640). The medium was supplemented with 10% heat-inactivated FBS together 
with 100 μg/ml streptomycin and 100 units/ml penicillin. The cells were maintained in a 
cell culture incubator (THERMO Electron Corporation, MA) with humidified atmosphere 
of 37
o
C and 5% CO2:95% O2, before passaging. The morphology of cells was examined 
with a Nikon Eclipse TS100 microscope (Nikon Corporation, Japan) attached with a 
Digital Sight DS-U1 camera. The setup is also equipped with the ACT-2U imaging 
software version 1.60. 
 
2.3.2 AuNP treatment in vitro 
As-synthesized AuNPs were used to prepare a range of concentrations (0, 0.1, 0.25, 0.5, 1 
and 2 nM) from 10 nM of AuNP stock solution, for treating the cells for 24 h, 48 h and 
72 h. 
 
2.3.3 Automegallography (AMG) 
50 µl GoldEnhance™ from the silver enhancement kit (Cytodiagnostics, Canada) 
sufficient to cover the specimens, were applied at 24 h post exposure to AuNPs in SAECs 
and MRC5 fibroblasts, and allowed to develop for 10 min. The reaction was then stopped 
by rinsing with deionized water. After which, micrographs of cells showing deposition of 
silver ions on Au under light microscopy were taken. 
 
 
Materials and Methods 
25 
 
2.3.4 TEM and Energy Dispersive X-ray (EDX) microanalysis 
SAECs and MRC5 fibroblasts were treated with 1 nM AuNPs for 72 h and cultured in 
LabTeck culture chambers. AuNPs exposed cells were fixed in 2.5% glutaraldehyde (GA) 
for 1 h before rinsing 3 times with PBS at the time interval of 5 min each. Samples were 
osmified with 1 % osmium tetroxide (OsO4) and bits of potassium ferrocyanide (KFeCN) 
(Agar Scientific Ltd, UK) at room temperature for 1 h. Following which, samples were 
dehydrated by immersing in a graded series of ethanol for 10 min each and embedded in 
epoxy resin (polymerization at 60 °C overnight) (Ted Pella Inc, USA).  This was 
followed by slicing of ultrathin sections, which were subsequently mounted on formvar-
coated copper (Cu) grids. Sections were then doubly stained with uranyl acetate (BDH, 
UK) and lead citrate (BDH, UK). Digital micrographs were obtained using a Gatan 792 
Bioscan 1k×1k Wide Angle Multiscan CCD camera attached to the Philips EM280S 
transmission electron microscope. Determination of the elemental composition in the 
sample was achieved by elemental analysis using the CM120 BioTWIN electron 
microscope coupled with a Philips EDAX Microanalysis system. 
 
2.3.5 Inductively coupled plasma mass spectrometry (ICPMS) 
Nitric acid (HNO3) and hydrochloric acid (HCl) purchased (Merck, Germany) for ICPMS 
were of analytical grade. Cells pre-treated with AuNPs were harvested by using trypsin. 
Aqua regia solution was prepared by mixing one part of HNO3 to three parts of HCI for 
dissolving Au. Aqua regia was added into each specimen and acid digestion of cells was 
performed overnight. 
Specimens were diluted at a concentration of 1 aqua regia: 9 ultrapure (UP) water. 
The calibration standard solution of Au and Platinum (Pt) (as internal standard) were 
prepared from single element stock solutions and diluted to the desired range of 
concentrations. UP water was used as the diluent. The quantification and calculation was 
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performed by using external calibration with internal standard correction. All 
measurements were carried out with the ICPMS Agilent 7500 instrument (Perkin Elmer, 
USA). 
 
2.3.6 Focused ion beam-scanning electron microscopy (FIB-SEM), nanotomography, 
elemental analysis and mapping 
Polymerized resin blocks were trimmed and polished with a glass knife to expose the 
SAECs on the block surface. The block was then mounted on aluminum SEM specimen 
stub with silver adhesive paint, leaving the block face exposed to enhance electrical 
conductivity during the milling and imaging process. A Zeiss Auriga 60, CrossBeam 
instrument (Carl Zeiss Microscopy, Germany) equipped with a Cobra-focused gallium 
ion beam column and Gemini electron column with a Schottky field emission gun was 
employed for all the milling and imaging work in this study. For milling and imaging, the 
sample was tilted to 54
o
 angle and positioned at 5 mm working distance such that the 
sample surface was aligned perpendicular to the intersection point (defined as the 
meeting point of the electron beam and ion beam). 
To acquire the 3D stacks in an automated process alternating between milling 
and imaging, the ion beam was set at 30 kV and 600 pA current to remove a slice 
thickness (z-axis) of 8 nm each time. The milling volume was set at x = 30 µm, y = 30 
µm and z = 5 µm. Backscattered electron (BSE) imaging was performed using electron 
beam at an acceleration voltage of 2 kV with a 1.2 nA probe current. The backscattered 
electrons signal was collected by an in-column Energy-selective Backscattered detector. 
The imaging frame was set at a field-of-view of x = 25 µm by y = 10 µm and store 
resolution of 3840 resulted in image pixel size of 8 nm. All post-processing of the data 
set was done using the ImageJ software (National Institutes of Health, NIH). First, 
alignment of the image stack was performed using the StackReg Plugin. Milling 
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consistency was then assessed via continuous playback of the images. The 3D stack was 
reconstructed with the 3D Viewer Plugin. 
For elemental analysis, the ultrathin sections were further analyzed in a Zeiss 
Libra 120, Energy Filter TEM system. Elemental distributed mapping was calculated 
using Energy Spectroscopic Imaging (ESI) with three window power law method. The 
recorded images were taken with a slow scan CCD camera and processed with iTEM 
software (OSIS, Germany). 
 
2.3.7 Lipid hydroperoxide (LPO) assay 
AuNP-treated and untreated SAECs and MRC5 fibroblasts were trypsinized and 
centrifuged at 1,000 rpm for 5 min. A positive control sample was prepared by treating 
the cells with 50 µM H2O2 for 1 h. 600 μl of UP water was added to the pellet and 
sonicated on ice at 50 amplitude for 40 s, with manual pulsing every 10 s using 
VibracellTM ultrasonic processor (Sonics & Material, USA). Lipid hydroperoxides were 
extracted in chloroform and quantified using the Lipid Hydroperoxide Assay Kit 
(Cayman Chemical Company, USA) following the manufacturer’s instructions. After 
addition of the chromogen for color development, the samples were aliquoted into 96 
well glass plates and absorbance readings were taken at 500 nm with spectrophotometer. 
 
2.3.8 Lactate dehydrogenase (LDH) assay 
The Roche Cytotoxicity Detection Kit was used to quantify AuNP-mediated cytotoxicity 
by measuring the amount of LDH released from the cytosol of damaged cells. Briefly, 
cells were seeded into a 96 well plate for 24 h. Subsequently, the medium was aspirated 
and replaced with 200 μl of medium containing 0, 0.1, 0.25, 0.5, 1 and 2 nM of AuNPs 
into each well. After 24 h, 48 h and 72 h incubation, 100 µl of supernatant was decanted, 
spun down to remove AuNPs and transferred to a new plate. 100 µl of reaction mixture 
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(consisting of a catalyst and dye solution) was then added. Following 30 min of 
incubation at room temperature, the LDH activity in the supernatant was quantified using 
a SpectraMax M5 MicroPlate reader at 490 nm wavelength. Controls which test for 
AuNP interference were included. 
 
2.3.9 Trypan blue dye exclusion assay for cell viability 
SAECs and MRC5 fibroblasts were cultured in 6 well plate and subjected to AuNP 
treatment for 24 h, 48 h and 72 h at different concentrations. After each time point, cells 
were harvested and spun down before resuspending with fresh medium. 50 µl of 
trypsinized cell suspension was added into 50 µl of 0.4% Trypan blue stain (1:1 dilution) 
(Sigma, USA) and mixed well. 10 µl of stained cell suspension was filled to a 
hemocytometer for cell counting either manually or by using an automated cell counter. 
For the manual method, the number of non-viable cells that were stained blue and viable 
cells that excluded the dye, was scored separately under a light microscope. 
 
2.3.10 Acridine orange and ethidium bromide (AO/EtBr) staining 
1 mg/ml acridine orange and ethidium bromide were constituted from the powder form 
with PBS. For discrimination of live from dead cells, acridine orange fluoresces as green 
color, indicating live viable cells; ethidium bromide fluoresces as orange color when 
intercalated with DNA, representing dead cells. The medium was first removed from 
AuNP-treated cells. Stock solution was further diluted 100x with PBS to working 
concentration before adding into cells. Diluted dyes were added for 1 min at room 
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2.3.11 Flow Cytometry (FCM) for cell cycle analysis 
Cells were plated onto 6 well culture plates and AuNP treatment was performed for 48 h 
and 72 h. After each time point, both adherent and floating cells were pooled into a 15 ml 
centrifuge tube and then pelleted by centrifugation at 1800 rpm for 5 min. Cell pellets 
were washed twice with PBS and then fixed in 70% ethanol (and chilled to -20°C ) 
overnight. A hypotonic cocktail consisting of 8 ml PBS + 2 ml RNase A + 10 µl TX + 
200 µl Propidium Iodide (PI) was prepared. After washing twice with PBS, 1 ml of the 
cocktail was added to the samples. DNA content of cells was counterstained with 1 
mg/ml PI (Sigma-Aldrich, USA). 1x 10
4
 events for each sample were analyzed and 





2.3.12 Alkaline single-cell gel electrophoresis (Comet assay) 
The SAECs were first embedded in 0.8% low melting point agarose (IBI Scientific, USA) 
on specially prepared comet slides (Trevigen, USA) and lysed in cold lysis solution 
(comprising 2.5 M NaCl, 0.1 M EDTA, 10 mM Tris base, at pH 10) containing 1% 
Triton X (Trevigen) for 1 h at 4°C. SAECs were denatured in alkaline electrophoresis 
buffer (0.3 M NaCl, 1 mM EDTA) in the absence of light, at room temperature for 40 
min. Subsequently, electrophoresis was performed at 25 V and 300 mA for 20 min. 
Alkaline condition was removed by using neutralization buffer (0.5 M Tris-HCl, pH 7.5) 
for 15 min. Dehydration was achieved using 70% ethanol. Subsequently, the slides were 
dehydrated before stained with SYBR green dye. The tail moments of the SAECs nuclei 
were scored as an indication of DNA damage. 100 comets were analyzed per 
concentration and this was done by using comet imager v1.2 software (Metasystems 
GmbH). 
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2.3.13 RNA extraction, reverse transcription (RT) and quantitative real-time RT-
PCR (qRT-PCR) 
The RNeasy Mini Kit (QIAGEN, Germany) was used to isolate total RNA. The RNA 
quality was anlayzed using the NanoDrop® ND-1000 Spectrophotometer at absorbance 
reading of 260 nm and 280 nm wavelengths. Cultured monolayer of SAECs and MRC5 
fibroblasts were lysed, followed by addition of an equal volume of 70% ethanol. Samples 
were then transferred into an RNeasy MinElute Spin Column and centrifuged for 15 s at 
13200 rpm. Samples were subjected to washing steps using RWI and RPE salt buffer, 
spun dry to remove excessive ethanol, followed by elution with RNase-free water. 
For cDNA conversion, Super ScriptTM III First-Strand Synthesis System for RT-
PCR kit (Invitrogen, USA) was used for RT according to manufacturer’s instructions. 
The volume needed to reverse-transcribe RNA is shown below: 
n μl of total RNA 
1 μl of 50 ng / μl random hexamer 
1 μl of 10 mM dNTP mix 
n μl of DEPC-treated water (make up to total volume of 10 μl) 
Firstly, samples were incubated in the PCR machine at 65ºC, 5 min, and then 
chilled on ice for ≥1 min. For 1 reaction, cDNA Synthesis Mix were prepared by addition 
of the following reagents in the following order as per instruction: 
2 μl 10x RT buffer 
4 μl 25 mM MgCI2 
2 μl 0.1 M DTT 
1 μl RNAseOUT 
1 μl SuperScript III 
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Samples were further incubated in the thermocycler following the thermal profile 
as indicated: 25°C for 10 min, 50°C for 50 min and 85°C for 5 min. Storage was at -20°C 
for later use. 
The primer sequences for MT isoforms, cell cycle related genes, DNA repair, 
antioxidant genes used in this study are listed in Table 2.1. Mixture consisting of diluted 
cDNA, SYBR Green PCR Master Mix (Applied Biosystems, Foster City, California, 
United States) and primer for each gene were run by a 7900HT Fast Real-Time PCR 
machine (Applied Biosystems, USA) following the thermal profile settings: 95°C, 20 s; 
95°C, 1 s followed by 60°C, 20 s for 40 cycles. The Ct values were normalized to an 
endogenous housekeeping gene (GAPDH) where ΔCt= Cttarget- CtGAPDH. The average 
values of the Δ Ct of the samples were then used to calculate the ΔΔCt value (ΔΔCt= 
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Table 2.1: List of primers’ sequences used for qRT-PCR. 
Gene Symbol Forward Reverse 
SLC38A5 GTTGGGTGGCAAGGAGTTTA GCTTGGATTACACGGCATTT 
ZC3HAV1 GGCAGCACTTACCTTGCTTC TCTGGTGGTCACAGCTTCAG 
VEGFC TACAGACGGCCATGTACGAA TTTGTTAGCATGGACCCACA 
ITGA2 CAAGTGGGATTCAGTGCAGA GAGCACCAGCAACAAAGTGA 
RELN ATGTGGTAAAGGCGTTCCTG AACCCAGGGGCTGTAGAAGT 
ATP10A AAGCTGGAGAGGCAGATGAA GCTGTGACTGGGGATAAGGA 
ADAR GTCAACTGGTGTCTGGCTGA TAGTCACGGGCAGCTTTCTT 




PROS1 CCTAGTGCTTCCCGTCTCAG TTTCCGGGTCATTTTCAAAG 
C5orf21 CGCTCACATTAAGGCTGACA GATTAAGGAGGGGGAAGCAG 
FAP CTTGTCCTGGCTTCAGCTTC AGGTGGCAACTCCAAATACG 
IDI1 CAGTCAGCCACTGCTTTTGA GGGTTTTATCCAGCCCAAAT 
ZMAT3 GGCAGAGAATTCCACGTGAT CCTGTACCGCTGTTCAGACA 




RFTN2 CGGGGCTATTCATCCTGTTA TTCTTTTGCTGCGTCATTTG 
FYB TTCCCTAAGGCCCCTTCTAA TAAGACGTCTGGCCTTTGCT 
AKR1C2 GGTCACTTCATGCCTGTCCT ACTCTGGTCGATGGGAATTG 
KYNU CAAGAGAGGGGGAAGAAACC TAACAACCCTTCGCTTGTCC 
SAA1 TGGTTTTCTGCTCCTTGGTC CCCGAGCATGGAAGTATTTG 
NQO1 TTACTATGGGATGGGGTCCA CCACAAGAGGGCAGTGTTTT 
TXNRD1 AATTTGCCCCTGTGTGCTAC TCAGCTTGCTTAGACCAGCA 
AKR1C3 GATTTGGCACCTATGCACCT CACACTGCCATCTGCAATCT 
FTH1 GCTAAGCCTCGGGCTAATTT CGGCACTTAAGGAATCTGGA 
PTGR1 CCTGCTTGAAGCTTTGTTCC AGAAATGGAGTGCGTTGTCC 
CYP24A1 CCCTGCCTACCACATTCACT TTCATGGGAGGCCTGATAAC 
UIMC1 TGATGGAGAGGAACCAAAGG GGTAGCGGAAGCATCAGAAG 
PNLIPRP3 GGGAGTTTGCCATTGTCAGT AGCATGGTTTCAGGTTCTGG 
DSC2 CGTCCTGTAGATCGTGAGCA TCGTGTCAGGCTCATCTTTG 
NTN4 GGCCTGGAAGATGATGTTGT TTGAGGCTCTTCGTTCAGGT 
NRIP1 GCACTGTGGTCAGACTGCAT GTGTTCACAAGGGCTTGGTT 
SH3KBP1 CGGAAGAGGCTGTCTGATTC AGGGCATATCCTTGCTCCTT 
TLR2 GGGTTGAAGCACTGGACAAT TCCTGTTGTTGGACAGGTCA 
TLK1 CTGTGATCTCAGACGGCAAA TGAAGCGCCATGTCTAACTG 
CDK1|CDC2 CCATGGGGATTCAGAAATTG CCATTTTGCCAGAAATTCGT 
SERPINE1 CAACTTGCTTGGGAAAGGAG GGGCGTGGTGAACTCAGTAT 
CAT GCCTGGGACCCAATTATCTT GAATCTCCGCACTTCTCCAG 
GPX1 GGACTACACCCAGATGAACGA A  GCACTTCTCGAAGAGCATGAA 
GPX2 CAAGCGCCTCCTTAAAGTTG  GAGGGTTGGGAGAGGAAAAG 





SOD1 GAAGGTGTGGGGAAGCATTA  ACATTGCCCAAGTCTCCAAC 




SOD2 TCCACTGCAAGGAACAACAG  TCTTGCTGGGATCATTAGGG 
SOD3 TCTCTTGGAGCTGGAAAG CGTACATGTCTCGGATCCACT  
APEX2 AATCAGGAACCCAGCAACTG CACTGGGGTAGCATTGTCCT 
ATM GGACAGTGGAGGCACAAAAT GTGTCGAAGACAGCTGGTGA 
ATRX ATACTCCCATGCTGCCAAAG GCTTCATACTCAGCCCAAGC 
BTG2 CCTGGGCAGAGAGTGAAAAG CCTTCCATCCTAACCCCAAT 
ERCC2 GCTGGACATCTACCCCAAGA CCGGATCACAGCAATATCCT 
LIG1 ACAAATATGACGGGCAGAGG ACTTGGAATGGCTGGATCTG 
RPA1 CCGACTCAGGACTGCAATAAG CAGCAGACTCCTGGAAACAAG 
XPA GCGAAGAATGTGGGAAAGAA CCCATTGTGAATGATGTGGA 
XPC GACAAGCAGGAGAAGGCAAC GGTTCGGAATCCTCATCAGA 
XRCC1 GATTCTGGGGACACAGAGGA AGGGAACTCCCCGTAAAGAA 
MT-1A CTCGAAATGGACCCCAACT ATATCTTCGAGCAGGGCTGTC 
MT-1B GCTTGTCTTGGCTCCACA AGCAAACCGGTCAGGTAGTTA 
MT-1E GCTTGTTCGTCTCACTGGTG CAGGTTGTGCAGGTTGTTCTA 
MT-1F AGTCTCTCCTCGGCTTGC ACATCTGGGAGAAAGGTTGTC- 
MT-1G CTT CTC GCTTGGGAACTCTA AGGGGTCAAGATTGTAGCAAA 
MT-1H CCT CTTCTCTTCTCGCTTGG GCAAATGAGTCGGAGTTGTAG 





MT-3 CCGTTCACCGCCTCCAG CACCAGCCACACTTCACCACA 
MT-4 CATGGACCCCAGGGAATGTGT GGGGTGGGAACGATGGA 
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2.3.14 Global gene array and data analysis 
Transcriptomic analysis using the Affymetrix Human Gene 1.0 ST Array comprising 
764,885 gene probes, was carried out to compare global gene expression patterns of the 
MRC5 lung fibroblasts and SAECs treated with or without AuNPs. RNA was extracted 
following the method mentioned above. RNA samples were sent to Origen Laboratories 
Pte Ltd (Singapore) for further analysis (comprising labeling, hybridization, scanning and 
data analysis. 
Data was analyzed with GeneSpring software GX v11.5. The fold change of each 
gene that was ≥ 1.5 fold and with p value < 0.05 was selected. These genes were 
hierarchically clustered based on either up-regulation or down-regulation. 
 
2.3.15 Validation of microarray results and Database for Annotation, Visualization 
and Integrated Discovery (DAVID) 
The differentially expressed genes were clustered according to their functional groups 
using data clustering, annotation and functional characterization of genes available from 
DAVID version 6.7, Functional Annotation Bioinformatics Microarray Analysis. 
 
2.3.16 Total RNA isolation and qRT-PCR (for miRNAs) 
Total RNA was isolated from SAECs and MRC5 fibroblasts using the mirVana™ 
miRNA Isolation Kit (Ambion, Austin, TX). Quantity and purity of extracted RNA were 




Mature hsa-miR-155, hsa-miR-125b, hsa-miR-146a and endogenous controls, U6 
snRNA and SNORD68 were quantified using TaqMan® (Applied Biosystems) or 
miScript (Qiagen) microRNA assay kits specific for each miRNA. RT was performed 
using the settings of: 16°C, 30 min; 42°C, 30 min; 85°C, 5 min,
 
before holding at 4°C. 
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The expression of mature miR-155 relative to internal control, U6 snRNA was 
determined using SYBR green qRT-PCR assay. For qPCR, the setting was 95°C,
 
1 min; 
95°C, 15 sec followed by 60°C, 30 sec
 
and cycled 40 times using 7900HT Fast Real Time 
PCR System equipped with sequence detection system software (Sequence Detection 
System, version 2.1; Applied Biosystems). 
For miScript system, miScript II RT kit was used for RT. The volume needed to 
reverse transcribe miRNAs is shown below: 
4 µl miScript HiSpec buffer 
2 µl 10x miScript Nucleics Mix 
n µ l RNase-free water 
2 µl miScript RT mix 
n µl template RNA 
Total volume: 20 µl 
Samples were incubated at 37
o
C for 60 min followed by 95
o
C for 5 min. For 
quantitative PCR, the setting was 95
o
C, 15 min; 94
o
C 15 sec followed by 55
o
C, 30 sec 
and 70 
o
C, 30 sec and cycled 40 times. 
miRNA expression was expressed as fold change and was calculated the same 
method as mentioned in section 2.3.13. 
 
2.3.17 Proteome profiling by multiplex peptide stable isotope dimethyl labeling and 
mass spectrometry 
This experiment was performed based on a protocol described earlier (Boersema et al., 
2009). Briefly, AuNP-treated and untreated SAEC protein lysates were subjected to 
trypsin digestion, let dry, followed by isotopomeric dimethyl labeling. Labeling reaction 
was halted by adding 1% ammonia solution followed by formic acid. Differentially 
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labeled samples were loaded and analyzed by nanoLC Orbitrap-MS (Thermo Scientific). 
MS data were analyzed using MaxQuant software. 
 
2.3.18 Western Blot 
Protein from cells was extracted using MPER lysis buffer. Protein lysate was collected 
and denatured with loading dye at 95°C. The protein sample was separated by 
electrophoresis (SDS-PAGE) using 10% sodium dodecyl sulfate–polyacrylamide gel. 
Subsequently, proteins were transferred onto a PVDF membrane (Bio-Rad). Blocking 
was carried out with 5% milk for an hour. 
Primary antibodies used were: PROS1 (Abcam, USA); SAA1, TLR2 and beta-
actin (Bio-Rad, USA) (as internal loading control). Following overnight incubation of the 
primary at 4°C, the secondary antibody-HRP conjugate (Amersham Biosciences, NJ) was 
then added. The bands of the proteins of interest were visualized at their respective 
protein sizes using the SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientific). Band intensity was quantified by densitometer GS-710 (Bio-Rad, USA). 
 
2.3.19 Co-immunoprecipitation (co-IP) and western blot 
The agarose beads (Roche Applied Science) were washed three times prior use. The 
protein lysate was prepared in Co-IP buffer (150 mM NaCI, 20 mM TrisCI pH 8.0, 1% 
Triton-X100, 2 mM PMSF, 1 mM sodium orthovanadate, 5 mM sodium fluoride). Next, 
the protein was incubated with anti-SAA1, TLR2 and IgG (Santa Cruz) antibodies in 
rotating motion for 2 h at 4°C. Following that, the agarose beads were incubated together 
for 1 h and washed with Co-IP buffer to remove unbound proteins. The bound proteins 
were analyzed on western blot. 
Next, the protein complexes pulled down from co-IP were separated using 10% 
and 15% SDS-PAGE. The protein bands of interest were visualized at 12 kDa (SAA1) 
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and 90 kDa (TLR2) using SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientific). 
 
2.3.20 Transient transfection and luciferase assay using Cignal finder reporter array 
50 μl of Opti-MEM was added into each well of a Stress and toxicity Cignal Finder Array 
plate (Qiagen) and resuspended thoroughly. Mixture was left 5 min at room temperature 
before addition of 50 μl diluted Attractene transfect reagent (1:1 ratio). The diluted 
nucleic acid construct-Attractene was mixed before incubating for 20 min to allow 
complexes formation. SAECs post exposed to 1 nM AuNPs were trypsinised and final 
cell density of 1×10
4
 cells/well resuspended using Opti-MEM (Gibco) complemented 
with 10% FBS was seeded. The complexes and cells were mixed gently and incubated for 
24 h at 37°C. After 24 h transfection, medium was replaced and Dual-Glo Luciferase 
Assay (Promega) was performed according to manufacturer’s instruction. Briefly, for 
measurement of firefly luciferase activity, equal volume of Dual-Glo® Luciferase 
Reagent was added into culture medium (1:1 ratio) and firefly luminescence was measure 
after 20 min. For Renilla luciferase activity, equal volume of Dual-Glo® Stop & Glo® 
Reagent (Promega) was added before measurement was taken after 20 min. Luciferase 
activity was measured and results are expressed as fold change of activation. T-test was 
performed by comparing the normalized luciferase activities for the Nrf2/Nrf1 and NFkB 
reporter treated with AuNPs versus the normalized luciferase activity for the untreated 
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2.3.21 Trichostatin A (TSA) and 5-Azacytidine (5-Aza) treatment 
8x10
4
 of MRC5 cells were plated onto a 6 well plate. 400 nM of TSA (Sigma Aldrich, 
USA) was used to treat MRC5 cells for 48 h followed by 72 h AuNP treatment. 
For 5-Aza (Sigma Aldrich, USA) and TSA in SAECs, 5x10
4
 cells were plated. 
After 24 h, 4 µM of 5-Aza was used to treat the cells for 6 days followed by 72 h of 
AuNP treatment. 
RNA was extracted from cells following TSA or 5-Aza treatment. 
 
2.3.22 Cell Proliferation assay (MTS) 
The cytotoxicity of cellular uptake inhibitors against MRC5 fibroblasts was determined 
using the MTS assay. Briefly, MRC5 fibroblasts (seeded at 1×10
4
 cells/well) were 
incubated for 24 h in 96 well plates. 0.5 μg/mL concanavalin A, 10 μg/mL 
chlorpromazine and 25 μg/mL nystatin were separately added and incubated for 4 h. 
After 4 h, the Promega CellTiter 96® AQueous Non-Radioactive Cell Proliferation 
Assay Kit (Promega, USA) was used to quantify cell viability by measuring the amount 
of formazan formed. After removal of existing medium, 100 μl of fresh medium followed 
by 20 μl of MTS tetrazolium reagent, was added to each well. Incubation was carried out 
for 3-4 h before the reading was measured using SpectraMax M5 MicroPlate reader at 
490 nm wavelength. A control and a blank set (wells with only culture medium and no 
cells) were also prepared. The % of cell viability was calculated as shown below. 
% cell viability = (AbsTest – AbsBlank) / (AbsControl - AbsBlank) x 100% 
 
2.3.23 Hoechst 33342 staining for confocal microscopy 
After AuNP cellular uptake inhibitor treatment, cells were fixed in 4% paraformaldehyde 
(PF) at room temperature for 20 min. Cells were then washed with PBS for 3 times with 
the interval of 5 min each, stained with Hoechst 33342 stain, before being mounting  onto 
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a glass slide using Dako mounting medium (Dako Corporation, USA). Specimen was 
kept moist in the dark. The specimens were observed using the Olympus Fluoview™ 
FV1000 confocal laser scanning microscope (cLSM) equipped with Fluoview v5.0 
software to capture images of the cellular architecture. A negative control was included 
and processed similarly. 
 
2.3.24 Endocytosis inhibition and ICPMS 
Endocytosis inhibitors, concanavalin A, chlorpromazine and nystatin (Sigma Aldrich, 
USA) for endocytosis were applied to MRC5 lung fibroblasts. Inhibition of clathrin-
mediated endocytosis was performed with 0.5 μg/ml concanavalin A and 10 μg/ml 
chlorpromazine; and caveolae-dependent endocytosis inhibition with 25 μg/ml nystatin. 
All the inhibitors used were following reported concentrations reported in the literature 
(Singh et al., 2003; Morisco et al., 2008; Vercauteren et al., 2010) with treatments carried 
out for 4 h at 37°C. After which, the medium was replaced with 1 nM AuNPs and 
incubated for 24 h at 37°C. Subsequently, cells were rinsed with PBS, trypinized then 
pelleted by undergoing centrifugation for 5 min at 1,000 rpm. Acid digestion was 
performed using aqua regia on the cells collected overnight. Samples were analyzed as 
described in section 2.3.5 with the ICPMS instrument. 
 
2.3.25 Immunocytochemistry (ICC) 
AuNP-treated and untreated cells cultured on the Lab-Tek® 4-Chambered Coverglass 
were washed with PBS thrice for 5 min each. Fixation of cells was performed using 4% 
PF. The cells were again washed with PBS, followed by 0.2% Triton-X 100 in 1x PBS 
(PBS-TX) (pH 7.4) to permeabilize the cells. 0.5% hydrogen peroxide was added and 
incubated for 30 min to prevent endogenous peroxidase. This was followed by blocking 
with 5% horse serum (Vectastain® ABC Kit, Vector Laboratories, CA) for 1 h, room 
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temperature and lastly primary mouse antibody for MT (Abcam, UK), (Dako Corporation, 
USA) and incubated at 4 ºC, overnight. For the negative control, the primary antibody 
was omitted. 
Following overnight incubation, the cells were rinsed with 0.2% PBS-TX, 
followed by addition of 200 μl of biotinylated, affinity-purified secondary anti-mouse 
antibody (1:200) and incubation at room temperature for 1 h. This was followed by 
incubation for 1 h at room temperature in ABC solution (comprising Avidin DH and 
Biotinylated Horseradish Peroxidase H diluted in PBS-TX) (Vector Laboratories, CA) 
before addition of 3,3-diaminobenzidene (DAB) mixture (comprising 1 ml of 10x DAB, 
9 ml of TBS and 3.3 μl of hydrogen peroxide, H2O2) for 10 min. The cells were washed 3 
times with TBS and the coverslip at the base of the chambered coverglass was detached 
using a blade. The brown color stained cells were counterstained with Shandon’s 
Haematoxylin, and mounted onto a glass slide with Permount® (Fisher Scientific, USA). 
The air dried slides were examined under a microscope. 
 
2.3.26 FCM for protein quantification 
5x10
5
 MRC5 cells were seeded separately into a 6 well plate before exposure to 1 nM 
AuNP for 72 h. After 72 h, the used medium was aspirated out and rinsed thrice with 
PBS. Cells were permeabilized with 0.1% PBS-TX before incubation with diluted 
primary antibodies for MT (1:200) at 4 ºC, overnight. Next, Cy-3 conjugated secondary 
anti-mouse antibody (1:200) was added for 1 h at room temperature. The cells were 
washed, and finally resuspended in fresh medium. Samples were stored in the dark before 
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2.3.27 Luciferase reporter assay 
DH5α competent Escherichia coli transformation with plasmid for pMiR-Luc reporter 
gene for miR-155 (Signosis, CA) was performed to propagate the plasmid prior to the 
start of this assay. Heat shock transformation was done and the transformed DH5α cells 
were plated by streaking on Luria-Bertani (LB) plates containing 100 μg/ml Ampicillin 
and cultured overnight at 37°C. A single bacterial colony was picked and transferred to 1 
ml LB medium containing 100 μg/ml Ampicillin and shook at 37oC overnight. Plasmids 
was purified and checked on gel for specificity. 
Triplicate samples of 1.5x10
4
 cells resuspended in RPMI supplemented with 
serum without antibiotics were seeded into 24 well plate. Cells were transfected with 0.2 
µg of the reporter vector using 0.6 µl of FuGENE®6 Transfection Reagent (Roche 
Molecular Biochemicals, Germany). Reporter vector/ FuGENE®6 complexes formed 
after 30 min incubation was added into the cell culture medium (up to final volume of 
500 µl). Following this, the cells were incubated overnight, before exposure to AuNPs for 
another 48 h. Transfected cells were then lysed and the luciferase expression level was 
quantified using the Luciferase Assay System (Promega, USA). The relative renilla 
luciferase light output was normalized to parallel firefly luciferase output (relative light 
unit, RLU). 
 
2.3.28 Target genes prediction 
Given that miRNAs perform their biological function as regulator for their target protein-
coding genes, the predicted targets of miRNAs were analyzed in this study. The 
prediction was performed using the top 5 most used miRBase algorithms, including 
PicTar (http://pictar.mdc-berlin.de), miRanda (http://microrna.sanger.ac.uk), TarBase,, 
mirBase (http://www.mirbase.org/), TargetScan Release 6.2 (http://www.targetscan.org), 
and MicroCosm Targets Version 5. 
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2.3.29 Silencing of mir155 in MRC5 cells 
2.3.29.1 Sequence of miRNA inhibitor 
Anti-miR™ miRNA 155 inhibitor (Ambion, Inc.) was used to suppress the endogenous 
mir-155 expression. The sequence of the miR-155 inhibitor can be found online from 
Anti-miR™ miRNA Inhibitors and Libraries (Ambion, Inc.) The mature (capitalized 
‘miR’) miR-155 sequence was UUAAUGCUAAUCGUGAUAGGGGU which can be 
retrieved from either the miRNA Registry or the Sanger miRBase database. 
 
2.3.29.2 miR-155 knockdown 
Knockdown of miR-155 in MRC5 fibroblasts was performed using HiPerFect 
Transfection Reagent (Qiagen). Experiments (including the negative control set) were 
performed in triplicates. Transfection efficiency was pre-optimized in MRC5 cells prior 
to the start of experiment. Parameters such as density of cells, duration of exposure, 
amount of transfect reagent used (Cy-3 conjugated scrambled siRNA and anti-miR-155 
oligonucleotide) were adjusted during optimization. Transfection complexes were 
prepared as per manufacturer’s guideline. A final concentration of 20 nM anti-mir-155 
was used. After removal of existing culture medium, fresh medium together with 
transfection complexes were added to the cells before further incubation for another 24 h. 
RNA or proteins were subsequently extracted for downstream analysis. 
 
2.3.30 Methylation analysis 
2.3.30.1 Bisulfite conversion of genomic DNA 
Total genomic DNA for MRC5 fibroblasts (post-treated with 1 nM of AuNPs) was 
extracted using DNeasy Blood and Tissue Kit (Qiagen) following the instructions of the 
manufacturer. The proteinase K digestion step was included to get rid of the proteins 
before subjected to bisulfite conversion. 
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Next, bisulfite conversion of total genomic DNA of MRC5 cells was performed 
using EpiTect Bisulfite Kit (Qiagen).  This step allows the conversion of unmethylated 
cytosines residues to discriminate from methylated cytosines (U (T) –residues). Briefly, 1 
μg of DNA was treated with sodium bisulfite, denatured at high heat of 95°C for 5 min, 
followed by bisulfate conversion at 60°C. DNA samples were cleaned and eluted after 
desulphonation. 
 
2.3.30.2 DNA methylation-specific PCR analysis and qRT-PCR 
Methyl Primer Express® Software (Applied Biosystems) was used for primer design. 
Two types of bisulfite PCR primers were designed and MSP primer selection criteria 
were as outlined by Li and Dahiya (2002). Methylation-Specific PCR (MSP) was used to 
study the methylation status of CpG sites in the PROS1 using qRT-PCR. Bisulfite 
Sequencing PCR (BSP) was designed for DNA methylation analysisn by sequencing 
method by Axil Scientific/ 1
st
 BASE, Singapore. 
Amplification of PROS1 CpG islands was performed using GoTaq® Colorless 
Master Mix (Promega). Subsequently, the amplified DNA was PROS1 gene-specific, 
with RT–PCR amplicons of 280 bp when run on a 2% agarose gel. DNA bands were 
visualized under UV transilluminator (CHEMI GENIUS2 CG2/D2, USA) and the 
electrophoretic image was photographed using the GeneSnap image acquisition software 
version 6.03.01 (SynGene, UK). The product size was then determined using 100 bp 
DNA ladder (Promega) by comparison. For qRT-PCR, MSP primers were used and qRT-
PCR was preformed as described in section 2.3.13. 
 
2.3.30.3 Bisulfite sequencing of methylated PROS1 and gene cloning 
The PROS1 gene in AuNP treated and untreated samples were selected for BSP-based 
sequencing. Subcloning of PROS1 CPG island into pDrive Cloning Vector (Qiagen) was 
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performed to confirm the degree of methylation. The plasmid was transfected into 
competent cells and plated on LB agar plate. Blue-white screening and ampicillin 
selection were employed to select colony (white) before further clone expansion. Purified 
amplicon insert size was verified via PCR and agarose gel before sent for sequencing by 
Axil Scientific/ 1st BASE Pte Ltd. Sequences were aligned using BiQ Analyzer (Max-
Planck Institut fur informatik, Germany) to generate lolli-pop grid to study the degree of 
methylation. 
 
2.4 Co-culture Experiments with AuNPs 
2.4.1 SAEC-MRC5 Co-culture  
For the co-culture system, SAECs were cultured in Transwell chambers with or without 
AuNPs. After 72 h, the SAECs were then co-cultured with MRC5 lung fibroblasts and 




Figure 2.1: Schematic drawing of the SAEC-MRC5 lung fibroblast co-culture system. 
SAECs (treated with and without AuNPs) were seeded in the upper chamber of a 
Transwell polycarbonate membrane with the SILAC-labeled MRC5 lung fibroblasts 
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2.4.2 Stable isotope labeling by amino acids in cell culture (SILAC) 
Incorporation of “heavy” amino acids consisting of substituted stable isotopic nuclei 
(deuterium, 13C, 15N) into the proteome of MRC5 lung fibroblasts was performed. 
MRC5 lung fibroblasts were grown in DMEM without Lysine and Arginine amino acids, 
supplemented with either “light” or with “heavy” forms of the two amino acids isotopes 
(with13C615N2-L-lysine and 13C615N4-L-arginine). Media were then supplemented 
with 10% dialyzed FBS and 1% penicillin/streptomycin. “Light” and “heavy” MRC5 
lung fibroblasts were grown consecutively for four passages before an incorporation 
check was performed. 
The forward experimental set is defined as lung fibroblasts that were incubated 
with light isotopes of arginine and lysine (also labelled as “light” or “L” cells) and 
conversely, the reverse set was incubated with heavy isotopes of arginine and lysine 
(regarded as “heavy” or “H” cells). 
 
2.4.3 Mass spectrometry analysis 
Whole proteomes of the MRC5 lung fibroblasts were extracted after 72 h, and the “light” 
and “heavy” protein lysates were mixed in a 1:1 ratio according to the weight of the 
proteins. After 10% SDS-PAGE separation, protein bands were digested with the trypsin 
enzyme overnight at 37°C. Extraction of tryptic peptides were carried out before LC-
MS/MS analysis using the LTQ-Orbitrap mass spectrometer. Protein identification and 
quantitation were performed using the Mascot (version 2.2; Matrix Science, UK) 
software against the International Protein Index (IPI) human protein database (V3.68). 
Fold change was obtained from the normalized ratio of peptides which were quantified in 
the experimental MRC5 cells labeled with heavy (K8R10) isotopes compared to control 
MRC5 cells that had been labeled with light (K0R0) and statistical significance was 
calculated by the MaxQuant version 1.0.13.13 software. 
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2.4.4 Gene Ontology and IPA analysis 
Gene Ontology (GO) annotations enrichment analysis was performed by importing the 
gene ID into the program and IPA pathway analysis (www.ingenuity.com) was 
performed by importing the IPI number into the program, with automatic mapping of the 
pathways performed. 
 
2.4.5 Cell adhesion assay 
Co-cultured MRC5 cell suspension was prepared by resuspending the cells in medium at 
a concentration of 5×10
5
 cells/ml. 100 µl of cell suspension (5x10
4
 cells) was seeded into 
microwell plates (pre-coated with Collagen I or Fibronectin) for adhesion assay. The 
plated MRC5 cells were allowed to incubate for 30 min. Removal of non-adherent cells 
was carried out before washing the well with PBS. The unwashed wells served as loading 
controls. MTS assay was carried out to quantify number of adhered MRC5 cells. 
 
2.4.6 Immunofluorescence (IF) 
Cells were plated onto glass coverslip in a 6 well plate. Cells were fixed with cold 4% PF 
for 20 min, rinsed with 0.05% Tween-20-PBS, followed by permeabilization with 0.2% 
Triton-X (pH 7.4). After rinsing with 0.05% PBST, 1% BSA (diluted in 1x PBS) was 
added for 30 min for blocking non-specific proteins. 
Cells were incubated using primary mouse anti-vinculin antibody (Milipore) at   
4 ºC, overnight. For the negative control, the primary antibody was omitted. Following 
overnight incubation, the cells were washed thrice with 0.05% PBST for 5 minutes each, 
followed by 1 h incubation in the dark with anti-mouse IgG Cy3 conjugate F(ab’)2 
secondary antibody (Sigma Aldrich, USA) (1:200). Cells were then washed and stained 
with Phalloidin for F-actin (Sigma Aldrich and Milipore) at a dilution factor of 1:50 for 
30 min. Nuclei were counterstained with DAPI (1:1000) for 5 min before the last wash 
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with 0.05% PBST. The coverslip was removed from the 6-well plate using a forcep and 
mounted onto a glass slide with Fluorescent Mounting Medium (Dako, Denmark) and 
kept in the dark at 4°C. Fluorescence images were taken with an Olympus Fluoview™ 
FV1000 cLSM. 
 
2.5 In vivo experimentation with AuNPs 
2.5.1 Animals 
Male Wistar-Kyoto rats aged, 6–8 week old (approximately 250 g body weight) 
purchased from the Centre for Animal Resources in Lim Chu Kang, were housed at the 
Comparative Medicine (CARE) facility, National University of Singapore (NUS), 
Singapore. 1-week acclimatization period was held for newly purchased rats before 
commencement of study. The rats were housed two per disposable cage provided with 
free access to water and rodent diet under controlled temperature, humidity and lighting 
(12-12 h light-dark cycle). All procedures were pre-approved by NUS Institutional 
Animal Care and Use Committee (IACUC) (protocol number 118/11). 
 
2.5.2 AuNP treatment in vivo 
For the animal study, washed AuNPs were further diluted with ultrapure (UP) water, 
resulting in a final mass concentration of 256 µg/ml based on measurement obtained from 
ICPMS. The concentrated and purified AuNPs were then used for subsequent 
administration into rats. 
Rats were anesthetized by inhalation of 5% isoflurane during AuNP 
administration. Single doses AuNP suspension was injected intravenously into the rat tail 
vein of Wistar rats and observed for 1 week/ 1 month/ 2 months. Rats were assigned 
randomly into 7 groups (n = 6 per group for different single doses and time points), in 
which there were 4 tested concentrations (single injection at 0.025 mg/kg; 0.05 mg/kg; 
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0.1 mg/kg; 0.2 mg/kg) and animals were sacrificed after 1 week; single injection of 0.1 
mg/kg and animals were sacrificed at 2 time points (1 month & 2 months post injection) 
and UP water (as vehicle-only control). The control group was injected with 0.2 ml UP 
water. This group served as the internal control to determine the safety of water-only 
injection. Colloidal Au and UP water were sterile prior to injection. Individual body 
weight was monitored and recorded 3 times a week. The tested AuNPs were dissolved 
directly in sterile ultra pure water as mentioned earlier, and IV injection was given once 
and rats will be euthanized at the stated time points mentioned above. 
Tissues were removed for histopathological analysis and blood for serum testing. 
The dose used in this study was derived from a clinical trial study (Libutti et al., 2010) 
and based on human equivalent dose (HED) and US Food and Drug Administration 
(FDA) guidelines. 
 
2.5.3 Rat tissue collection 
Tissues from all 7 groups were harvested from the rats at 1 week, 1 month and 2 months 
post-injection. At each time-point the rats were euthanized using carbon dioxide in excess. 
Blood was collected from the animals via cardiac puncture with 3.8% trisodium citrate 
(in ratio of 1:10) used as an anti-coagulant. The blood was centrifuged (3000 rpm for 5 
min) and plasma was collected and stored at -80°C for further analysis. The lungs were 
collected and fixed in 10% formalin followed by paraffin embedding. Tissues were either 
snap frozen using liquid nitrogen before transferring into -80°C for storage or fixed and 
preserved for light and electron microscopic analysis. 
 
2.5.4 Quantification of Au in lung tissues 
The biodistribution of AuNPs was investigated quantitatively by ICPMS at different time 
points after different doses of single injection. To perform microwave digestion, all the 
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quartz inserts, QI, glasswares and Teflon vessel were cleaned with 1% HNO3 followed by 
rinsing the glasswares with ultrapure water (3-4 times). Tissues of weight between 100-
120 mg were put into each vial. 200 µl Cd standard solution with a concentration of 10 
ppm in the final solutions was used as an internal standard and added to the sample inside 
the QI before putting on the glass cap. 1.5 ml of ultrapure water was added into the 
Teflon vessel followed by 1 ml water into QI. 2 ml concentrated nitric acid HNO3 (69%) 
and 2 ml of HCI (30%) were added to QI using glass pipette before adding 1 ml H2O2 
solution. 0.5 ml H2O2 solution into was also added into the Teflon vessel. QI was put into 
the Teflon vessel using plastic tweezers and was then placed inside the microwave vessel 
for digestion. After digestion, the vessel was taken out and cooled. The clear sample 
solution inside the QI was diluted to 20 ml with ultra pure water and transferred to the 
cleaned plastic vial and was kept at ~ 4 °C before quantifying with ICPMS. 
 
2.5.5 Enzyme-linked immunosorbent (ELISA) assay 
Plasma Transforming growth factor beta (TGF-β) and Interleukin 6 (IL-6) were used as 
indicators of inflammation. Plasma TGF-β and IL-6 concentration were analyzed in the 
Control and AuNP groups (6 groups) using rat TGF-β and IL-6 Platinum ELISA 
commercial kits (eBioscience) following the instructions included in the kit. Each well 
was washed once with wash buffer before adding in the sample (10 µl of HCI and NaOH 
pre-treated sample), standard and blank (assay buffer) in duplicate. Samples were 
incubated for 2 h, on a slow shaker at room temperature. After that, wells were washed 
five times with washing buffer before the addition of Biotin-Conjugate. Samples were 
incubated for another hour, washed again, and finally incubated with the Streptavidin-
HRP for another hour. Samples were washed, added with TMB substrate solution and 
incubated for 30 min. The optical density was read at 620 nm to determine the 
absorbance of the samples tested. 
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2.5.6 Prothrombin time (PT) test 
Rat blood collected from cardiac puncture procedure was emptied into a tube containing 
3.8% sodium citrate (at the ratio of 1:10) and centrifuged at 3000 rpm for 10 min at 4
o
C. 
Plasma was extracted and immediately stored at -80°C while the pelleted red blood cells 
were stored in a plastic test tube with a cap at 4°C for subsequent analysis. Separated 
plasma was used for PT test. Prior to performing prothrombin time test (PT), plasma was 
thawed at 37°C quickly and was then transferred to siliconized glass. The time required 
for a fibrin clot to form after the addition of bovine brain thromboplastin (Sigma Aldrich, 
USA) and calcium (to decalcify rat plasma) was studied. Plasma was mixed with 
constituted thromboplastin at 37°C and an excess of calcium chloride (25 mM) was 
added to initiate coagulation. Using tilt-tube technique, a stopwatch was started when the 
calcium is added and stopped when the clot formed. The time taken for blood clot 
formation was recorded. 
 
2.5.7 Western Blot 
Citrate-treated rat blood was centrifuged at 3000 rpm for 15 min) to obtain plasma. The 
pellet was discarded and protein quantification was done using Bio-Rad Protein Assay 
(Bio-Rad, USA). Primary rabbit anti-rat IL-1α antibody (Santa Cruz) and primary rabbit 
anti-rat albumin (Aviva, USA) (as internal loading control) were used. Rest of procedure 
is as described in section 2.3.18. 
 
2.5.8 Histopathologic analysis using Hematoxylin and Eosin (H&E) staining 
Lung tissues harvested for microscopic examinations were fixed in 10% formalin. 
Tissues were trimmed, immersed in fresh formalin, dehydrated in alcohol, cleared in 
clearene and lastly embedded in wax using ATP 700 Tissue Processor. Tissues were 
paraffinized, sectioned into thickness of 5 µm before H&E staining. Briefly, paraffin 
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sections were dewaxed with clearene and rehydrated in descending percentage of ethanol. 
Sections were stained with hematoxalin followed by eosin. Samples were dehydrated, air-
dried and mounted using Permount solution before being examined microscopically. 
Only four groups of animal tissues based on ELISA analysis of inflammatory 
cytokines were selected for H&E staining. 
 
2.5.9 Immunohistochemistry (IHC) 
Rat lung tissue section were deparaffinized and rehydrated as mentioned in section 2.5.8. 
Before performing immune-staining in rat lung tissues, enzymatic antigen retrieval was 
performed. Proteinase K treatment was carried out for 30 min at 37
o
C. Sections were then 
allowed to cool at room temperature before rinsing with PBST. Endogenous peroxidation 
was prevented by incubating the section with 0.5% H2O2 prior to blocking with horse 
serum. Incubation of primary rabbit anti-rat IL-1α antibody (1:200) was performed, 
followed by secondary antibody and DAB staining as described in section 2.3.25. 
 
2.5.10 Immunofluorescence (IF) 
Antigen retrieval and endogenous peroxidation blocking were performed as described in 
section 2.5.9. Next, lung section was incubated with primary rabbit anti-CD68 (Acris, 
Germany) (1:200) for 2 h before incubating with secondary goat anti-rabbit Cy-3 
conjugated antibody (1:200). Subsequent steps are the same as described in section 2.4.6. 
 
2.5.11 miRNA isolation from lung tissue for miRNA PCR array 
Total miRNA was isolated from the rat lung tissues by using the TRIZOL reagent 
(Invitrogen) and Qiagen miRNA extraction kit according to the manufacturer's 
instructions. Lung tissues were first homogenized before mixing with chloroform. 
Centrifugation was performed to extract the aqueous phase separated followed by 
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addition of 100% ethanol. Samples were washed and total mRNA together with small 
RNA were eluted with RNAse free water. 
 Inflammatory Response and Autoimmunity miRNA PCR Array (SA Bioscience), 
which comprises of 84 miRNAs that regulate the expression of pro-inflammatory or anti-
inflammatory genes (prediction) was used. A set of controls present on this array were 
used as calibrator and data analysis was done using the ΔΔCT method of relative 
quantification. The expression of a focused panel of miRNAs predicted to regulate 
inflammatory and autoimmune response genes were analyzed with this array. The control 
group served as the calibrator, and the average value of calibrator was used against 
treated groups and the results were expressed as a fold difference. The water-only group 
(control) was used as the normalizer. 
 
2.5.12 qRT-PCR  
Rat lung tissues were weighted, approximately 30 mg, before mixing with 350 µl of 
TRIZOL lysis reagent. The tissues were homogenized on ice and spun at high speed 
before removing the pellet. The supernatant, which contains RNA, was added with equal 
volume of ethanol before processing the same way as described in section 2.3.13 for 
RNA extraction and qRT-PCR. Table 2.2 is a list of all the primers used for qRT-PCR of 
the genes of interest in the lung tissues. 
 
Table 2.2: List of primers and their sequences used for qRT-PCR for in vivo specimen. 
Gene Forward sequence Reverse sequence 
Rat PROS1 CCTTTCCTTGGACCTTGACA TCACGAAGTGCAATCAGGAG 
Rat Tissue Factor GCTCAATGCCTTCTCTCAGG CACCACTTGTAGCTCGGTGA 
Rat SERPINE1 GACAATATGTGCCCTGTGATTGTC AGGCTGCTCTACTGGTCCTTGC 
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2.6 HumanTissueScan™ qPCR Array 
TissueScan Human Normal (48 Tissues) qPCR array (OriGene, MD) consisting of pre-
normalized cDNA from 48 human normal tissues was selected. In brief, the array plate 
was thawed to room temperature. A pre-mix of SYBR® Green dye and PROS1 primer 
was prepared and added into each well as instructed by manufacturer’s protocol. The 
plate was sealed tightly and let stand on ice for 15 min. The sequence for PROS1 primers 
used were forward 5’- CCTAGTGCTTCCCGTCTCAG-3’; reverse 5’-
TTTCCGGGTCATTTTCAAAG-3’. Real-time detection of PROS1 gene expression 
using Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems) was 
performed. The thermocycling conditions used were: 95
o
C for 15 min for one cycle, 
followed by 40 cycles of 94
o
C for 15 sec, 60
o
C for 30 sec and 72
o
C for 60 sec. 
 
2.7 Statistical analysis 
Statistical calculations were performed using the Graph Pad Prism Version 5.0 
(GraphPad Software, USA). Data was presented as mean values ± standard error of the 
mean (SEM) from triplicates (n=3). Student’s t-test was used to analyze differences 
between two groups; while One Way ANOVA with post hoc test (Tukey’s Multiple 
Comparison Test) was used if there were three or more groups of data involved for 














































3.1 Characterization of AuNPs 
TEM was used to examine the morphology and size of as-synthesized AuNPs. TEM 
images of AuNPs showed that AuNPs were well dispersed, well defined and spherical in 
shape (Fig 3.1A) with an average size distribution of about 20 nm. AuNPs size 
distribution was analyzed using DLS, which provided size information in aqueous 
medium (Fig 3.1A inset; Fig 3.1C), and the data was plotted and displayed as % of 
intensity (Fig 3.1C). The mean hydrodynamic radius measured for spherical AuNPs was 
20.15 nm in solution, which is in agreement with the TEM observation. The size of 
AuNPs increased from 20.15 nm to 44.69 nm (Fig 3.1C cf D), and the zeta potential 
changed from -28.5± 0.21 mV to -24.6±0.3 mV (Fig 3.1E cf F) (due to citrate-ion 
capping), after coating with FBS. UV–vis spectroscopy was used to examine the optical 
absorbance spectra of AuNPs. UV-Vis absorption spectra of AuNPs showed absorption 
peak at 525 nm (Fig 3.1B). 
NPs were provided as a 2 nM colloidal suspension and concentrated and 
reconstituted to obtain a final concentration 10 nM (486.5 µg/ml). Actual concentrations 
of AuNPs were determined ICPMS after acid digestion of sample aliquots. Suspensions 
of FBS-coated AuNPs constituted in biological media were freshly prepared prior use. 
After optimization, 1 nM of AuNPs was selected as the main concentration used in 
treating the cells for further experimentation since this dose had been used in previous 
studies by members of the same laboratory (Li et al., 2008; Li et al., 2010a; Li et al., 
2011a). The 1 nM AuNP concentration used in this study is equivalent to 48.65 µg/ml 
and falls within the range of AuNP concentrations that are utilized for nanotoxicity 






Figure 3.1: Characterization of AuNPs. (A) Representative TEM micrograph of as-
synthesized AuNPs (with inset showing size distribution of AuNPs from DLS). AuNPs 
were synthesized by Turkevich method but modified to obtain a 20 nm size. (B) UV-vis 
of the as-prepared AuNPs revealed an absorption peak at 525 nm. (C) DLS Z‑average 
measurements showed the AuNPs were approximately 20.15 nm and (D) 44.69 nm (after 
coated with FBS) in diameter in solution. (E) Zeta potential of AuNPs and (F) FBS-




3.2 Biological effects of AuNPs in SAECs  
3.2.1 Uptake of AuNPs into SAECs 
(A) LM and AMG study 
Internalization of AuNPs did not cause significant morphological changes in SAECs. 
Aggregates of AuNPs were visualized as bright blue spots under LM (Fig 3.2B cf A). 
AuNPs were clearly seen after AMG enhancement due to silver ion deposition on AuNPs. 
Deposition of AMG grains in AuNP-exposed SAECs was clearly visible under LM (Fig 
3.2D), in contrast to unexposed SAECs which showed clear cytoplasm (Fig 3.2C). 
Figure 3.2: AuNP-untreated and AuNP-treated SAECs as observed using LM and AMG. 
(A) AuNP-untreated SAECs. Scale bar: 200 µm. (B) Micrograph of AuNP-treated 
SAECs showing appearance of AuNPs as bright blue spots (aggregates of particles). 
Scale bar: 200 µm. (C) AuNP-untreated SAECs after AMG showed clear cytoplasm. 
Scale bar: 100 µm. (D) Formation of AMG grains (arrows) as detected using silver 
enhancement kit. AMG grains were spotted at cytoplasm. Scale bar: 100 µm. Inset shows 




(B) TEM-EDX Analysis 
Internalization of AuNPs into SAECs was verified using both conventional TEM and 
FIB-SEM. Under conventional TEM, AuNPs were observed to be taken up by SAECs 
and localized mainly as clusters inside vesicles in the cytoplasm, but not in the nucleus 
(Fig 3.3B cf A). Electron dense AuNPs, appearing as black clusters, were found to be 
enclosed within vesicle-liked structures (arrow). There were no free AuNPs present in the 
cytosol or the nucleus. Using EDX analysis, presence of AuNPs was confirmed as 
readings from the M and L shells of Au with a P/B ratio of 6.57 and 59.8 respectively 
(Fig 3.3C) were detected. Besides, Cu was detected as the specimen was mounted on a 
Cu grid; while presence of Os was due to the osmification process that was introduced 





Figure 3.3: Subcellular morphology and AuNP localization in SAECs observed after 1 
nM AuNP treatment for 72 h. (A) Micrograph shows the negative control of SAECs 
without any AuNPs. Scale bar: 1 µm; inset: 0.5 µm. (B) AuNPs were taken up by SAECs 
(red arrow) and localized predominantly at cytoplasm, with some enclosed within the 
endosomes. Scale bar: 2 µm; inset: 1 µm. (C) Micrograph shows AuNPs localized in the 
endosomes of SAECs as electron dense black clusters. These clusters were verified to be 
Au using EDX analysis which showed the presence of Au M shell (2.2 KeV) and L shell 




(C) FIB-SEM, elemental mapping, STEM-EDS and nanotomography 
The FIB-SEM was also used to verfy the uptake of AuNPs in SAECs. To identify the 
initial location of internalized AuNPs in SAECs, SEM was first used to locate a suitable 
region on the block for FIB-SEM. The milling window size or imaging face (square) was 
set at width of 20 µm and height of 10 µm and subsequently cut with a gallium ion beam. 
Figure 3.4A illustrates the set up and pre-selection of a region to be focused later at 
magnification of 3.98k. Subsequently, the milling process was continued till a smooth 
imaging face was obtained. Figure 3.4B shows an overview image of a part of SAEC at 
magnification of 10k with visible structural details obtained using an Energy selective 
Backscattered (EsB) detector operated at low voltage (1.5 keV) for backscattered imaging. 
Micrographs were taken from the milled sections of the same area and same specimen of 
araldite embedded SAECs which had been incubated with AuNPs. 
 
Figure 3.4: Micrographs on FIB-SEM set up and area selection. (A) Milling chamber 
which consists of sample holder, gallium ion beam and electron beam were used for 
milling and imaging purpose. Scale bar: 200 µm. (B) SEM was used to survey the area of 
interest for milling and imaging at higher magnification and resolution subsequently. 





A BSE image of SAECs shows ultrastructural details such as a double membrane nucleus 
and nucleolus, and cytoplasmic organelles that include endoplasmic reticulum, lysosomes 
and endosomes (Fig 3.5A). Heavy elements such as AuNPs and osmium-incorporated 
plasma membrane appear bright under BSE detector. The milled and raw image as shown 
in Fig 3.5B was then subjected to contrast reversal. Fig 3.5C shows the AuNP clusters 
observed as dark deposits in the in contrast-inverted FIB-SEM image of back-scattered 
electrons, rendering them easily recognizable. 
Fig 3.5: FIB-SEM images of AuNP-treated SAECs. (A) Micrograph shows AuNP 
aggregates localized in the endosomes of SAECs. Scale bar: 1 µm. (B) Micrograph shows 
the enlarged image of the boxed area in (A) as recorded by the EsB detector, with AuNPs 
appearing as bright spots. Scale bar: 1 µm. (C) Inverted contrast of image (B) with the 




Element distribution mapping of the electron dense deposits was performed using EDX 
and the elemental distribution within endosomes was generated based on digital 
information from an electron detector. AuNPs were represented on the EDX map as red 
dots (Fig 3.6A). These were performed with a Zeiss Libra 120 Plus Energy Filter TEM. 
Elemental distribution mapping was calculated using Energy Spectroscopic Imaging (ESI) 
with 3-window power law method. Figure 3.6B shows the selected area in SAECs with 
large cluster of AuNPs found within vesicles. Using elemental analysis STEM-EDS 
coupled with EDAX Octane Plus software, presence of Au in SAECs was confirmed as 
depicted by the presence of Au M shell (Fig 3.6C, D). Besides, presence of carbon 





Figure 3.6: Elemental identification of Au and STEM-EDS analysis. (A) Elemental 
distribution after background substraction is shown for Au (left image), elemental net 
distribution is presented in red (middle image) and overlay (right image). (B) The 
contours of the embedded cells are visible and presence of AuNPs was rendered as bright 
spots (boxed area) as captured by BSE (left). Contrast reversal was performed from raw 
FIB-SEM image (right). Scale bar: 2 µm. (C) EDX spectrum shows the presence of Au in 
SAECs using Zeiss Libra 120 Plus Energy Filter TEM. (D) EDS shows the presence of 





3D imaging of AuNPs inside the cells followed by 3D reconstruction for 
nanotomography was performed (Fig 3.7). A video of the 3D reconstruction is included 









Figure 3.7: 3D Nanotomography using FIB-SEM for visualizing the 3D architecture of 





3.2.2 AuNPs induced oxidative stress in SAECs 
(A) LPO assay 
LPO is an established marker of oxidative stress. There was an increase of the LPO 
content after 72 h treatment as observed in 1 nM AuNP treated SAECs compared with 
control (Fig 3.8A). This provides evidence that AuNPs were able to induce oxidative 
stress in SAECs. Besides, transient transfection of luciferase reporter plasmid containing 
the transcriptor factor Nrf2/Nrf1, a well-known transcription factor for oxidative stress, 
showed a significant increase in their activity triggered by AuNPs in SAECs (Fig 3.8B). 
 
Figure 3.8: Studies on oxidative stress induced by AuNPs in SAECs. (A) Lipid 
peroxidative stress in SAECs following exposure to AuNPs. A higher level of LPOs was 
observed in AuNP-treated SAECs when compared with control cells. H2O2 treatment 
served as positive control. (B) Transient transfection studies utilizing Nrf2/Nrf1-regulated 
luciferase reporter demonstrated an increase their activity following AuNP treatment of 





(B) MT anti-oxidant gene screening 
As oxidative stress was induced after AuNP treatment in SAECs, gene expression of 
Metallothioneins (MTs), which are known antioxidants and free radical scavengers (Inoue 
et al., 2009) was investigated. The expression of functional MT-1 and MT-2 gene 
isoforms was assessed in SAECs (Fig 3.9A). In agreement with previous publication, 
MT-1A, MT-1E, MT-1X and MT-2A were found to be the most abundantly expressed 
isoforms in SAECs. There was a significant decrease in MT-1A expression in AuNP-
treated SAECs in comparison with untreated cells (Fig 3.9B). MT-1E, MT-1X and MT-2A 
gene expression showed no significant changes, although a general down-regulated trend 





Figure 3.9: MT expression in untreated and AuNP-treated SAECs. (A) Bar chart of MT 
isoforms that were present endogenously in SAECs. (B) Significant difference in fold 
change of the MT-1A gene in SAECs was observed after treatment with 1 nM AuNPs. 
No significant gene expression changes observed in (C) MT-1E, (D) MT-1X and (E) MT-





(C) Screening of other anti-oxidant genes 
Next, the transcripts of 8 genes (CAT, GPX1, GPX2, SOD1, SOD2, SOD3, Prx1, Prx3) 
which are involved in anti-oxidative response were examined in SAECs after exposure to 
1 nM of AuNPs for 72 h. There was a general upward trend in the expression of anti-









Figure 3.10: Fold change of 8 selected anti-oxidant genes on AuNP exposed SAECs 





3.2.3 Cytotoxicity of AuNPs 
3.2.3.1 Cell viability assessment of AuNP-treated SAECs 
(A) LDH assay 
As compared with MRC5 fibroblasts, SAECs were more vulnerable towards AuNP 
treatment. At all tested time points of 24, 48 and 72 h, 1 nM AuNPs caused a significant 
release of LDH at all concentration tested in SAECs (Fig 3.11A-C). 
 
Figure 3.11: LDH assay was used to determine cytotoxicity of SAECs treated with a 
range of dose with AuNPs. (A) At 24 h, (B) 48 h and (C) 72 h, SAECs showed 
significant release of LDH into the culture media, as an indicator of cellular membrane 
disruption at all ranges of tested AuNP concentration. All the experiments were 





(B) Trypan blue assay 
Cell viability was significantly decreased as early as 24 h after treatment with 2 nM 
AuNPs (Fig 3.12D), and persisted after 48 h and 72 h (Fig 3.12E, F) AuNP treatment at 
the same concentration. There was a decrease of 24.25%, 18.25% and 20.5% in cell 
viability between the untreated control SAECs and 2 nM AuNP treated SAECs at 24 h, 
48 h and 72 h respectively. In conjunction with these observations, total cell count 
showed a general downward trend as the cell proliferation rate was affected due to the 
increase in cell death (Fig 3.12A-C). Significant decrease of total cell count was observed 
when SAECs treated with 2 nM AuNPs, which is in agreement with cell viability data. 
Figure 3.12: Viability of SAECs was determined by 0.4% Trypan blue dye exclusion 
assay following 24 h, 48 h and 72 h AuNP exposure. (A) Total cell count was decreased 
when treated with AuNPs at 24 h and was significantly decreased at (B) 48h of 1 nM and 
2 nM AuNPs. (C) Total cell count was decreased as low as at 0.5 nM AuNPs. (D-F) 
Graphical representations of % of cell viability at 24 h, 48 h and 72 h of AuNPs. SAECs 
showed significant decrease in cell viability when treated with 2 nM of AuNPs. All the 





(C) AO/ EtBr staining 
Microscopic examination of SAECs was performed to examine the nuclear changes and 
formation of apoptotic bodies during AuNP-induced cytotoxicity. SAECs were examined 
after staining using AO/ EtBr, which showed membrane blebbing (indicated by arrows) 
under a fluorescence microscope. In agreement with the LDH results, AuNP treated 
SAECs which have lost their membrane integrity were readily stained with EtBr. Live 
SAECs appeared uniformly green, while dead SAECs (in red) showed formation of blebs, 
cell shrinkage and condensed nuclei, indicating late apoptosis (Fig 3.13). 
 
Figure 3.13: Morphologic observation with acridine orange/ethidium bromide (AO/EB) 
staining. (A) SAECs were treated without AuNPs showed uniform green staining which 
indicates viable cells. Scale bar: 100 µm. (B) Bright red color staining (arrows) indicates 





(D) Cell cycle analysis 
Cell cycle analysis showed a significant decrease in the S+G2/M phase in 48 h 1 nM 
AuNPs treated SAECs (Fig 3.14A). Ten cell cycle related genes were chosen and cell 
cycle gene transcription analysis revealed a significant down-regulation in the expression 
of CDKN2a, an important gene regulating cell cycle checkpoint and cell cycle arrest (Fig 
3.14B). 
Figure 3.14: Cell proliferation and related genes studies after AuNP treatment in SAECs. 
(A) Cell cycle analysis shows a significant decrease in total S and G2/M phase of cell 
cycle, indicates a decrease in cell proliferation rate after treated with 1 nM of AuNPs for 
48 h. (B) Decreased in cell proliferation was accompanied by a decrease in CDKN2a 
gene expression level, an important regulator of cell cycle checkpoint and cell cycle 





3.2.4 Genotoxicity induced by AuNPs in SAECs 
The Comet assay revealed heightened oxidative stress-induced DNA fragmentation after 72 h 
AuNP exposure. Tail moment, which refers to the percentage of DNA present in the tail 
multiplied by the length between the center part of head and tail, was significantly greater in 1 
nM AuNP-treated SAECs, indicating that a larger extent of DNA fragmentation incurred in 
AuNP-treated cells (Fig 3.15A). Next, the transcripts of 10 genes (APEX2, ATM, ATRX, 
BTG2, ERCC2, LIG1, RPA1, XPC, XPA and XRCC1) which are involved in DNA repair were 
examined in SAECs after exposure to 1 nM of AuNPs for 72 h. Xeroderma pigmentosum 















Figure 3.15: Genotoxic effects in AuNP-treated SAECs. (A) Comet assay of SAECs treated 
with 1nM AuNPs at 72 h and subsequently run on alkaline electrophoresis and stained in 
SYBR green which visualizes the comet “tail”, the length of which is an indicator of DNA 
damage. Analysis of 100 cells per treatment was performed. Control cells (upper right insert) 
showed little to no tail. AuNP-treated cells (bottom right insert) displayed a comparatively 
longer tail, indicative of the presence of higher DNA damage. (B) qRT-PCR revealed an 
increase in the fold change of XPA gene expression level after treated with AuNPs in SAECs. 




3.2.5 Microarray analysis of AuNP-treated SAECs 
The quality of RNA samples was determined before sending for micro array analysis. 
The A260/A280 ratio of RNA samples that were sent for analysis were measured by 
spectrophotometry. The OD260/OD280 ratios of the 6 samples were found to be between 
1.9 – 2.21, and concentrations ranged from ~130 ng/μl to ~323 ng/μl (Fig 3.16A). The 
good quality of the total RNA isolated were also verified by gel electrophoresis (Fig 
3.16B). The RNA integrity values or RNA integrity Number (RIN) ranged from 9.1 to 10. 

















Figure 3.16: Characterization of RNA quality of SAECs for microarray study. (A)The 
quality of RNA samples was determined. Absorption 260/280 ratio ≥ 1.8 were used as 
indicators of acceptable purity. (B) Gel image of RNA samples which showed a band 
intensity ratio of 28S rRNA (at 4.5kb) to 18S rRNA (at 1.9kb) of 2. (C) 
Electropherograms of 28S and 18S rRNA with flat baseline and no additional peaks in 




The heat map generated using GeneSpring software reflected two distinct clusters. One 
cluster corresponds to up-regulated genes (red panels), and the other cluster (represented 
by green panels) depicts those genes which were down-regulated (Fig 3.17A). A volcano 
plot was generated to compare the transcriptomes of SAECs treated with AuNP versus 
the cells that were not exposed to the AuNPs (Fig 3.17B). Genes that fulfilled these 
criteria are represented by the red triangles, while the grey squares represent genes that 
failed to satisfy these conditions. 
 
Figure 3.17: (A) Hierarchical clustering for differentially expressed mRNAs in SAECs 





Differential expression of 42 genes (fold change≥1.5, p < 0.05) was observed as 
compared with AuNP unexposed SAECs. Microarray analyses identified gene expression 
signature consisting of 40 genes that were up-regulated and 2 genes that were down-
regulated (Table 3.1). qRT-PCR was performed and showed a good concordance with 
microarray data (Fig 3.18). Next, gene ontology analysis was conducted to map genes 
that were differentially expressed to functional categories using DAVID (Table 3.2). 
Aberrant genes expressed are related to processes involving the immune system, lipid 
metabolism, cell homeostasis, stress response, and biological regulation. 
Notably, AuNP exposure resulted in increased levels of mRNA for acute phase 
markers serum amyloid A-1 (SAA1) and immune response gene Toll-like receptor 2 
(TLR2) and interferon gamma receptor 1. Besides, microarray analysis revealed aberrant 
expression of genes which encode proteins involved in blood coagulation such as serpin 
peptidase inhibitor, clade E (SERPINE1) and also FYN binding protein, which is involved 
in platelet activation. Expression of genes associated with acute phase, inflammation, 
immune response and impaired regulation of blood coagulation were enriched after 48 h 
post exposure to AuNPs. The Kyoto Encyclopedia of Genes and Genomes (KEGG) 
pathways database which was used to identify specific biological pathways associated 
with the differentially expressed genes, predicted inflammation, complement cascade 
perturbation and possibly in association with prothrombotic changes. Other affected 






Table 3.1: Differential expression of genes identified from the Affymetrix Human Gene 
1.0 ST Array. 
Gene symbol p-value FC Absolute regulation 
FYB 0.022860235 3.2837753 up 
AKR1C2 0.009191448 2.9732397 up 
KYNU 0.04031548 2.6664615 up 
SAA1 0.04730334 2.4743495 up 
NQO1 0.009716617 2.408126 up 
TXNRD1 0.005305763 2.3999944 up 
AKR1C3 0.025623498 2.390597 up 
FTH1 0.001159682 2.3368406 up 
PTGR1 0.03761124 2.051098 up 
CYP24A1 0.020748194 1.9938025 up 
UIMC1 0.022960871 1.9693946 down 
PNLIPRP3 0.001092176 1.9500183 up 
Serpine1 0.01707216 1.9259968 up 
DSC2 0.009166447 1.8937527 up 
NTN4 0.011789325 1.8485426 up 
NRIP1 0.003064263 1.8251534 up 
SH3KBP1 0.009215917 1.8186193 up 
TLR2 0.013492571 1.7701886 up 
POPDC3 0.001029478 1.7483084 up 
TFPI2 0.018800564 1.7164173 up 
TLK1 0.042959712 1.6870462 up 
AKR1B10 0.014765623 1.6808671 up 
ADAM28 0.032992497 1.6552218 up 
CDK1|CDC2 0.04141343 1.6473414 down 
TM4SF1 0.035336994 1.6408422 up 
ERO1L 0.016450878 1.6303246 up 
C13orf31 0.002072332 1.6300972 up 
UBE2H 0.01624855 1.6162099 up 
HTATIP2 0.026787775 1.6044718 up 
EPGN 0.038746186 1.60123 up 
TACSTD2 0.008609537 1.5931822 up 
MTSS1 0.014715695 1.5912739 up 
RBP1 0.016130637 1.5851606 up 
BVES 0.007454179 1.5648742 up 
SEL1L3 0.047575198 1.5641564 up 
GPR109A|NIACR1 0.027815467 1.5623207 up 
MAP1B 0.024445523 1.5576143 up 
DAB2 0.005454687 1.5454847 up 
IFNGR1|LOC100131120 0.007339169 1.5366831 up 
NRCAM 0.014389291 1.5358087 up 
RAI14 0.025009122 1.5215092 up 
DSG2 0.032455098 1.5195131 up 







Figure 3.18: Selected gene expression profiles derived from micro-array were verified by 





Table 3.2: Classification of differentially expressed genes into functional groups using 
the Database for Annotation, Visualization, and Integrated Discovery (DAVID) software. 
Processes Genes involved 










Response to stress SAA1 
NQO1 
Metal ion homeostasis FTH1 
SAA1 
Homeostatic process TXNRD1 
FTH1 
SAA1 




































3.2.6 Protein profiling using dimethyl labeling and mass spectrometry analyses 
To assess the effects of AuNPs on proteome expression, dimethyl labeling and mass 
spectrometry on AuNP-treated SAECs were performed. Profiling of proteins between 
AuNP-treated and untreated SAECs identified 157 differentially expressed proteins, 
comprising of 82 up-regulated (Table 3.3) and 75 down-regulated proteins (Table 3.4). 
Among these proteins, 7 proteins were the same as those identified from microarray data 
with good correlation between the technical replicates (Fig 3.19). Notably, TLR2 protein 
expression was up-regulated with high ratio of 12. Presence of SAA1 was undetectable 
using MS. 
 
Figure 3.19: Graphical representation shows a good concordance of the 7 overlapping 





Table 3.3: Up-regulated proteins as quantified by mass spectrometry.  
Gene Name Normalized H/L Counts 
Forward Reverse 
AKR1C2 2.2743 0.43243 3 
MX1 1.9933 0.47952 11 
VDAC3 1.9592 0.5218 9 
PODXL 1.9581 0.45725 2 
AKR1C1 1.8314 0.56086 26 
TXNRD1 1.7807 0.6103 24 
AKR1C3;AKR1C4 1.7236 0.70263 8 
ACTN1 1.7058 0.59428 80 
LCP1 1.679 0.54943 5 
HK1 1.678 0.59785 43 
HLA-C 1.6706 0.7603 2 
IL1A 1.6645 0.77256 5 
ACTN4 1.6509 0.58093 34 
FTH1 1.6257 0.72765 4 
IFIT1 1.6237 0.5283 4 
LIPA 1.6232 0.51041 2 
AKR1D1 1.5975 0.61471 3 
ATP6V0D1 1.59 0.5928 4 
SERPINE1 1.5872 0.65773 7 
VDAC2 1.5866 0.63935 19 
LTBP2 1.5775 0.66815 2 
SAMHD1 1.5726 0.70344 4 
STAT1 1.5546 0.66881 26 
CTSA 1.5522 0.52373 4 
FADS2 1.5386 0.50655 2 
HEATR7A 1.5123 0.77185 2 
NT5E 1.5033 0.61791 9 
OAS2 1.4779 0.60354 3 
DDX58 1.4753 0.57631 6 
HCLS1 1.467 0.68602 8 
VDAC1 1.4646 0.654 20 
CTSL1;CTSL2;CTSK;CTSL3 1.4556 0.72535 2 
C3 1.4534 0.77324 4 
HLA-A 1.4528 0.6943 9 
GLB1 1.4484 0.59064 2 
CCDC56 1.4481 0.81239 3 
ICAM1 1.4434 0.62865 16 
OAS3 1.4363 0.65464 6 
MMP9 1.4293 0.72073 11 
ATP6AP2 1.4284 0.68892 2 
HIST1H4A 1.4164 0.63119 10 




IL1B 1.4103 0.70253 5 
ANPEP 1.4012 0.75199 33 
CORO1C 1.3965 0.70967 14 
TLR2 1.391 0.70046 12 
HIST1H3A 1.3793 0.77193 2 
GCLM 1.3725 0.79589 9 
RAB1B;RAB1C 1.3698 0.79192 3 
ATP6V0A1 1.3687 0.66258 5 
H2AFX 1.3422 0.81385 10 
F3 1.3411 0.54824 7 
OCIAD2 1.3403 0.8096 12 
CYGB 1.3323 0.73613 14 
DHRS7 1.3276 0.81053 9 
ERAP1 1.3238 0.72575 11 
KIAA1279 1.317 0.64104 2 
MGST3 1.308 0.69423 5 
PSAT1 1.307 0.76046 11 
SEC61B 1.3026 0.66886 5 
ARMCX3 1.3008 0.7308 6 
TP53I3 1.2883 0.81357 16 
TRIM25 1.2837 0.78302 15 
TAPBP 1.2769 0.81465 7 
ACADVL 1.276 0.73839 14 
KRT18 1.2735 0.77276 24 
GHITM 1.2661 0.7255 3 
CLN5 1.2651 0.60156 3 
GCLC 1.2598 0.79398 14 
MTCH2 1.2541 0.75574 9 
NDUFA4 1.2509 0.62878 2 
CD47 1.2471 0.73924 3 
GLG1 1.2452 0.78204 15 
ANXA6 1.2409 0.79771 51 
GBP1 1.2402 0.73278 4 
STOM 1.2378 0.79191 12 
PGD 1.2337 0.76832 30 
CLTA 1.2314 0.73569 5 
IGF2R 1.2295 0.81054 7 
NQO1 1.2225 0.73055 15 
HIST2H2BF 1.2177 0.64264 11 






Table 3.4: Down-regulated proteins as quantified by mass spectrometry. 
Gene Name Normalized H/L Counts 
Forward Reverse 
ITGA3 0.84053 1.4741 13 
WDR77 0.83947 1.2858 3 
HBXIP 0.83823 1.5911 2 
C19orf10 0.83629 1.3384 4 
THOC3 0.83526 1.2611 2 
HIST1H1B 0.83041 1.2002 8 
SORD 0.82921 1.1917 5 
TF 0.82742 1.2016 11 
RPS9 0.82583 1.1929 16 
TXN 0.82572 1.3374 13 
HNRNPH1 0.81697 1.3507 10 
LSM3 0.8166 1.4384 5 
IVNS1ABP 0.80995 1.3479 2 
UBE2M 0.80964 1.3093 7 
PYCARD 0.80919 1.5353 2 
CSTB 0.80758 1.5329 6 
SNAP29 0.80715 1.2787 2 
LAD1 0.80177 1.1949 11 
PDLIM1 0.80128 1.1993 16 
DSP 0.79658 1.247 134 
S100A16 0.79482 1.3092 7 
MANF 0.79466 1.1986 10 
EIF4H 0.78782 1.2364 3 
TOMM34 0.78699 1.3286 3 
LAMTOR2 0.78656 1.4582 2 
EHD2 0.78564 1.4655 8 
RTN3 0.78448 1.2264 4 
ITGA6 0.78316 1.6618 6 
ITGB4 0.78172 1.2673 22 
PPIA 0.77424 1.2515 24 
TBCA 0.76362 1.7206 4 
NSFL1C 0.75873 1.4327 2 
NDUFA5;DKFZp781K1356 0.74809 1.262 3 
MYO6 0.74285 1.3016 8 
HSPB1 0.73718 1.4247 14 
PEBP1 0.73011 1.2794 13 
YAP1 0.72622 1.2002 3 
S100A10 0.72043 1.2144 6 
TAGLN2 0.72025 1.2359 36 
SRSF7 0.71743 1.5481 4 




CD9 0.70643 1.2762 2 
HSP90AB4P 0.70611 1.2632 4 
TPM1 0.70592 1.2921 2 
TNS4 0.69924 1.4825 9 
DTYMK 0.69894 1.2604 2 
CCDC58 0.69654 1.41 3 
ABI1;ABI2 0.6962 1.228 6 
IVL 0.6948 1.1984 2 
FUBP1 0.69281 1.2335 12 
SH3BGRL3 0.68818 1.8901 2 
NDRG1 0.68721 1.4779 28 
MIF 0.68616 1.3837 3 
F11R 0.685 1.3353 4 
STMN2 0.67678 1.3355 2 
DYNLRB1;DYNLRB2 0.65854 1.2752 3 
DDT;DDTL 0.6562 1.257 3 
CYCS 0.64469 1.4331 11 
UBE2L3 0.64194 1.2726 6 
FKBP1A 0.62827 1.3717 6 
LGALS3 0.61825 1.3443 7 
SNX3 0.59245 1.4392 6 
ACP1 0.57683 1.4534 3 
S100A14 0.57446 1.6576 10 
NOTCH1 0.57153 1.2829 2 
MOB4 0.56097 1.2695 6 
SCP2 0.55508 1.4574 3 
TACSTD2 0.52731 1.797 5 
HSPE1 0.49777 1.19 6 
S100A8 0.43532 1.9754 8 
S100A9 0.37158 2.4236 8 
HTRA1 0.37149 2.6637 2 
CARHSP1 0.31468 1.2272 2 
CYR61 0.23697 4.2387 8 






3.2.7 Co-immunoprecipitation (coIP) assay and protein structural alignment 
analysis 
As TLR2 has been identified as a functional receptor of SAA1, coIP assay was performed 
with TLR2-SAA1 in SAECs to address the question as to whether TLR2 and SAA1 are 
indeed interlinked. The two proteins tested were found to be immunoprecipitated with 
each other in SAECs (Fig 3.20A). It was clearly indicated that SAA1 specifically 
interacts with TLR2 and vice versa, although the majority of the TLR2 protein pool 
remained as uninteracted form. TLR2 has been demonstrated to bind SAA and this was 
confirmed through the coIP analysis and structural modeling (Fig 3.20B). These results 













Figure 3.20: Co-immunoprecipitation (coIP) experiments showing TLR2 interacts with 
SAA1 in SAECs. (A) CoIP was performed using anti-SAA1 and anti-TLR2 from the 
lysates of SAECs. The precipitates were analysed by immunoblot with anti-SAA1 and 
anti-TLR2 antibodies, as indicated. Western blots for SAA1 and TLR2 proteins indicate 
that coIP was seen when using SAA1 antibody as well as with TLR2 antibody. (B) 
Structural modeling and interaction prediction using Swiss PDB showed asymmetric unit 




3.2.8 AuNPs induced NFkB activation in SAECs 
To further investigate which signaling pathways involved in transmitting extracellular 
signal into SAECs after AuNP exposure, transient transfection and luciferase reporter 
assay were performed. Using NFkB luciferase reporter plasmid, the effect of AuNPs on 
NFkB activity in SAECs, which were treated with 1 nM of AuNPs for 48 h, was 
evaluated. There was a significant induction of NFkB activation as revealed by an 













Figure 3.21: NFkB activation. SAECs were transiently transfected with NFkB luciferase 
reporter plasmid after treated with 1 nm AuNPs for 48 h. Luciferase enzyme activity was 
measured in relative light units (RLU) and represented on the y-axis as NFkB activity 





3.2.9 Epigenetic mechanisms induced by AuNPs in SAECs 
(A) Assessment of miRNAs induced by AuNP exposure 
To examine the role of miRNAs in regulating cellular response post AuNP exposure, 
three miRNAs which were reported to be NFkB downstream targets, viz., miR-155, miR-
146a and miR-125b were chosen for qRT-PCR analysis. However, miRNA expression 
levels for AuNP exposed SAECs were not significantly different from control SAECs, 
(Fig 3.22A-C). Gene expression of PROS1, which is known to be regulated by miR-155 
in MRC5 lung fibroblasts after exposure AuNPs as reported previously (Ng et al., 2011), 
was also not unaffected in AuNP-treated SAECs (Fig 3.22D cf C). 
 
Figure 3.22: miRNA expression in AuNP-treated SAECs. (A) There was no significant 
change in miR-125b expression level as well as (B) miR-146a and (C) miR-155. (D) 
PROS1 gene expression in AuNP-treated SAECs. There were no significant changes to 




(B) DNA methylation 
The UIMC1 and CDK1 genes, which are the only two down-regulated genes from the 
microarray study, were examined to study if DNA methylation could play a role in 
inhibiting their expression. 5-Aza, an inhibitor of DNA methylation was used to treat 
SAECs for 6 days before exposure with AuNPs for 72 h. There was no altered expression 
with 5-Aza treatment, indicating that CDK1 and UIMC1 gene expression in AuNP-
treated cells was not modulated by this mechanism (Fig 3.23A, B). 
 
 
Figure 3.23: Effects of DNA methylation on AuNP-treated SAEC gene expression. (A-B) 
Down-regulated genes from microarray data analyses, which include UIMC1 and CDK1 
expression levels were not affected before and after treatment with 5-azacytidine. Error 





(C) Histone deacetylation 
Next, the expression of UIMC1 and CDK1 genes were examined to study if histone 
modification could play a role in inhibiting their expression. Trichostatin A, an inhibitor 
for class I and II mammalian histone deacetylase (HDAC) were used to treat SAECs for 
48 h before exposure with AuNPs for 72 h. CDK1 expression was significantly up-
regulated after treatment with TSA (Fig 3.24B) but there was no altered expression with 
UIMC1 gene (Fig 3.24A). 
 
 
Figure 3.24: Effects of histone modification on AuNP-treated SAEC gene expression. (A) 
Gene expression of UIMC1 was not affected by TSA treatment. (B) CDK1 gene 
expression increased significantly after treated with TSA. Error bars = SEM; *p < 0.05 





3.3 Biological effects of AuNPs in MRC5 lung fibroblasts  
3.3.1 Uptake of AuNPs into MRC5 lung fibroblasts 
(A) LM, AMG and CLSM 
In addition to SAECs, biological effects of AuNPs were also examined in MRC5 lung 
fibroblasts. MRC5 fibroblasts showed no apparent morphological alteration after 
exposure to AuNPs for 72 h as compared with unexposed fibroblasts (Fig 3.25B cf 
3.25A). Under LM, AuNPs which were originally wine-red color, appeared blue-black in 
color (arrow) inside MRC5 fibroblasts, after aggregation (Fig 3.25B). 
Exposure of MRC5 lung fibroblasts to 1 nM AuNPs resulted in internalization of 
the AuNPs as observed under LM but was more obviously seen after AMG enhancement 
(Fig 3.25D cf Fig 3.25C). AuNPs were mainly observed as small aggregates appearing as 
black spots of AMG grains (Fig 3.25D). Enhancement with AMG caused the internalized 
AuNP aggregates clearly observed due to silver deposition on the AuNPs, inside the 
fibroblasts (Fig 3.25D, inset). 
Under cLSM, nuclei of MRC5 fibroblasts were stained blue. There was no 





Figure 3.25 Morphological examination of MRC5 fibroblasts. (A) LM micrograph shows 
control MRC5 lung fibroblast without AuNP treatment. Scale bar: 200 µm. (B) 
Internalized AuNPs appearing as blue particles under LM. Scale bar: 200 µm. (C) LM 
micrograph shows control MRC5 lung fibroblasts without AuNP treatment after 
enhancement with AMG. Scale bar: 200 µm. (D) AMG grains formed after silver 
enhancement in AuNP-treated MRC5 fibroblasts. Scale bar: 100 µm. (E) CLSM 
micrograph shows clear cytoplasm without AuNPs. Scale bar: 20 µm. (F) CLSM 
micrograph shows dark deposits of AuNPs (indicated by arrows) in the cytoplasm of 




(B) TEM-EDX Analysis 
TEM was performed to validate that AuNPs were indeed internalized by the MRC5 
fibroblasts. Intracellular distribution AuNPs in the fibroblasts were visualized in ultrathin 
sections by TEM. At the ultrastructural level, the well-defined spherical shape and 
electron dense property of AuNPs enabled their unambiguous identification in ultrathin 
sections. AuNPs were visualized as black agglomerates 72 h post AuNP exposure (Fig 
3.26B cf Fig 3.26A) that were trapped in endosomes and lysosomes (Fig 3.26C), but were 
not able to enter the nucleus. Some free AuNPs were also found in the cytoplasm of the 
fibroblasts (Fig 3.26B) (arrows). To confirm the identity of the black deposits as Au, 
EDX analysis was conducted and verified that the electron dense aggregates were Au as 
depicted by the presence of two peaks that represent the gold M and L shells (arrows) 





Figure 3.26: Subcellular morphology of MRC5 cells and AuNP localization after 72 
hours AuNP treatment. (A) Micrograph shows the negative control on MRC5 cells 
without any AuNP uptake. Scale bar: 5 µm. (B) AuNP was taken up my MRC5 cells (red 
arrows) and localizes predominantly at cytoplasm, with some enclosed within the 
endosomes. Scale bar: 2 µm. (C) Electron dense AuNPs were clearly seen under EM and 
localized in the endosomes as black clusters. Inset shows enlarged micrograph on AuNPs 
localized in vesicles. Scale bar: 0.2 µm. (D) EDX spectrum shows the presence of Au in 





(C) ICPMS and mechanistic study on AuNP cellular uptake 
To accurately measure the number of AuNPs in MRC5 fibroblasts, ICPMS, a quantitative 
analysis technique, was employed to analyze the content of Au. The results showed that 
AuNPs taken up by MRC5 fibroblasts increased linearly with time, peaking at 72 h, 
before decreasing (Fig 3.27). 
 
Figure 3.27: ICPMS analysis on the amount of AuNPs (measured in ppb) internalized by 
MRC5 cells. Uptake of AuNPs increased over the time and peak at 72 h, saturated after 





AuNPs were enclosed within double membrane cellular vesicles as seen in the TEM 
shown in Figure 3.29. Hence, it was postulated that AuNP uptake might occur via 
Receptor Mediated Endocytosis (RME). RME inhibitors were used to study which 
endocytic pathway was involved in internalization of AuNPs into MRC5 cells. Inhibition 
of the clathrin-mediated pathway using concanavalin A significantly inhibited the uptake 
of AuNPs into MRC5 lung fibroblasts by 18.2% as compared with control cells (Fig 











Figure 3.28: Effect of endocytosis inhibitors on the AuNP uptake into MRC5 cells. 
ICPMS analysis revealed a significant decrease in AuNP uptake after MRC5 cells were 
treated with Concanavalin A in comparison with control. Experiments were performed in 





To ensure that the endocytosis inhibitors did not have an effect on cellular toxicity, 
thereby influencing uptake of the AuNPs, the viability of the MRC5 cells after treatment 
with the inhibitors was evaluated using the MTS assay. MRC5 fibroblasts were relatively 
insensitive to concanavalin A and chlorpromazine treatment since there were no 
significant differences in cell viability, although nystatin exhibited slight cytotoxicity at 
25 μg/ml, but still maintaining an average of 82% cell viability (Fig 3.29A). The F-actin 
structure which can affect uptake of AuNPs, was also not affected in cells treated with 
these endocytosis inhibitors (Fig 3.29B). This result indicated no cellular stress was 
induced by the use of inhibitors which could potentially alter the cytoskeleton network 






Figure 3.29: Cell viability and F-actin distribution in MRC5 lung fibroblasts treated with 
endocytosis inhibitors only. (A) There was no significant cytotoxicity observed in MRC5 
lung fibroblasts, following exposure to the different endocytosis inhibitors for 4 h. 
Percentage of cell viability was expressed as mean ± SEM. (B) Confocal microscopy 
images of MRC5 lung fibroblasts showed the F-actin morphology in control cells and 
following incubation with concanavalin A, chlorpromazine, and nystatin for 4 h. There 
was no increase in stress actin bundles in treated cells, indicating no changes in 
cytoskeletal structure organization. (Blue DAPI stained nuclei, Texas red-phalloidin 




3.3.2 Oxidative stress generated in MRC5 fibroblasts after AuNP exposure 
(A) LPO Assay 
There was an increase of the LPO content as observed in MRC5 fibroblasts after 72 h of 








Figure 3.30: Lipid peroxidative stress in MRC5 cells following exposure to 1 nM AuNPs. 
A higher level of LPOs was observed in AuNP-treated MRC5 cells when compared with 





(B) MT anti-oxidant gene screening 
The expression of functional MT-1 and MT-2 gene isoforms was assessed initially in 
MRC5 fibroblasts (Fig 3.31A). The MT-1E, MT-1X and MT-2A genes were the most 
abundant isoforms expressed by MRC5 fibroblasts (denoted by a lower delta CT value). 
There was a significant increase expression of MT-1X and MT-2A mRNA transcripts in 
comparison with untreated fibroblasts after exposure to 1 nM AuNPs (Fig 3.31B, C). At 
the protein level, MT protein expression was higher as validated using ICC (denoted by 
higher color intensity) (Fig 3.31E cf D). Moreover, there was a right shift in fluorescence 





Figure 3.31: MT isoform expression in MRC5 lung fibroblasts exposed to AuNPs. (A) 
Bar chart of MT isoforms endogenously expressed in MRC5 cells, with MT-2A showing 
the highest expression. (B) Significant up-regulation of MT-2A after exposure to AuNPs. 
(C) MT-1X was observed to be increased after treatment with 1 nM AuNPs. (D) LM 
micrograph of MRC5 cells stained with anti-MT E9 antibody (DAB with haematoxylin 
counterstain) for AuNP untreated MRC5 cells. (E) AuNP-treated MRC5 cells exhibited 
higher MT staining (more brown intensity). Scale bar: 50 μm. (F) Detection of MT using 
flow cytometryr showed a right shift of MT protein, indicating a higher protein 
expression in AuNP-treated MRC5 cells. (G) The mean intensity obtained from (F) was 
quantified and the results indicated a higher MT protein expression in AuNP-treated 





(C) Screening of other anti-oxidant genes 
Next, the transcripts of 8 genes (CAT, GPX1, GPX2, SOD1, SOD2, SOD3, Prx1, Prx3) 
which are involved in anti-oxidative response were examined in MRC5 cells after 
exposure to 1 nM of AuNPs for 72 h. There was no significant difference in the 
expression of anti-oxidant genes (Fig 3.32), in comparison with control MRC5 cells. 
 
Figure 3.32: Fold change of 8 selected anti-oxidant genes on AuNP exposed MRC5 cells 





3.3.3 Cytotoxicity of AuNPs  
(A) LDH assay 
It was observed that AuNPs induced significant cellular release of LDH at 0.5, 1 and 2 
nM concentrations at 24 h, indicating cell damage and toxicity (Fig 3.33A). However, 
only cells treated at 1 and 2 nM AuNPs showed significant LDH release post 48 h and 72 
h treatment (Fig 3.33B, C). 
 
 
Figure 3.33: LDH assay was used to determine cytotoxicity of MRC5 cells treated with a 
range of dose with AuNPs. (A) At 24 h, (B) 48 h and (C) 72 h, MRC5 showed significant 
release of LDH into the culture media, as an indicator of cellular membrane disruption at 
0.5 nM, 1 nM and 2 nM. All the experiments were conducted in triplicates. Error bars= 





(B) Trypan Blue assay 
Using trypan blue assay, there was a significant decrease in cell viability of MRC5 
fibroblasts treated with 2 nM AuNPs at 24, 48 and 72 h. Although there was a slight 
decrease in total cell count, the difference was not significant across all time points (Fig 
3.34D-F). There was no significant loss of cell viability at 48 and 72 h for all tested 
concentration except for 1 nM at 24 h (Fig 3.34A), 2 nM at 48 h (Fig 3.34B) and at 72 h 
(Fig 3.34C). 
Figure 3.34: Viability of MRC5 cells was determined by 0.4% Trypan blue dye exclusion 
assay following 24 h, 48 h and 72 h AuNP exposure. (A) Graphical representations of % 
of cell viability at 24 h, showed significant decrease in cell viability when treated with 1 
nM of AuNPs; and 2 nM at (B) 48 h and (C) 72 h. Total cell count was decreased when 
treated with AuNPs at (D) 24 h (E) 48 h and (F) 72 h, although these were not significant. 





(C) Hoechst 33342, AO/ EtBr staining and cell cycle analysis 
Hoechst 33342 nucleus staining for living cells was observed in fixed MRC5 fibroblasts, 
indicates no loss of cell viability after AuNP treatment (Fig 3.35B cf A). On the other 
hand, AO/EtBr staining showed that the some cells treated with 1 nM of AuNPs appeared 
orange-red in color (dead cells), while control cells appeared yellowish-green (live cells) 
under a phase contract microscopy (Fig 3.35D cf C). 
Figure 3.35E shows a representative flow cytometry DNA histogram for control 
and AuNP-exposed MRC5 lung fibroblasts. The percentage of at subG1 and S+G2/M 
phase of the cell cycle was determined using PI staining. The results show that there was 
no significant increase in apoptotic cells (denoted by subG1 phase) and no significant 
decrease in cell proliferation rate (denoted by S+G2/M phase) (Fig 3.35F), which is in 





Figure 3.35: Cytotoxic effects of AuNPs on MRC5 cells. (A) Hoechst 33342 nucleus 
staining (in blue) in (A) control and (B) AuNP-treated MRC5 cells. There was no 
apparent nuclear change in MRC5 cells after treatment with AuNPs. Scale bar: 50 µm. (C) 
AO/EtBr staining in control MRC5 cells shows green staining, indicating live viable cells. 
Scale bar: 50 µm. (D) Some red staining (arrow) was spotted in AuNP-treated MRC5 
cells, indicating occurrence of cell death. Scale bar: 50 µm. (E) DNA histogram revealed 
no changes in cell proliferation rate after treated with AuNPs in MRC5 cells. (F) Bar 




3.3.4 Microarray analysis of AuNP-treated MRC5 lung fibroblasts 
The quality of RNA samples was determined the same way as SAECs. All the samples 
displayed OD260/OD280 ratios of between 2.01 – 2.21, and concentrations ranged from 
~209 ng/μl to ~530 ng/μl (Fig 3.36A). The quality of the RNA was confirmed by 
performing gel electrophoresis (Fig 3.36B). The RIN obtained ranged from 8.3 to 9.2. For 
transcriptomic analysis, 300 ng total RNA from each sample was used (Fig 3.36C). 
Figure 3.36: Characterization of RNA quality of MRC5 for microarray study. (A) The 
good quality of RNA samples with 260/280 ratio ≥ 1.8. (B) Gel image of RNA samples. 




A cut-off at 1.5-fold absolute change was applied for analysis between untreated and 
treated samples. Heat map (Fig 3.37A) and volcano plot (Fig 3.37B).for the microarray 







Figure 3.37: Microarray data analysis. (A) A heat-map representation showing the clustering 
of the control and AuNP-treated MRC5 cells into two separated subclusters. Differentially 
expressed genes which were represented by their respective Affymetrix probe set Ids are 
shown in the rows. Columns represent MRC5 RNA samples (Sample A-C: control MRC5 
lung fibroblasts; Sample D-F: AuNP-exposed MRC5 lung fibroblasts). (B) Volcano plot for 
comparison of the transcriptomes of MRC5 cells treated with AuNP versus cells not exposed 
to the nanoparticles. 
19 genes were identified and were regulated over the 1.5-fold change cut off (Table 3.5). 
Among them, 9 genes were over-expressed, and 10 genes were down-regulated in AuNP-
treated cells compared with the untreated MRC5 cells. 11 genes selected for verification 
by real time RT-PCR had expression levels that were consistent with the data derived 
from microarray analysis (Fig 3.38). 
Figure 3.39: A comparison of gene expression profiles derived from microarray and 
q(RT)-PCR; the bars show the fold changes which were determined for the samples from 
AuNP treated and untreated MRC5 cells. Expression of the 11 genes by both methods 




Table 3.5: Differential expression of genes detected by Affymetrix Gene Analysis in 
AuNP-treated MRC5 lung fibroblasts. 
Gene name (description) Gene Accession Fold change 
Up-regulated genes   
FLJ10246 AK001108 1.70 
SLC38A5 NM_033518 1.69 
ZC3HAV1 NM_080660 1.60 
VEGFC NM_005429 1.60 
ITGA2 NM_002203 1.59 
RELN NM_005045 1.58 
MIRNA155 NR_001458 1.56 
ATP10A NM_024490 1.53 
ADAR NM_001033049 1.52 
Down-regulated genes   
SC4MOL NM_006745 1.91 
TAF9B|LOC728198 NM_015975 1.88 
PROS1 M15036 1.85 
C5orf21 NM_018356 1.82 
FAP NM_004460 1.75 
IDI1 NM_004508 1.66 
ZMAT3 NM_022470 1.60 
TRPA1 NM_007332 1.59 
STYX|LOC730432 NM_145251 1.51 
RFTN2 NM_144629 1.51 
*Genes that have at least a 1.5 fold change in AuNP-treated MRC5 lung fibroblasts as 





Using DAVID analysis, the differentially expressed genes could be classified into stress-
responsive genes and genes that are known to regulate cellular morphogenesis, blood 
coagulation, hemostasis, hydrolase activity, metal ion binding and sterol metabolism, as 
shown in Table 3.6. Genes that are related to sterol biosynthetic process, such as 
isopentenyl-diphosphate delta isomerase 1 (IDI1) and sterol-C4-methyl oxidase-like 
(SC4MOL) have been associated with synthesis of cholesterol while the other identified 






Table 3.6: Functional classification of genes using using DAVID analysis. 
Processes Genes involved 
Response to stress RELN 
  ZMAT3 
  TRPA1 
  PROS1 
  ITGA2 
    
Cellular structure morphogenesis  RELN 
  ZMAT3 
  ATP10A 
  ITGA2 
  VEGFC 
    
Metal ion binding  ZC3HAV1 
  IDI1 
  ZMAT3 
  ATP10A 
  SC4MOL 
  TRPA1 
  PROS1 
  ITGA2 
  ADAR 
    
Sterol biosynthetic process  IDI1 
  SC4MOL 
    
Hemostasis  PROS1 
  ITGA2 
    
    
    
    
Hydrolase activity RELN 
  IDI1 
  FAP 
  STYX|LOC730432 
  ATP10A 
  ADAR 





3.3.5 Epigenetic mechanisms induced by AuNPs in MRC 5 lung fibroblasts 
(A) Modulation of miR-155 which altered PROS1 gene expression following AuNP 
exposure  
A gene of interest identified from the microarray analysisis up-regulation of the non-
protein coding RNA, microRNA 155 (miR-155) which was concomitant with down-
regulation of 10 other genes (including the PROS1 gene) in AuNP treated fibroblasts. Up-
regulation of miR-155 after AuNP exposure was verified using a reporter assay 
containing a firely luciferase construct with a target site that is complementary to miR-
155. AuNPs was found to repress firefly luciferase activity by 63% in MRC5 fibroblasts 
transfected with the pmiR-155-Luc reporter, demostrating an increased turnover of 







Figure 3.39: MRC5 cells were transfected with the pMiR-Luc Reporter Vector for miR-
155 followed by 48 h post AuNP exposure. Firely luciferase activities of AuNP-treated 
fibroblasts and controls were measured for luminometry using the Dual-Glo™ Assay 
System. The luciferase activities were measured and showed a significant reduction in 
firely luciferase activity. The result indicated a higher miR-155 expression following 
AuNP treatment, resulting in more suppression on firely luciferase activity. Error 





Given that miR-155 performs its biological function by regulating the target protein-
coding genes, the predicted targets of miR-155 were anlayzed using six miRBase 
algorithms, PicTar (http://pictar.mdc-berlin.de), TarBase, miRanda 
(http://microrna.sanger.ac.uk) and TargetScan Release 5.1 (http://www.targetscan.org), 
mirBase (http://www.mirbase.org/) and MicroCosm Targets Version 5. However, none of 
the differentially expressed genes identified from the microarray data matched the 
potential predicted miR-155 targets. 
In order to better understand the biological role of miR-155 in this experimental 
setting, anti-miR-155 mediated silencing was performed in lung fibroblasts so as to detect 
any altered expression of the other 10 down-regulated genes from the microarray data. 
With this purpose in mind, the MRC5 lung fibroblasts were transfected with anti-miR-
155. Prior to this, optimization of the transfection condition using Cy-3 conjugated 
scrambled siRNA was performed and good transfection efficiency was achieved post 48 
h transfection using HIPERFECT (Fig 3.40A). qRT-PCR showed that anti-miR-155 
effectively reduced miR-155 expression with a knock down efficiency of 81.8% (Fig 
3.40C) coupled with increased in threshold cycle (Fig 3.40B). Silencing of miR-155 was 





Figure 3.40: Knockdown efficiency of miR-155. (A) A good transfection efficiency was 
achieved using Cy-3 conjugated scrambled siRNA after 48 h of transfection. (B) 
Graphical representation of silencing efficiency (denoted by a higher CT value) of miR-
155 after inhibited with anti-miR-155. (C) Significant down-regulation of miR-155 
expression at 48h post transfection in MRC5 cells with 81.8% of knockdown efficiency. 
(D) MTS assay revealed non-cytotoxic effect after MRC5 was transfected with anti-miR-





Silencing of miR-155 caused an increased expression of PROS1 at both mRNA and 
protein levels (Fig 3.41A-D). Taken together, these results appear to suggest that 
although endogenous miR-155 was expressed at relatively low levels in the lung 
fibroblasts, inhibiting its expression induced enhanced levels of PROS1 expression, 
thereby, indicating that miR-155 could regulate expression of PROS1. Both RNA and 
protein expression results imply that PROS1 is a target of miR-155. 
 
Figure 3.41: Effects of miR-155 inhibition on PROS1 expression. (A) Graphical 
representation of qRT-PCR analysis of PROS1 gene expression in MRC5 cells using 
G3PDH as a normalizer. PROS1 gene expression was up-regulated in anti-miR-155 
treated MRC5 cells. ** p<0.01; Error bar = SEM. P value obtained with respect to anti-
miR™ miRNA inhibitors negative control. (B) Silencing of the miR-155 gene caused an 
up-regulation of PROS1 protein expression as revealed by western blot. (C) Western blot 
analysis performed with antibodies against PROS1 and (D) the housekeeping protein 
beta-actin (as housekeeping loading control, data not shown). Graphical representation 
showed the densitometric quantitation of the western blot band intensities. Results are 




To show the relevance of the study, the level of PROS1 mRNA was quantitated in a 
commercially available normal human tissue array which comprised 48 different human 
tissues. PROS1 mRNA was detected in 45/48 normal tissues, and found to be absent in 
lymphocytes, mammary gland and muscle (Fig 3.42). The highest expression of the 
PROS1 gene was detected in lung tissue, which was followed by small intestine, adrenal 
gland, uterus, pituitary gland, heart, stomach, gonads (penis and ovary) and liver. 
Figure 3.42: TissueScan Human Normal Tissue used in a real-time PCR protocol in a AB 
7500 thermal cycler using PROS1 primers. The PROS1 amplification products were 
detected using the SYBR Green I, as fluorescence readings. Result showed that PROS1 






(B) DNA Methylation Profiling Analysis of PROS1 gene 
In view of the above finding that miR155 modulate the PROS1 gene, the CpG island at 
PROS1 promoter region was subjected to PCR using BSP primer before cloning into the 
vector. The PCR product was specific with a product size of approximately 280 bp (Fig 
3.43A). There was no change in DNA methylation profile of the PROS1 gene in AuNP-
treated cells as analyzed by bisulfite sequencing (Fig 3.43B), indicating that the absence 
of AuNP-induced epigenetic modifications with regard to the DNA methylation status of 
PROS1 gene. Moreover, MSP analysis was done using primers specific for un-
methylated or methylated DNA respectively. MSP result indicated that AuNP-exposed 
MRC5 cells do not display a high frequency of PROS1 methylation (Fig 3.43C). 
Figure 3.43: DNA methylation status analysis of PROS1. (A) Electrophoretic image 
depicting the specificity of PCR which shows 280 bp amplicon of PROS1 CpG island. (B) 
“Lollipop” schematic diagram of methylation patterns of the PROS1 promoter CpG 
island region using ClustalW (1.83) multiple sequence alignments. Results are derived 
from 2 AuNP-untreated samples and 2 AuNP-treated samples are shown. A black 
lollipop corresponds to a methylated C; white lollipops represent unmethylated C; and a 
stick corresponds to a non-CpG position. (C) MSP PCR analysis using primers specific 
for unmethylated (U) and methylated (M) sequences. qRT-PCR values were normalized 




(C) Chromatin reorganization in AuNP-treated MRC5 cells 
Transmission electron microscopy (TEM) revealed the presence of chromatin 
condensation in AuNP-treated fibroblasts as compared with untreated fibroblasts (Fig 
3.44A). An apparent reorganization of nuclear content and chromatin condensation in 
AuNP-treated MRC5 lung fibroblasts was observed under confocal microscopy (Fig 
3.44B), thereby, complementing the TEM results. 
TSA inhibition was also performed and the inhibitory effect on PROS1 gene was 
reversed, indicating that PROS1 gene expression was partly regulated through HDAC 




Figure 3.44: Histone modification and its effects on gene expression. (A) EM micrograph 
on chromatin condensation pattern in AuNP-treated MRC5 cells and large dark bodies 
are denoted as nucleoli (ncl). Chromatin reorganization was seen as electron-dense 
heterochromatin areas in the nucleus of AuNP-treated cells that are not present in 
untreated cells. Scale bar: 2 µm. (B) The morphological appearance of the confocal 
microscopic image following DAPI staining to stain the nucleus. (Left) Micrograph 
shows the normal morphology of nucleus. (Right)There was visible nuclear condensation 
in the nuclei. (C) TSA treatment reversed the inhibition on PROS1 gene expression. Error 





3.4 Biological effects of AuNPs in a co-culture system 
3.4.1 Differential protein expression induced by AuNP-exposed SAECs in 
neighboring lung fibroblasts 
SAECs were co-cultured in the upper chamber of a Transwell polycarbonate membrane 
with SILAC-labelled MRC5 lung fibroblasts in the lower chamber. AuNP pre-exposed to 
SAECs were subsequently co-cultured with lung fibroblasts to mimic the physiological 
environment present in the lung. 
To ensure that the downstream effects observed later in MRC5 fibroblasts were 
triggered by cellular crosstalk and not due to AuNPs which could have leaked through the 
membrane pore, TEM on MRC5 fibroblasts after co-culturing was performed. There 
were no AuNPs found in both the cytoplasm and nucleus of the MRC5 fibroblasts (Fig 
3.45). 
Figure 3.45: EM micrographs of MRC5 cells after co-cultured with AuNP pre-exposed 
SAECs. Micrographs show that there were no AuNPs found at both cytoplasm and 




(A) SILAC proteomic analysis 
Proteins from the SILAC-labeled MRC5 lung fibroblasts were isolated after 72 h of co-
culturing with SAECs for quantitative proteomics analysis. Prior to this, incorporation 
check was performed and a good incorporation efficiency of 97% was achieved, 
indicating a successful metabolic incorporation of stable isotope labeled amino acid 
Arginine and Lysine into MRC5 fibroblasts (Fig 3.46). Based on replicates of the forward 
and reverse experimental sets, over 3000 proteins were quantified and applied statistical 
processing to derive high confidence datasets. Protein ratios with significant values of 
p(forward)<0.05 and p(reverse)<0.05 were considered as differentially expressed proteins. 
Using these criteria, there were 47 up-regulated proteins and 62 down-regulated proteins 
being identified in the lung fibroblasts (Table 3.7, 3.8). 
 
Figure 3.46: Labeling efficiencies for light- and heavy-labeled peptides were determined 
and clearly distinguishable by using MS analysis. MRC5 cell protein lysates were 
removed earlier on to check incorporation of the light and heavy amino acids after 4-5 
doubling times and revealed a successful and high incorporation rate. (A) Incorporation 





Table 3.7: 47 up-regulated proteins in MRC5 fibroblasts based on quantitative mass 
spectrometry. 
Gene Name Normalized H/L p(Fwd)xp(Rev) Counts 
Forward Reverse 
PDIA5 5.4591 0.60086 6.13E-135 1 
PLIN2 4.3003 0.18267 2.83E-114 9 
SLC2A14;SLC2A3 3.6165 0.37036 8.98E-100 10 
NDRG1 3.341 0.21767 2.09E-67 22 
NMES1 3.3287 0.46204 1.04E-28 1 
SLC2A1 3.1503 0.39533 2.39E-85 25 
FTL 3.0698 0.50011 1.92E-51 35 
RHOB 2.2926 0.44888 1.11E-15 3 
FTH1 2.1853 0.3553 7.11E-21 66 
IRS2 2.111 0.529 1.09E-09 1 
DEK 2.0135 0.69679 2.45E-13 10 
AHNAK2 1.9154 0.68351 1.43E-08 5 
HK2 1.8372 0.58478 1.89E-16 20 
ERO1L 1.8056 0.48635 3.19E-11 22 
BCAR1 1.8025 0.47369 1.46E-14 8 
UAP1 1.7718 0.63016 1.19E-09 18 
FAM107B 1.7716 0.6019 4.68E-07 2 
PLOD2 1.7673 0.53173 3.46E-10 65 
TPBG 1.7617 0.51584 1.08E-10 11 
CDK6 1.7383 0.60224 2.17E-07 3 
ENO2 1.6915 0.37861 3.98E-15 15 
SLC7A5 1.6912 0.62297 5.79E-08 6 
S100A10 1.6743 0.53803 3.55E-09 13 
AKAP2 1.6273 0.71723 9.71E-07 15 
INF2 1.5444 0.71692 9.67E-06 22 
PGM2L1 1.5031 0.69229 1.56E-04 3 
LOX 1.4909 0.35849 2.56E-09 5 
RRAGC;RRAGD 1.4891 0.66958 1.27E-04 3 
PTTG1IP 1.4888 0.6217 9.57E-07 6 
GBE1 1.4869 0.62165 1.63E-05 56 
CAV1 1.4847 0.62148 6.56E-08 24 
C4orf3 1.4687 0.62623 8.61E-05 4 
PXN 1.4679 0.62124 1.06E-05 10 
FAM129A 1.4277 0.5735 8.21E-05 4 
ASNS 1.4219 0.49107 4.95E-07 25 
PRKCDBP 1.4184 0.64449 5.05E-05 7 
CRIP2 1.4127 0.7025 1.19E-04 6 
KIAA1609 1.3935 0.68247 3.83E-05 3 




SLC25A4 1.3719 0.65692 7.59E-04 3 
DEGS1 1.354 0.66756 9.14E-05 4 
KIAA1715;LNP 1.3459 0.62208 6.97E-04 1 
EFTUD1 1.3438 0.68398 1.52E-03 5 
FAM210A 1.3191 0.68605 1.88E-03 2 
MAP2K1 1.2962 0.69139 1.46E-04 12 
PGRMC1 1.2882 0.71251 2.63E-04 14 






Table 3.8: 62 down-regulated proteins in MRC5 fibroblasts based on quantitative mass 
spectrometry. 
Gene Name Normalized H/L p(Fwd)xp(Rev) Counts 
Forward Reverse 
NACA 0.79062 1.2567 1.87E-03 14 
DDX5 0.76527 1.5726 1.72E-07 33 
HIST1H1B 0.7462 1.3763 1.82E-04 10 
PCNA 0.7396 1.2926 2.62E-04 23 
SERPINB2 0.73444 1.3664 4.25E-05 30 
G3BP1 0.73344 1.3609 4.74E-05 28 
PSME3 0.73332 1.5614 3.98E-06 18 
ITGA1 0.72895 1.3761 3.18E-04 41 
PRMT1 0.72859 1.3563 4.64E-05 32 
AASDHPPT 0.72169 1.3848 6.90E-04 7 
FASN 0.71522 1.6752 7.94E-10 193 
RANGAP1 0.7126 1.34 1.32E-04 29 
G3BP2 0.71001 1.3228 1.53E-03 10 
KIAA0664 0.70684 1.5065 4.78E-05 21 
HIST1H1C 0.69903 1.3046 6.44E-05 16 
GPX4 0.69785 1.5034 1.80E-04 5 
KPNA2 0.69768 2.1906 2.76E-18 14 
ATXN10 0.6938 1.4889 5.43E-05 7 
MAT2A 0.69175 1.4271 8.63E-06 14 
VWA5A 0.68396 1.8526 4.52E-11 30 
TFRC 0.6814 1.6278 2.00E-09 57 
HIST1H1E 0.66914 1.3088 8.38E-04 2 
HNRNPL 0.66636 1.5016 1.02E-05 12 
CAPRIN1 0.66313 1.5067 3.33E-06 19 
CHD4 0.66269 1.4346 2.73E-04 27 
STAT1 0.66004 1.2437 6.23E-05 39 
SOD2 0.65974 1.4192 1.11E-06 43 
RBBP4 0.64746 1.4318 6.53E-05 6 
TGM2 0.62083 2.1027 2.35E-21 37 
NUP160 0.61909 1.7419 1.74E-04 5 
RBM4;RBM4B 0.61524 1.5384 1.24E-04 3 
PELP1 0.6078 2.1472 1.79E-07 4 
RRM1 0.60579 1.9317 1.58E-11 13 
DDX18 0.60532 1.5384 7.67E-04 5 
RNF181 0.60477 1.6514 1.03E-03 2 
CSDA 0.60371 1.3085 4.37E-05 6 
LARP4 0.60174 1.5805 4.15E-04 1 
DNMT1 0.57596 1.9552 1.29E-09 12 
PABPN1 0.5711 1.3895 7.00E-04 2 
C1orf198 0.55695 2.0824 2.30E-06 2 




RANBP2 0.54531 1.9551 1.75E-07 7 
CTGF 0.51782 2.0994 3.59E-09 5 
IGFBP4 0.50764 2.0219 1.82E-07 7 
HNRNPC 0.49956 2.5119 3.17E-25 11 
TYMS;TS 0.49653 1.8434 8.27E-09 6 
SPARC 0.48948 1.3466 7.67E-05 6 
CYP51A1 0.4882 1.6908 1.04E-04 1 
WNT5A 0.47709 1.9729 4.27E-08 2 
BRIX1 0.47247 1.6834 5.94E-05 2 
ACSL4 0.46869 1.9827 1.31E-16 18 
FADS2 0.46501 2.2737 1.15E-11 5 
PLAU 0.44408 3.0376 3.57E-18 1 
COL3A1 0.43769 1.3665 5.94E-08 24 
SORT1 0.419 2.033 2.40E-09 3 
DHFR 0.38923 2.5522 5.54E-12 2 
COL7A1 0.36909 1.3365 3.47E-09 64 
TXNL1 0.33098 5.2248 1.17E-163 11 
NDUFA4 0.32199 2.311 7.13E-21 13 
SAA1 0.30659 4.894 4.02E-49 3 
C3 0.27835 2.0353 8.01E-09 3 






(B) Pathway analysis of differentially expressed proteins 
For further evaluation of the significance of the altered proteins in the MRC5 lung 
fibroblasts and elucidation of potential mechanistic pathways, up- and down-regulated 
proteins clusters were subjected to pathway analyses using the Gene Ontology (GO) 
program (Fig 3.47A). The results revealed that the dysregulated proteins were mainly 
involved in cell adhesion and extracellular matrix (ECM)/cytoskeleton remodeling (Fig 
3.47B). Proteins associated with promoting cell migration such as Plasminogen activator, 
urokinase (PLAU, UPA) and chemokine growth-regulated oncogene 1 (GRO-1) were 
significantly down-regulated in MRC5 lung fibroblasts. These proteins are major hubs in 





Figure 3.47: AuNP-treated SAECs induced differential protein expression in MRC5 lung 
fibroblasts. (A) The number of proteins with each ratio value was plotted on the y axis 
against log2 SILAC ratio values on the x axis. The abundance of each protein which is 
indicated by the position of the dot on the y axis was determined by summing all 
individual light and heavy peptide intensities. (B) GO (C) Protein interaction networks 
for the MRC5 proteins involved in cell adhesion. Four out of five proteins with high 




3.4.2 Cell adhesion and cytoskeleton staining in MRC5 lung fibroblasts 
To address the importance of the three up-regulated adhesion proteins Paxillin (PXN), 
breast cancer anti-estrogen resistance 1 (BCAR1) and Caveolin-1 (Cav-1) with regard to 
cell adhesion, the differences in adhesive ability using different substrate coating were 
evaluated. MRC5 lung fibroblasts co-cultured with AuNP-exposed SAECs exhibited a 
significant increase in cell adhesion towards fibronectin (Fig 3.48A), as well as Collagen 
I (Fig 3.48B), compared to the control. As up-regulation of PXN, BCAR1 and Cav-1 are 
known to be involved in FA formation and regulate local FA dynamics, possible 
disruption of the cytoskeleton in the MRC5 lung fibroblasts was further examined. 
Indeed, there was altered F-actin arrangement in the cytoskeleton of the MRC5 lung 
fibroblasts, coupled with an increase in stress fiber or FA formation (Fig 3.48C) and an 
increase in vinculin binding sites, which are involved in anchoring F-actin to the cell 





Figure 3.48: Cell adhesion and cell cytoskeleton remodeling. (A) Cell adhesion on 
fibronectin substrate was approximately 19% higher compared to control MRC5 lung 
fibroblasts, Error bar=SEM; *p<0.05. (B) Cell adhesion on collagen I substrate showed 
an increase percentage of adhered cells compared to control lung fibroblasts. (C) MRC5 
lung fibroblasts co-cultured with SAECs treated with or without AuNPs were stained for 
F-actin (green) and DAPI (blue). Lung fibroblasts co-cultured with AuNP-treated SAECs 
exhibited an increase in stress fibers with enrichment at the cell membrane and adhesion 
sites. Scale bar =20 µm. (D) Alteration of adhesion dynamics in lung fibroblasts co-
cultured with AuNP-treated SAECs, showing an increase in vinculin (in green) adhesion 




3.5 Biological effects of AuNPs in an in vivo model 
3.5.1 Dosimetry of AuNPs 
ICP-MS analysis of the AuNP stock formulation gave a concentration of 256 µg/ml; thus, 
single dose at 0.1 mg/kg of the formulation would correspond to ≈ 20 µg of Au, on the 
basis that a single IV injection was performed into a 200 g rat (assuming even AuNP 
distribution inside rat body). The dose used for animal study is equivalent to the dose 
used in a Phase I clinical trial (Libutti et al., 2010), so as to achieve a physiologically 
relevant dose. The highest dose of AuNPs used in this study (0.2 µg/g) is on the lower 
side of doses that have been reported in available published literature, which ranges from 
0.01 µg/g to 2700 µg/g (Khlebtsov and Dykman, 2011). 
 
3.5.2 Biodistribution of AuNPs 
The results of the biodistribution studies after 1 week, 1 month and 2 months post single 
IV injection are given in Table 3.9 and visualized in Figure 3.49. Au was detected at 
levels exceeding those of the control rats, and consistently found in the lungs for all 
treatment groups. Au uptake was the highest in 0.025 mg/kg/p.e 1week rat and lowest in 
0.1 mg/kg/p.e 1 month rat, where the average concentrations were 100.8 ng/g and 28.02 
ng/g, respectively (Table 3.9). However, it was observed that the level of Au in the lung 
showed a decrease with time post 1-week, 1 month and 2 months injection (from 64.61 
ng/g to 28.02 ng/g) with the same single exposure dose of 0.1 mg/kg, suggesting 
clearance from the respiratory organ. No traces of Au were detected in the blood of all 
AuNP-injected rats following injection. As expected, the animals administered with UP 
water showed negligible Au accumulation. Accumulation of AuNPs in organs such as 
kidneys and liver decreased over time, indicating that the AuNPs were slowly being 














; 1 week 
0.2mg/kg





Lung 0.2x10-7±18.28 100.8±117.8 96.51±43.5a** 64.61±30.1a** 51.53±19.02a* 58.96±42 28.02±51.94 
Kidney 1.8x10-2±6.465 13.42±9.508 1.964±14.77 3.692±29.77 12.6±32.97 5.695±12.61 38.06±30.47 
Liver 536.7±583.4 NA NA NA 2172±2408 4.074±15.16 95.42±189.9 
Values indicate mean concentration and standard deviation (ng/g of tissue). 
a
 Indicates significant increase compared to non-injected controls based on independent-t 
test. 
There wasn't a significant difference for all comparison using one-way ANOVA with 
Tukey's post-hoc test. P>0.05. 
 
 
Figure 3.49: Amount of deposited Au measured with ICPMS in the seven experimental 
groups. In comparison with rats untreated only with AuNPs (below the detection limit), 
the amount of deposited Au was not significantly different in rats among all the treated 





3.5.3 Gross observation and body weight changes 
The body weight of the rats was monitored and weighed before necropsy. The injections 
were well tolerated and no adverse effects were observed during the entire experiment 
(Fig 3.50). There was no lethal effect observed on rat injected with AuNPs. No severe 
sickness, loss of appetite, weight loss, change in fur color, and shorter average lifespan 
were observed. 
 
Figure 3.50: Body weight of 7 male Wistar rat groups. The body weight was weighted 
every alternate day from period of 1 week to 2 month experiment period for every 
experimental groups and control groups. There was no mortality observed in this study. 
Animals of AuNP-treated groups showed normal and consistent gain in body weight 
when compared to the control group of animals. The IV injection of AuNPs of six 
different doses for different duration did not cause significant death and weight loss in 




3.5.4 Effects of AuNP exposure on inflammatory cytokine expression 
Changes in serum cytokine expression following single dose of AuNP treatment were 
also noted in this study. There was a significant increase of cytokines in the serum of 
treatment groups, suggesting the presence of inflammation. 1 week, 1 month and 2 
months after single injection of 0.1 and 0.2 mg/kg of AuNPs showed mild systemic 
inflammation as assessed by blood serum cytokine level using ELISA. Significant 
expression was observed in serum Transforming growth factor beta (TGF-β) expression 
in single dose of 0.1 mg/kg AuNP-treated rats post-exposed for 1 week, 1 month and 2 
months, as compared to controls (Fig 3.51A). However, at low dose of AuNPs (0.05 
mg/kg; p.e 1 week), there was no significant inflammation observed. Proinflammatory 
cytokine Interleukin 6 (IL-6) expression was significantly higher in 0.1 mg/kg AuNP 
treated rats and persisted up to 2 months post exposure (Fig 3.51B). Another 
proinflammatory cytokine, IL-1α, was found to be expressed highly in 0.1 mg/kg and 0.2 





Figure 3.51: Anti- and pro-inflammatory cytokine expression in rat plasma. (A) TGF-β 
and (B) IL-6 in rat plasma. There was a significant change in inflammatory cytokines, 
especially for rats exposed to AuNP for 1 month & 2 months. (C) IL-1α in rat plasma was 
significantly higher in 1 week AuNP exposed rats. P.e= post exposure; Error bar=SEM; 




3.5.5 Prothrombin time (PT) test 
The Prothrombin time (PT) test was performed using ex vivo whole plasma from Wistar 
rats. The plasma was clotted using thromboplastin and CaCl2. In this test, blood clot 
formation occurred after the addition of CaCl2. The clotting process proceeded normally 
for control group, 0.025 mg/kg; p.e 1 week and 0.05 mg/kg; p.e 1 week AuNP-exposed 
group. However, when compared with AuNP unexposed rats, PT was significantly higher 
in rats injected with single dose of 0.2 mg/kg; p.e 1 week and 0.1 mg/kg; p.e 1 month 
(Fig 3.52A), indicating the influence of AuNPs on the coagulation pathway. PT was 
prolonged in both 0.2 mg/kg; p.e 1 week and 0.1 mg/kg; p.e 1 month AuNP-exposed rats 
as compared to rats exposed to 0.1 mg/kg; p.e 2 months and unexposed rats (Fig 3.52B). 
Notably, rats exposed to single dose of 0.1 mg/kg for 2 months rats had reversal of 
prolonged PT, indicating a recovery from AuNP-induced inhibitory effects on blood 





















Figure 3.52: Prothrombin time (PT) was prolonged in 0.2 mg/kg; 1 week and 0.1 mg/kg; 
1 month AuNP-exposed rats. (A) PT test for rats treated with AuNPs. AuNPs increased 
prothrombin time/ coagulopathy in rats. (B) The 0.2 mg/kg; 1 week and 0.1 mg/kg; 1 
month rat blood plasma did not form a blood clot after 600 seconds. There was formation 
of blood clot observed in rats exposed to 0.1mg/kg for 2 months and control rats. In 0.1 
mg/kg; 2 months AuNP-exposed rat, there was partial/incomplete blood coagulation 






3.5.6 PROS1 gene expression in rat lung tissues 
As PROS1 gene expression was found to be altered in MRC5 cells, RT-PCR on PROS1, 
together with SERPINE1 and TF was performed. It was observed that there was a 
significant increased in PROS1 gene expression, an upstream target for SERPINE1, in 0.2 
mg/kg; p.e 1 week AuNP-exposed rats (Fig 3.53). This is also accompanied by a decrease 
in the expression of TF (the primary initiator of coagulation). TF, a key mediator of the 
activation of coagulation in the lung, which was decreased in 0.2 mg/kg; p.e 1 week and 
0.1 mg/kg; p.e 1 month AuNP-exposed rats. 
 
Fig 3.53: PROS1 gene expression levels in rat lung tissues. There was a significant 
increase in the pulmonary expression of PROS1 in single dose 0.1 mg/kg; 1 month rats 
post AuNP exposure in rats. On the other hand, TF expression was decreased in the      






3.5.7 Histopathology of lung tissues 
Histpathological analysis was performed on sections of the lungs, for pathological 
changes. The histopathological examination of the lung revealed signs of focal 
inflammation with influx of lymphocytes in AuNP-treated rats (Fig 3.54), which were 
absent in control rats. 
Figure 3.54: Photomicrographs of sections representative of the histological changes 
observed. In 0.1 mg/kg and 0.2 mg/kg; 1 week post exposure AuNP-treated rats, there 
were areas with lymphocytic infiltration. High-power magnification (on the right) shows 
the enlarged boxed area with lymphocytes. The results indicate the presence of 
inflammation in the rat lung after IV injection of AuNPs in comparison with unexposed 




Other than induction of plasma IL-1α, expression of IL-1α in rat lung tissues was also 
studied using IHC. Concomitant with influx of lymphocytes as observed in Figure 3.54, 
there was a dose-dependent increase in IL-1α staining in 0.2 mg/kg; p.e 1 week AuNP-
exposed rats as compared with 0.1 mg.kg; p.e 1 week AuNP-exposed rats. This results 
indicate that higher amount of AuNPs was capable of triggering more inflammatory 
response. Control unexposed rat lung tissue showed a faint staining for IL-1α (Fig 3.55). 
Figure 3.55: IHC staining for IL-1α (in brown) in rat lung tissues. Micrographs on the 
right (Scale bar: 50 µm) show higher magnification of micrographs on the left (Scale bar: 




Other than lymphocytes, macrophages in the lung form the first line of defence in 
response to internal and external insults to the lung. An increased number of 
macrophages (Fig 3.56, Fig 3.57) and influx of lymphocytes suggested inflammation to 
the lung tissues. 
Figure 3.56 Immunofluorescent detection of macrophage in rat lung tissues. The 
distribution of fluorescence (in red) for CD68, a marker for macrophage in rat lung 
tissues was examined. The regions of greatest intensity of fluorescence was found in 0.2 
mg/kg; 1 week AuNP-exposed rat; lesser intensity in 0.1 mg/kg; 1 month rats. Control 
rats exhibited CD68 staining too, indicated the presence of resident macrophages in lung. 





Figure 3.57 Quantitation of the fluorescence intensity of macrophage in rat lung tissues. 
The distribution of fluorescence intensity for CD68 is the greatest in 0.2 mg/kg; 1 week 
AuNP-exposed rat; lesser intensity in 0.1 mg/kg; 1 month rats. Control rats exhibited the 

























3.5.8 Inflammatory and autoimmune response related miRNA superarray 
To identify miRNAs which might play important roles in AuNP toxicity, restricted 
analyses focusing on inflammatory and autoimmune response was performed. The 
miRNA expression profile was found to be significantly altered in rats injected once with 
0.1 mg/kg and 0.2 mg/kg of AuNPs and exposed for 1 week as compared with control 
rats. Out of 84 screened miRNAs, three significantly down-regulated miRNAs in rat lung 
tissues were miR-29b-3p and miR-327. Compared with control group, qRT-PCR results 
identified significant dysregulation of miR-140-5p and miR-327 in 0.1 mg/kg; p.e 1 week 






Table 3.10: Dysregulated miRNAs in rat lung tissues. 
miRNAs Fold Regulation in 0.1 
mg/kg; p.e 1 week 
p-value Fold Regulation in 0.2 
mg/kg; p.e 1 week 
p-value 
rno-let-7a-5p -1.5987 0.377392 -1.518 0.28784 
rno-let-7b-5p 1.1375 0.748189 -1.4408 0.303721 
rno-let-7c-5p -1.0537 0.746078 -1.1065 0.409145 
rno-let-7d-5p 1.321 0.409699 1.2435 0.532552 
rno-let-7e-5p -1.0912 0.669534 -1.4926 0.283137 
rno-let-7f-5p -1.0766 0.84545 -1.0693 0.92495 
rno-let-7i-5p -1.7808 0.423329 -1.3422 0.320175 
rno-miR-101a-
3p 
1.8065 0.725296 -1.1982 0.356135 
rno-miR-101b-
3p 
2.148 0.656941 1.0318 0.439434 
rno-miR-106b-
5p 
1.0698 0.74723 -1.2157 0.277403 
rno-miR-125a-
5p 
1.1507 0.879843 -1.1681 0.170959 
rno-miR-125b-
5p 
-1.286 0.389319 -1.2464 0.194409 
rno-miR-128-3p 1.8421 0.928627 2.0044 0.355946 
rno-miR-136-5p -10.6111 0.138094 -4.7738 0.090587 
rno-miR-140-5p 2.3299 0.040413 1.4865 0.217244 
rno-miR-141-3p 2.5632 0.152477 -1.0025 0.851235 
rno-miR-142-3p 1.6901 0.260848 2.1199 0.118308 
rno-miR-144-3p 1.7774 0.26639 -3.3497 0.081302 
rno-miR-145-5p 1.0514 0.435742 -1.2831 0.30982 
rno-miR-148b-
3p 
1.0083 0.525642 -1.6989 0.14627 
rno-miR-152-3p 1.1783 0.419153 -1.1074 0.940519 
rno-miR-15b-5p 1.2942 0.703103 1.426 0.698452 
rno-miR-16-5p -1.2472 0.527782 -1.7009 0.118086 
rno-miR-17-5p 1.0733 0.885538 -1.2616 0.239769 
rno-miR-181a-
5p 
5.4806 0.315947 2.9008 0.888551 
rno-miR-181b-
5p 
2.8706 0.183425 1.9726 0.514787 
rno-miR-181c-
5p 
2.4091 0.353894 1.4664 0.936107 
rno-miR-181d-
5p 
3.2303 0.272705 1.3028 0.830934 
rno-miR-182 1.2914 0.808115 -1.1651 0.40767 
rno-miR-183-5p 3.9643 0.240197 2.2358 0.530359 
rno-miR-186-5p 2.2634 0.172856 -1.3532 0.577474 
rno-miR-195-5p -1.2782 0.436874 -1.8332 0.144182 
rno-miR-19a-3p -1.1392 0.347601 -1.2906 0.241939 






-1.0134 0.385322 -1.887 0.211852 
rno-miR-200c-
3p 
1.5166 0.82188 1.1599 0.414088 
rno-miR-203a-
3p 
-1.2557 0.557842 -1.3006 0.365274 
rno-miR-205 1.2821 0.745461 -1.5056 0.169321 
rno-miR-20a-5p 1.4012 0.594993 1.5676 0.352609 
rno-miR-20b-5p 1.4612 0.304098 -1.0181 0.782896 
rno-miR-21-5p 1.0393 0.859986 -1.0002 0.997611 
rno-miR-221-3p 1.2042 0.800468 -1.5474 0.074098 
rno-miR-222-3p 1.4622 0.822264 1.401 0.853995 
rno-miR-23a-3p 1.0371 0.938106 -1.5491 0.162065 
rno-miR-23b-3p -1.1086 0.987966 -1.2251 0.572609 
rno-miR-26a-5p 1.197 0.487675 -1.0976 0.731339 
rno-miR-26b-5p -5.5197 0.856543 -1.024 0.935448 
rno-miR-27a-3p 1.8343 0.159152 1.0787 0.908668 
rno-miR-27b-3p -1.0017 0.932404 -1.1636 0.441435 
rno-miR-291a-
3p 
-12.3147 0.084167 -7.5864 0.068704 
rno-miR-29a-3p -1.7434 0.11738 -1.8018 0.750108 
rno-miR-29b-
3p 
-2.3051 0.191506 -4.5094 0.022434 
rno-miR-29c-3p -1.9427 0.180824 -2.6236 0.068012 
rno-miR-30a-5p -1.0166 0.702256 -1.7904 0.139807 
rno-miR-30b-5p 1.1494 0.567398 -1.7255 0.090116 
rno-miR-30c-5p 1.135 0.592135 -1.9289 0.097851 
rno-miR-30d-5p -1.1318 0.547435 -1.8733 0.217862 
rno-miR-30e-5p -1.3488 0.258921 -2.1174 0.082282 
rno-miR-320-3p 1.2408 0.531505 -1.6922 0.343749 
rno-miR-322-5p -1.4606 0.441302 -1.4653 0.487905 
rno-miR-323-3p -11.2582 0.289463 -6.8182 0.202823 
rno-miR-325-3p -9.9159 0.1702 -6.9777 0.110941 
rno-miR-327 -5.881 0.02188 -8.4062 0.013541 
rno-miR-34a-5p 3.0584 0.272134 1.8963 0.937354 
rno-miR-34c-5p 1.3411 0.370652 1.8404 0.646683 
rno-miR-351-5p -1.5468 0.301245 -1.0805 0.325644 
rno-miR-369-3p -11.9486 0.174489 -8.9264 0.115413 
rno-miR-374-5p -1.3261 0.82026 -1.6879 0.43963 
rno-miR-381-3p -5.7765 0.15977 -11.5601 0.073183 
rno-miR-384-5p -6.0376 0.178463 -3.323 0.123838 
rno-miR-410-3p -7.5761 0.10439 -8.7947 0.083526 
rno-miR-429 -1.6002 0.240994 -1.9909 0.067821 
rno-miR-448-3p -11.9854 0.174491 -11.7942 0.095204 
rno-miR-449a-
5p 




rno-miR-495 -8.7793 0.179737 -5.6918 0.115526 
rno-miR-497-5p -1.1652 0.618521 -1.9703 0.193731 
rno-miR-539-5p -11.7053 0.174876 -9.4508 0.113622 
rno-miR-664-3p -1.4581 0.281782 -1.5736 0.338469 
rno-miR-673-5p -8.4445 0.223204 -6.9911 0.165498 
rno-miR-743b-
3p 
-13.3007 0.233447 -7.5757 0.115296 
rno-miR-878 -11.5563 0.166953 -9.6476 0.103136 
rno-miR-9a-5p -2.0776 0.632612 -1.3245 0.509295 
rno-miR-93-5p 1.5653 0.744229 1.308 0.908042 
rno-miR-98-5p 3.8687 0.142509 1.7355 0.23848 
cel-miR-39-3p -18.4395 0.184699 -28.3843 0.112443 



























4.1 Internalization of AuNPs by lung cells 
4.1.1 Functionalization of AuNPs with FBS 
In this present study, AuNPs were used as a model NP system for toxicity study due to its emergence in 
biomedical applications and the ease of controlling the size and shape of these NPs during synthesis 
(Chithrani and Chan, 2007). Moreover, spherical shape AuNPs with diameters between 20 to 30 nm have 
been reported to exhibit an easier uptake (Chen et al., 2013b). As citrate-capped AuNPs have been 
reported to be toxic (Tedesco et al., 2010), functionalization of the AuNPs is necessary prior to the 
toxicity studies. Hence, AuNPs was functionalized with FBS (refer to section 2.1) before use for 
experimentation. AuNPs pre-coated with FBS as a corona protein possesses lesser non-specific affinity to 
the cell surface than naked NPs, thereby reducing AuNP toxicity. In addition, opsonization of FBS on 
AuNPs would aid in the interaction of AuNPs with cell surface receptors and their uptake into the cells 
(Lynch et al., 2009; Tenzer et al., 2013). 
 
4.1.2 Cellular uptake of AuNPs 
To investigate the effects of AuNPs in the lung model, primary airway epithelial cells (SAECs) isolated 
from distal portion of human lung in the bronchiole area were used. SAECs are reported to be well suited 
for NP and other air-borne diseases studies (Russell et al., 2008), in addition to MRC5 lung fibroblasts 
which were used in the previous studies by Li et al (2008, 2010a, 2011a) as fibroblasts are present in the 
stroma of the lung. 
Internalization of AuNPs was observed under light and transmission electron microscopy. Under 
EM, AuNPs were found to be enclosed by cytoplasmic vesicles in cytoplasm of both SAECs and MRC5 
cells. Moreover, the AuNPs frequently appeared as clusters since agglomeration was also likely to occur 
in the majority of engineered NPs, due to inherent properties such as high surface activity (Kim et al., 





like vesicles, lead to the postulation that uptake of AuNPs was mediated by surface adsorption of serum 
proteins onto the AuNP surface via RME (Chithrani et al., 2006). RME comprises of clathrin- and 
caveolae-mediated pathways (Hao et al., 2012); and hence the pathway for AuNP uptake was determined 
by using chemical inhibitors that selectively inhibit specific endocytic pathways (Vercauteren et al., 2010). 
Quantitative analysis by ICPMS confirmed that internalization of AuNPs by the MRC5 fibroblasts was 
via clathrin-mediated endocytosis pathway, as inhibition of this pathway by concanavalin A significantly 
decreased the uptake of AuNPs. Caveolae-mediated endocytosis inhibitor, nystatin, did not markedly 
inhibit AuNP uptake. This is also consistent with other studies showing that uptake of 20 nm AuNPs in 
syncytiotrophoblasts of mouse placental tissues (Rattanapinyopituk et al., 2013a) and 20 nm carboxylate-
modified polystyrene fluorescent beads in HeLa cells are facilitated by clathrin-mediated endocytosis 
(Smith et al., 2012). By understanding the mechanism by which AuNPs are taken up by the cells, the 
design of AuNPs can be tailored for effective intracellular delivery of NPs for diagnostic and therapeutic 
uses (Wang et al., 2010). 
Scavenger receptors are a sub-group of structurally unrelated receptors which function to 
recognize and mediate the uptake of polyanionic ligands and modified low-density lipoprotein (LDL) 
(Patel et al., 2010; Wang et al., 2012), as well as nanoscale objects, including engineered NPs (Patel et al., 
2010; Kanno et al., 2007). Other than CME, scavenger receptor A mediated endocytosis was reported to 
mediate the internalization of negatively charged carboxydextran coated iron oxide NPs (diameters of 20 
and 60 nm) in human monocyte-derived macrophages (Lunov et al., 2011). Due to the anionic nature of 
AuNPs used in this study, CME is, however, not the only responsible mechanism responsible for the 
uptake and intracellular trafficking of AuNPs. Instead, multiple mechanism such as scavenger receptor 
mediated endocytosis mechanism may coexist to mediate the uptake of AuNPs, which requires further 
investigation. This is highly relevant as CME of AuNPs occurs when there is a clustering of AuNPs at the 





these clustered AuNPs into the double membrane vesicles at the plasma membrane to facilitate their 
subsequent endosomal trafficking within the cells (Wang et al., 2012). 
With regard to the intracellular fate of AuNPs after being internalized into the cells, it has been 
proposed that the endosomal-lysosomal pathway (comprising early endosomes, late endosomes and 
lysosomes) is responsible for the processing of the internalized NPs (Gilleron et al., 2013; Yang et al., 
2013), or AuNPs could also possibly be sequestered in autophagosomes and then acted upon by 






4.2 Biological effects of AuNPs in SAECs 
4.2.1 Effects of AuNPs on oxidative stress 
When SAECs were treated with AuNPs, there was an increase in lipid hydroperoxide content. Studies 
have shown that AuNPs can cause toxicity due to their ability to bind strongly to the -SH groups and 
trigger oxidative stress (Sperling and Parak, 2010; Tedesco et al., 2010b; Gerber et al., 2013). Oxidative 
stress due to an increase in ROS production would affect macromolecules such as proteins, lipids and 
carbohydrates, which could lead to the disruption of cell functions, oxidative damage (such as 
peroxidation of lipids) and eventual cell death (Khansari et al., 2009). This finding is also in concert with 
other studies on different types of NPs used, such as TiO2NPs and nickel oxide NPs (NiONPs), which 
showed induction of oxidative stress (Schins and Knaapen, 2007; Jin et al., 2008; Reeves et al., 2008; Lu 
et al., 2009a; Shukla et al., 2011). 
MT is a multi-functional protein that confers cytoprotective effect in the event of cellular insults 
(Tanaka, 2001). MT detoxifies heavy metals and acts as scavengers of oxidative free radicals (Cherian et 
al., 2003). Human MT genes are localized on chromosome 16 (16q13) (Karin et al., 1984). There are 10 
functional isoforms namely MT-1A, 1B, 1E, 1F, 1G, 1H, 1X, 2A, 3 and 4 which encode the 4 MT proteins. 
MT-1 and -2 proteins are ubiquitous in all tissues while MT-3 is site-specific (West et al., 1990; Stennard 
et al., 1994; Mididoddi et al., 1996; Vasak and Hasler, 2000). Only the expression of functional MT-1 and 
MT-2 gene isoforms were assessed initially in SAECs lung epithelial cells. In this study, there was a 
down-regulation of the MT-1A, -1X and -2A gene in SAECs. Down-regulation of MTs has also been 
reported to cause growth arrest and apoptosis in cancer cells (Li et al., 2005). Moreover, there was a 
general upward trend in the expression of other anti-oxidant genes such as GPX1, GPX2, SOD1, SOD2, 
SOD3, Prx1 and Prx3 in SAECs. 
4.2.2 Effects of AuNPs on cytotoxicity 
There was no apparent change in morphology after AuNP treatment in both SAECs. However, oxidation 





which may eventually stimulate intracellular signaling pathways for apoptosis (Ryter et al., 2007). Indeed, 
plasma membrane destruction was evident in SAECs in a dose dependent manner, when examined using 
the LDH assay. Moreover, AuNP-treated SAECs were found to have reduced total cell count and cell 
viability, implying that AuNPs could affect cell proliferation and survival; and these effects became more 
apparent at higher dose of 2 nM AuNPs. This observation could partially be explained by the difference in 
anti-oxidant MT expression as mentioned earlier. Additionally, AO/ EtBr staining showed increased 
incorporation of EtBr staining into the DNA of AuNP-treated SAECs, appearing orange-red color under a 
fluorescence microscope. On top of the observed color changes, blebbing of the plasma membrane in 
SAECs was also evident, indicating the occurrence of cell death after 72 h of AuNP treatment. 
Moreover, AuNP treatment significantly inhibited cell proliferation in SAECs as shown by a 
decrease in DNA content in both S and G2/M phases of the cell cycle. This decrease in cell proliferation 
was accompanied by down-regulation of CDKN2a gene expression. CDKN2a is an important regulator of 
the cell cycle checkpoint and cell cycle arrest (Koike et al., 2014). 
 
4.2.3 AuNPs and genotoxicity 
In this current study, there was significant DNA damage in SAECs exposed to 1 nM of AuNPs for 72 h, 
as revealed by the comet assay. The detection of DNA damage and up-regulation of the XPA gene (DNA 
excision repair gene), suggest the ability of AuNPs to disrupt genomic integrity. XPA is important for 
nucleotide excision repair (NER); translocation of XPA from cytoplasm to nucleus helps to recruit other 
NER factors in the presence of genotoxic insults. DNA damage-induced translocation of XPA into the 
nucleus is regulated by cell cycle phase dependent ataxia telangiectasia and Rad3-related proteins 
(occurring during S phase) (Li et al., 2013). As XPA was found to be up-regulated in this study, it is likely 







4.2.4 Genomic and proteomic studies of AuNP-treated SAECs 
The effects of AuNPs in modulating the genome of SAECs were analyzed using global human DNA 
microarray study. The Affymetrix Human Gene 1.0 ST Array comprising 764,885 probes which target 
28,869 genes, comprehensively covers the human genome, and are retrieved from databases like RefSeq, 
Ensembl and putative complete CDS GenBank transcripts. The probes cover only well-annotated content 
and out of 28,869 genes screened, GeneSpring analysis revealed 42 transcripts that were differentially 
expressed. Of these, there were 40 up-regulated genes and 2 down-regulated genes in 48 h AuNP-treated 
SAECs. From the gene ontology (GO) analysis, these differentially expressed genes can be categorized 
into different cellular functions including biosynthesis of steroids, stress-responsive genes, homeostasis, 
immune system and blood coagulation regulatory genes. Notably, AuNP exposure resulted in increased 
levels of mRNA for acute phase markers serum amyloid A-1 (SAA1) and immune response gene Toll-
like receptor 2 (TLR2) and interferon gamma receptor 1. In addition, microarray analysis revealed 
aberrant expression of genes which are involved in blood coagulation such as serpin peptidase inhibitor, 
clade E (SERPINE1) and also FYN binding protein, a gene which is involved in platelet activation. 
Expression of stress and stimulus responsive genes such as NAD(P)H dehydrogenase, quinone 1 (NQO1), 
ferritin, heavy polypeptide 1 (FTH1) and FYN binding protein (FYB) were also observed to be elevated  
Profiling of proteins using the MS-based dimethyl labeling method between AuNP-treated and 
untreated SAECs has identified 7 proteins, which were similar to those picked up from microarray data. 
These proteins were mainly stress-response and immune-response proteins; particularly, TLR2 was 
detected with a high ratio of 12 although SAA1 was not detected using MS.  
The Toll-like receptors (TLRs) family consisting of 10 members, is important in regulating innate 
immunity. Each member displays high specificity in recognizing different molecular patterns from 
pathogens, thus enabling detection of invasion by different pathogens (Takeda and Akira, 2004). TLR 
comprises an ectodomain (which is rich in leucine repeats (LRR) for mediating the recognition of 
microbe-specific molecular signatures), a transmembrane domain and a cytoplasmic Toll/IL-1 receptor 





and Kawai, 2014). Upon activation by a stimulus, TLRs recruit specific adaptor proteins which 
subsequently lead to downstream cascade activation, thereby contributing to host defense. Examples of 
TLRs adaptor proteins include MyD88 and TRIF (contain a cytoplasmic TIR domain) (Kawasaki and 
Kawai, 2014). 
Serum amyloid A (SAA1) is a member of apolipoprotein, as well as an acute phase responder, 
which is produced in the liver during inflammation and acute injury (Smallridge et al., 1990; He et al., 
2003; Paret et al., 2010). SAA plays a pivotal role in restoring homeostasis, thereby protecting biological 
systems from any insults which could be detrimental. Elevated SAA is associated with inflammation, 
suggesting its role in immune defense (Marzi et al., 2010). However, persistent inflammation may lead to 
amyloidosis, atherosclerosis and other clinical complications. Therefore, dysregulation of SAA protein 
level may serve as a potential biomarker in pulmonary diseases and cancers (Sung et al., 2011b). A 
previous study has demonstrated the induction of acute phase response genes including SAA after 
exposure to TiO2NPs (Halappanavar et al., 2011). Exposure to NPs by inhalation has been implicated in 
triggering a complex pulmonary response which alters the gene signaling pathway and causing 
thrombosis (Borm et al., 2006; Halappanavar et al., 2011). Combining the results from both microarray 
and MS studies, SAA1 and TLR2 were selected for subsequent studies. 
 
4.2.4.1 TLR2-SAA1 interaction triggers NFkB activation 
Studies have demonstrated TLR as a novel receptor for SAA1; in which SAA1 can bind to TLR2 and 
mediate inflammatory response, followed by activation of NFkB signaling pathway after their protein 
engagement (Filep and El Kebir, 2008; Baranova et al., 2010). Using saturation binding experiment, a 
previous study has identified TLR2 as a functional receptor to acute phase reactant, SAA1 and could 
mediate SAA1 regulatory function on pro-inflammatory activity (Baranova et al., 2010). To confirm the 
biological significance of the three genes/proteins from microarray and MS studies, the identified proteins 





assays. The two proteins were found to co-immunoprecipitate with each other in SAECs, although the 
majority of the TLR2 protein pool remained as un-interacted form. This result which indicates that SAA1 
specifically interacted with TLR2 and vice versa, was further verified with protein modeling analysis 
using the Swiss PDB viewer. 
The crystallized protein structure of SAA1 indicates that the native SAA1 structure is in 
hexameric form; comprising helix bundles which are involved in oligomerization of SAA1. Various 
oligomeric forms of SAA indicate differences in their function and pathogenicity; and it appears that the 
presence of C-terminal loop at the helix bundle is critical for protein binding and stability maintenance 
(Lu et al., 2014). Combined structural and functional studies have provided mechanistic insights into the 
pathogenic contribution of SAA1. Further investigation is needed to confirm if TLR2 interacts with 
SAA1 at the C-terminal loop. 
Following the verification of TLR2-SAA1 protein-protein interaction, a study was performed to 
investigate if there is an activation of intracellular NFkB transcriptional activity. Using the NFkB 
luciferase reporter plasmid, the effect of AuNPs on NFkB activity in SAECs pre-treated with 1 nM of 
AuNPs for 48 h was analyzed. There was a significant induction of NFkB activation, which is in 
concordance with a recent study by Monita Sharma et al (2013), who evaluated the eﬀect of AuNPs on 
NFkB activation in a B-lymphocyte cell line using 10 nm AuNPs. Engagement of TLRs transmits trans-
membrane signals which activate the NFkB pathway, thereby, regulating the downstream signaling 
cascade. Recently, a study has demonstrated the involvement of MyD-dependent TLR pathways in the 
expression of ZnONP-induced proinflammatory cytokines. TLR4 has also been reported to play a role 
ZnONP-induced inflammation (Chen et al., 2014). 
The NFkB is a complex transcription factor that comprises five subunits namely p50, p52, RelA, 
RelB, c-Rel, a family of inhibitors (IkBs), and upstream activating kinase complex (IKKs) (Ling and 
Kumar, 2012). Upon TGF-beta activated kinase 1 (TAK1) activation, TAK1 binds to the IKK complex 
(IKKα, IKKβ and NEMO), thereby inducing phosphorylation of IkBα to undergo proteasome degradation, 





2007; Ling and Kumar, 2012; Kawasaki and Kawai, 2014). Activation of NFkB could occur via the 
canonical, alternative or NFkB1/p105 pathways in response to different types of stimuli (Beinke and Ley, 
2004; Hoffmann et al., 2006). NFkB activation via the canonical pathway involves nuclear translocation 
of NFkB following IκBs degradation. On the other hand, activation of the non-canonical NFkB pathway 
does not involve IκBs degradation, but depends on the inducible processing of p100 (Sun, 2011). Whether 
the induction of inflammation is through canonical or non-canonical pathway warrants further 
investigation, although previous reports have demonstrated the involvement of canonical pathway for 
AuNPs (He et al., 2011; Sharma et al., 2013). 
Other than TLR-mediated NFkB activation, another possible mechanism responsible for NFkB 
activation is postulated to occur via direct Au-thiol group binding at the cysteine residue of NFkB protein 
(Sharma et al., 2013), a key residue for NFkB signal transduction proteins (IKKa and IKKb) (Perkins, 
2012). Since NFkB signaling pathway regulates inflammatory responses, activation of this pathway may 











Figure 4.1: Schematic drawing on the proposed mechanism of AuNP-induced NFkB activation mediated 
through SAA1-TLR2 ligand-receptor interaction. Upon activation of TLR receptor by a stimulus (AuNPs), 
activation of NFkB trigger increased cytokine expression through the ‘canonical’ NFkB signaling pathway. A 
physical interaction between AuNPs and IKKa and IKKb as well as Au-thiol group, which was demonstrated 





4.3 Biological effects of AuNPs in MRC5 lung fibroblasts 
4.3.1 Effects of AuNPs on oxidative stress 
MRC5 cells treated with AuNPs also showed an increase in lipid hydroperoxide content which is similar 
to that reported in previous studies, demonstrating an increased oxidative stress accompanied by 
cytoprotective effects by anti-oxidants in AuNP-exposed MRC5 lung fibroblasts (Li et al., 2008; Li et al., 
2010a). Other than MT-1 and MT-2 genes, MT-3 and MT-4 were also screened in MRC5 cells, although 
their expression was low. In this study, there was an up-regulation of the MT-2A and -1X genes in the 
MRC5 fibroblasts. This was accompanied by a general upward trend in the expression of other anti-
oxidant genes such as GPX2 and SOD2. The difference in MT expression between SAECs and MRC5 
cells suggests that MT responses to AuNP treatment may be cell-type specific (Khlebtsov and Dykman, 
2011; Shukla et al., 2011). 
 
4.3.2 Effects of AuNPs on cytotoxicity 
There was no apparent change in the morphology of MRC5 fibroblasts after AuNP treatment, which is 
similar with the observation in SAECs. AuNP treatment caused an increase in LDH leakage; albeit, less 
pronounced as compared with SAECs. Moreover, trypan blue assay showed that 1 nM AuNP treatment 
was not detrimental to cell survival and proliferation, except at the highest dose of 2 nM. As MT 
expression has been reported to prevent death in cardiac cells by attenuating ER stress (Xu et al., 2009) 
and up-regulation of MT genes could partly account for the less sensitivity of MRC5 towards AuNPs, as 
mentioned earlier. Additionally, AO/ EtBr staining showed a less extensive and less obvious cell death in 
AuNP-treated MRC5 cells, suggesting a varying degree of sensitivity towards AuNPs in different cell 
types. It would appear that AuNP treatment inhibited cell proliferation in MRC5 cells, although this was 







4.3.3 Effects of AuNPs on genotoxicity 
A DNA damage study has been previously performed using MRC5 cells (Li et al., 2011a). Other 
investigators have also observed the presence of genotoxicity induced by other types of NPs such as 
AgNPs, iron oxide NPs, TiO2NPs and MWCNT (Johnston et al., 2010b; Naqvi et al., 2010; Petkovic et al., 
2010; Guo et al., 2011; Lee et al., 2011; Li et al., 2011a; Shukla et al., 2011). Using 2D gel 
electrophoresis, a previous study has demonstrated that AuNPs induced oxidative damage-induced 
genomic instability, concomitant with dysregulation in protein expression (Li et al., 2011a). Down-
regulation of hnRNP C1/C2 in MRC5 cells implies involvement of the non-homologous end-joining 
pathway in repairing DNA damage caused by AuNPs. However, how AuNPs induced DNA damage as 
they were not found in the nuclei of cells in both cell lines in this study is still unknown. The findings 
lend support to studies which have established oxidative stress as the possible mechanism responsible for 
metal based NP-induced genotoxicity through heightened ROS production (Yang et al., 2009). 
 
4.3.4 Genomic and epigenetic studies of AuNP-treated MRC5 cells 
4.3.4.1 Transcriptomic study 
Global gene microarray analysis was carried out to compare the gene expression patterns of the MRC5 
lung fibroblasts treated with or without AuNPs. 19 genes have been found to be differentially expressed. 
These genes were classified into stress-response genes and genes that regulate blood coagulation, cellular 
morphogenesis, sterol metabolism, metal ion binding, hemostasis, and hydrolase activity. The genes 
related to sterol biosynthesis, which include isopentenyl-diphosphate delta isomerase 1 and sterol-C4-
methyl oxidase-like, were observed to be down-regulated. Other differentially regulated genes identified 
in AuNP-treated MRC5 fibroblasts, are known to  participate  in important cellular pathways, such as 
cellular morphogenesis, blood coagulation, hemostasis, hydrolase activity, metal ion binding and sterol 
metabolism (Dennis et al., 2003; Huang da et al., 2009). Similar to the microarray study in SAECs, genes 





4.3.4.2 Modulation of miR-155 induced by AuNP exposure 
Transcriptomic analysis revealed up-regulation of a non-protein coding RNA, miR-155 concomitant with 
decreased expression of 10 other genes (including the PROS1 gene) in AuNP-treated MRC5 cells. miR-
155 expression after AuNP treatment was subsequently validated using qRT-PCR analysis and reporter 
assay. This is the first study which demonstrates that AuNPs can modulate the expression of miR-155. 
Alteration in the expression of miRNAs has been implicated in the pathogenesis of diseases 
(Calin et al., 2005; Du and Zamore, 2007; Pillai et al., 2007; Standart and Jackson, 2007; Inomata et al., 
2009). miR-155 is one of the most well-studied miRNAs. Recently, studies have established the role of 
miR-155 in modulating inflammation and regulating both innate and adaptive immune responses (Tili et 
al., 2011; Li et al., 2014; Thounaojam et al., 2014). In line with a key role for miR-155 in modulating 
inflammation, a previous study has shown that miR-155 promotes inflammation and cytokine release by 
regulating the NFkB signaling pathway, and acts through the SHIP1 protein (Thounaojam et al., 2014). 
Other than inflammation, activation of TLR and stimulation of NFkB were also found to up-regulate 
miR-155 expression (Elton et al., 2013). Hence, miR-155 up-regulation in response to the pro-
inflammatory environment after AuNP exposure in MRC5 cells suggests that miR-155 is involved in 
modulating inflammatory response. 
Besides the prominent role of miR-155 in innate immunity and inflammation, miR-155 has been 
identified to participate in a number of cellular pathways, including the LPS signaling pathway (Boesch-
Saadatmandi et al., 2010), miR155-mediated pathway of AID regulation (Teng et al., 2008), regulation of 
type 1 Angiotensin II receptor (AT1R) (Faraoni et al., 2009), angiotensin II-induced extracellular signal-
related kinase 1/2 (ERK1/2) activation (Martin et al., 2006), TGF-β/Smad pathway (Kong et al., 2008), 
MAPK signaling pathway (Bhattacharyya et al., 2011), PI3K/Akt pathway (which subsequently affects 
the TNFα-dependent growth of B cell lymphomas) (Cremer et al., 2009; Pedersen et al., 2009; 
Bhattacharyya et al., 2011). These pathways are known to cause autoimmune disorders, carcinogenesis 






4.3.4.3 PROS1 gene as a possible target gene of miR-155 
In the present study, inhibition of miR-155 expression led to an increased expression of PROS1 at both 
the transcript and protein levels. These results indicate that although endogenous miR-155 was expressed 
at low levels in the lung fibroblasts, inhibition of its expression enhanced the expression of PROS1, 
thereby suggesting that miR-155 could modulate expression of PROS1. It would appear that the PROS1 
gene is a putative target of miR-155. 
A study has shown that mice exposed to TiO2NPs through the inhalation route suffered from 
inflammation in the lung tissues, together with up-regulation of miR-449a, miR-1, and miR-135b 
(Halappanavar et al., 2011). PROS1 deficiency is known to contribute to thrombosis in the pulmonary 
vasculature, causing lung infarction culminating in death (Zander et al., 2001) and pulmonary 
hypertension (Piazza and Goldhaber, 2011). The PROS1 gene encodes for Protein S, a vitamin K–
dependent plasma glycoprotein. 
 
Protein S participates in the inactivation of Factors Va and VIIIa, 
resulting in dire consequences such as bleeding diathesis (Simioni et al., 2006). Protein S is mainly 
synthesized mainly in hepatocytes, endothelial cells, megakaryocytes and interstitial Leydig cells (ten 
Kate and van der Meer, 2008). Modulation of PROS1 by miR-155 suggests a tight link between 
inflammation and PROS1 deficiency associated diseases. 
Moreover, the PROS1 gene was also expressed in lung tissues, as quantified by normal tissue 
array comprising 48 different human tissues. PROS1 expression was detected in 45/48 normal tissues, 
excluding lymphocytes, mammary gland and muscle. The highest expression the PROS1 gene (as denoted 
by a lower Ct value) was found in lung tissue, followed by small intestine, adrenal gland, uterus, pituitary, 
heart, stomach, penis, ovary and liver. 
 
4.3.4.4 PROS1 DNA methylation profiling analysis 
To study the DNA methylation status at the promoter region of PROS1 gene, both sequencing-based 





require bisulfite modification of DNA. Total DNA was subjected to sodium bisulfate modification for the 
conversion of unmethylated cytosines to uracil; so as to differentiate the unmethylated form from 
methylated form of cytosines. For the BSP sequencing method, BSP primers are used for PCR 
amplification before sequencing is performed. The percentage of unconverted cytosines (methylated form) 
and unmethylated cytosines (which has been converted to thymine nucleotides) at the CpG island can 
then be determined. MSP PCR analysis is achieved using two sets of primers namely the methylated and 
unmethylated primer sets (Shen and Waterland, 2007). 
It has been reported that alteration of miRNA expression contributes to other epigenetic changes 
such as aberrant DNA methylation (Calin, 2006; Kuhn et al., 2008; Gao et al., 2010). It has also been 
proposed that DNA methylation is the first step among other epigenetic platforms to modulate gene 
expression. This is evident as site-specific DNA methylation at the promoter region of a gene often leads 
to gene silencing (Gong et al., 2012). Both AuNP-treated and untreated MRC5 cells showed virtually no 
methylation by either bisulfite sequencing or MSP PCR analysis, indicating that AuNP treatment did not 
alter the DNA methylation status of the PROS1 gene. 
 
4.3.4.5 AuNP-induced chromatin reorganization/ heterochromatin formation in MRC5 cells 
As miRNAs are also known to be negative gene regulators through chromatin remodeling (Finnegan and 
Matzke, 2003; Gonzalez et al., 2008), changes in nuclear architecture were also evaluated in AuNP-
treated MRC5 fibroblasts. There is very limited literature on the effects of NP exposure on chromatin 
organization. Cellular responses towards NP exposure may show drastic differences in the event of 
perturbation to either hetero- or euchromatin (Mazumder and Shivashankar, 2007). There was an apparent 
reorganization of nuclear content and chromatin condensation in AuNP-exposed MRC5 cells. This 
finding indicates that AuNPs modulate chromatin architecture. Chromatin reorganization coupled to the 
nuclear architecture organization is important in regulating function of the genome. This process involved 





(Mazumder and Shivashankar, 2007). Proper proteinaceous scaffolding is essential in maintaining nuclear 
architecture, and this is regulated through histone tail modification. TSA, an inhibitor for HDAC, was 
used to probe if histone modification was instrumental in nuclear organization and hence, PROS1 gene 
suppression. HDAC inhibition results in increase acetylation at the histone tails, forming a looser 
chromatin structure (euchromatin) and allowing for higher gene transcription. Remarkably, the inhibitory 
effect on PROS1 gene expression was abrogated in the presence of TSA treatment. This study provided 
evidence of AuNP-induced perturbation of chromatin assembly. PROS1 was found to be negatively 
regulated by HDAC and histone tail modification was partly involved in regulating PROS1 transcriptional 






4.4 Bystander effects of AuNP exposure in a SAEC-MRC5 co-culture system 
4.4.1 Co-culture system and SILAC analysis 
 
Despite the wide availability of toxicity studies, there is a scarcity of knowledge with regard to the AuNP-
lung interaction effects on neighboring cells, not exposed to the NPs. Hence, an in vitro SAEC-MRC5 
lung fibroblasts co-culture system (to mimic the respiratory tract) was adopted for this purpose. SAECs, a 
lung epithelial cell line, are the first line of contact with inhaled NPs surrounded by stromal lung 
fibroblasts in the lung (Yu et al., 2013). Primary exposure of SAECs to AuNPs was performed before 
seeding in the upper cell culture insert of a Transwell polycarbonate membrane and the MRC5 lung 
fibroblasts were seeded in the lower inserts. AuNPs pre-exposed SAECs were subsequently co-cultured 
with MRC5 cells to simulate the physiological environment present in the lung. Cellular crosstalk among 
different cell types present in tissues was studied using the co-culture system, which allows an in depth-
understanding of cell-cell communication in response to an external stimulus. Moreover, a co-culture 
system can serve as a sophisticated in vitro model, reflecting a realistic physiological condition in the 
lung, for NP-related studies in order to minimize the animal usage (Herzog et al., 2014). 
The co-culture system has been utilized for modeling biological interactions in immunology, 
cancer biology, stem cells differentiation as well as in nanotoxicology (Stephens et al., 2001; Gebhardt, 
2002; Diabate et al., 2008; Brandenberger et al., 2010; Bogdanowicz and Lu, 2013; Chuang et al., 2013). 
For example, Brandenberger et al has employed a triple cell type (alveolar epithelial cells, macrophages 
and dendritic cells, simulating the alveolar lung epithelium) co-culture system to study the modulation of 
inflammation after aerosolized exposure to AuNPs at the air-liquid interface (Brandenberger et al., 2010). 
Small airway epithelial cells (SAECs) and microvascular endothelial cells (HMVEC) have also been co-
cultured to study alveolar-capillary interaction post-exposure to MWCNT for the detection of changes 
occurred in the vascular endothelium (Snyder-Talkington et al., 2013). 
In this present study, a SILAC-MS based proteomics approach was also employed for the study 





compare the proteome expression changes (Swa et al., 2012). Metabolic incorporation of stable isotope-
labeled Arginine and Lysine into the cellular proteome was achieved by constitutively culturing of cells 
using SILAC medium for four passages. Next, two populations of cells, namely the light and the heavy 
cells were mixed in equal proportion after co-culturing before being subjected to MS analysis. 
Quantification of the relative protein abundance in MRC5 cells after co-culture with SAECs which were 
pre-exposed and not exposed to AuNPs was determined based on relative MS intensities. Derivatization 
of protein abundance between the two sets of samples enabled the identification of proteins that were 
dysregulated in neighboring AuNP-unexposed MRC5 cells. These dysregulated proteins may shed light in 
identifying the cellular response/ bystander effect on neighboring cells induced by AuNP-exposed cells. A 
combination of both technologies (co-culture system and SILAC-MS approach) has provided further 
biological insights into NP-related toxicity. 
 
4.4.2 Pathway analysis of differential protein expression induced by AuNP-exposed SAECS in 
neighboring MRC5 fibroblasts 
Quantitative proteomics analysis has identified 47 up-regulated and 62 down-regulated proteins in the 
MRC5 fibroblasts, based on replicates of Forward and Reverse experiments. From the GO and pathway 
analysis, these dysregulated proteins were involved in cell adhesion, extracellular matrix 
(ECM)/cytoskeleton remodeling and cell migration, accompanied by phenotypic alterations. 
One of the key proteins involved in migration and invasion, PLAU was down-regulated, implying 
a decrease in cell migration (Jung et al., 2010; Lampidonis et al., 2011). Expression of cell adhesion-
related proteins such as Paxillin (PXN), breast cancer anti-estrogen resistance 1 (BCAR1) and Caveolin-1 
(Cav-1) were increased significantly. Taken together, AuNPs was found to alter key proteins which 
regulate the cell-cell and cell-matrix adhesive properties in the underlying unexposed MRC5 cell. A 
survey of the literature also revealed that alterations of these proteins have been implicated in cancer 
progression, as well as in pulmonary pathologies (Yang et al., 2006; Le Saux et al., 2008; Chanvorachote 





airway inflammation through activation of p38 MAPK and NFkB signaling (Garrean et al., 2006; Liu et 
al., 2013). Other than NFkB, sustained activation of PI3K/Akt pathway facilitates the ROS formation 
regulated by Cav-1 after cell detachment (Chanvorachote and Chunhacha, 2013). 
The results obtained here revealed that primary exposure of SAECs to AuNPs induced bystander 
effects, possibly through soluble factors secreted by SAECs into the culture medium, resulting in 
dysregulation of proteins involved in processes such as increased cell-substrate adhesion in the underlying 
unexposed MRC5 fibroblasts. 
 
4.4.3 Dysregulated proteins regulates cell adhesion and cytoskeleton in the MRC5 fibroblasts 
FA is a site where there is a close contact between cell and the underlying extracellular matrix. Studies 
have demonstrated PXN, BCAR1 and Cav-1 to be FA-associated (Schaller, 2001) and involved in 
formation and regulating local FA dynamics (Chao et al., 2010), leading to disruption of the cytoskeleton 
structure. These findings provide the biological basis for the coordinated signaling between PXN, BCAR1 
and Cav-1 in regulating cell spreading. In agreement with previous findings, F-actin arrangement in the 
cytoskeleton was altered, together with an increased in stress fiber or FA formation. In addition, there was 
an increased in FA-associated protein, vinculin in MRC5 lung fibroblasts. These altered proteins 
modulated phenotypic changes in the MRC5 fibroblasts, causing an increase in cell adhesion and changes 
to cytoskeleton that may affect lung function in the physiological condition. This observation is in line 
with a previous study in which direct exposure of MWCNT in endothelial cells resulted in manifestation 
of increased vascular permeability (Pacurari et al., 2012; Snyder-Talkington et al., 2013). Another similar 
finding is a study by Setyawati et al (2013) which showed perturbation of the cytoskeletal network 
involving formation of stress fibers and actin remodeling by VE–cadherin pathway triggered by TiO2NPs, 






4.5 Functional effects of AuNPs in an in vivo model 
4.5.1 Intravenous route of administration 
AuNPs have been identified as agents for drug delivery (Kim et al., 2009a; Jeong et al., 2013). Hence, 
there is an increase in propensity for human exposure to AuNPs via IV injection in the clinical setting. 
Entrapment of NPs in the lungs is common if administration of the NPs is mediated via the IV route 
(Fabian et al., 2008; Kendall and Holgate, 2012), thereby posing a high risk of possible toxicity to the 
lungs. Thus, assessing potential adverse pulmonary effects of AuNPs in vivo is of great importance. 
 
4.5.2 Dosimetry and relevance 
As AuNPs are directly administered into the blood stream as drug carriers, the dose applied should be 
carefully monitored. Administration of a physiologically relevant dose for both in vitro and in vivo studies 
has been challenging. There has been a lack of consensus on the dose metrics especially for in vitro 
studies (Joris et al., 2013). Relatively high doses applied in in vitro studies have raised questions on the 
relevance of the findings in the in vivo environment (Oberdorster et al., 2005). It has been advocated that 
the dose administered should be comparable in the different experimental settings (Johnston et al., 2010a), 
especially in preclinical studies that assess the toxicity of NPs using animal models (Madl and Pinkerton, 
2009). Hence, the dose for AuNPs used in this study was rationalized based on published data from a 
Phase I clinical trial (Libutti et al., 2010) and following US Food and Drug Administration’s guidelines. 
 
4.5.3 Biodistribution of AuNPs in rat lungs 
Concurrent with other reports (De Jong et al., 2008; Semmler-Behnke et al., 2008), AuNPs has been 
observed to reach secondary target organs via the systemic blood circulation in healthy rats. The levels of 
Au detected in the lungs are consistent with an earlier study by Balasubramanian et al (2010a), although 
the dose used in the present study was ten times higher. However, the amount of Au present in the 





could be adopted (Hirn et al., 2011). Therefore, it is assumed that amount of Au present in blood is 
negligible and insufficient to affect the amount of Au measured.  
The single dose IV administered AuNPs were translocated to the rat lungs and were retained after 
1 week, 1 month and 2 month post-exposure; with higher dose administered showing a faster clearance, 
decreasing at 2 month post-exposure. Several possible clearance pathways have been proposed for inhaled 
AuNPs, including mucociliary clearance and pulmonary surfactant protein D modulated clearance (Yu et 
al., 2007; Semmler-Behnke et al., 2008; Schleh et al., 2013), alveolar elimination by macrophages in the 
alveolar region (which does not apply to large agglomerates) (Takenaka et al., 2012) and hepato-biliary 
clearance from the liver (Hirn et al., 2011). 
 
4.5.4 Systemic effects of AuNPs in rats 
IV injection of AuNPs induced significant expression of both anti- and pro-inflammatory cytokine 
expressions. This observation indicates the presence of systemic inflammation in rats following AuNP 
exposure. In particular, more intense inflammatory response was observed after a higher single dose and a 
shorter duration post-exposure. The results concerning transient inflammatory response induced by 
AuNPs are similar to the results as observed by Khan et al (2013). In their study, 10 and 50 nm AuNPs 
induced transcriptional expression of cytokine genes on day 1, which declined on day 5. Exposure to 
other types of NMs has been reported to cause inflammation in vivo, for example, exposure of TiO2 has 
been reported to induce pulmonary airway irritation and inflammation in mice (Leppanen et al., 2014) and 
single-wall carbon nanotube, inflammatory gene expression changes after post intratracheal instillation in 
rats (Fujita et al., 2014). 
The effect of AuNPs on coagulation events was assessed by performing PT test. It has been 
established that exposure to AgNPs and silica NPs enhanced venous thrombus formation and platelet 
aggregation (Jun et al., 2011; Corbalan et al., 2012). In this study, administration of AuNPs caused a 





findings in this study, PROS1 gene was strongly induced in the lungs of rats exposed to AuNPs. PROS1 
is an anticoagulant plasma protein which controls thrombin generation; as well as a cofactor to activate 
protein C which degrades coagulation factors Va and VIIa (ten Kate and van der Meer, 2008). PROS1 
encodes for protein S, which is an anticoagulant and a cofactor for activated protein C to inhibit the blood 
coagulation cascade. Protein C plays a role in PT prolongation by inactivating FV and FVIII in this PT 
assay ex vivo (Youngwon et al., 2013). Hence, increased PROS1 expression may be associated with a 
stronger anticoagulant response. 
 
4.5.5 Pulmonary inflammation induced by AuNPs 
Histological and immunohistochemical examination revealed inflammatory features post AuNP exposure 
in rat lung. Inflammatory infiltrate of lymphocytes and macrophages was evident in the rat lung. 
Immunohistochemistry revealed a strong positivity of IL-1α staining, confirming pulmonary 
inflammation. Accumulation of AuNPs in animal models following their biodistribution via inhalation 
and intravenous route pose immune-modulatory effects and recruitment of macrophages (Hussain et al., 
2013). Particulate air pollution has been associated with inflammation, blood coagulation, and autonomic 
dysfunction (Zuurbier et al., 2011; Bind et al., 2012). Inhalation exposure to TiO2NPs was found to cause 
pulmonary inflammation in mice and rats, as characterized by infiltration of neutrophils (Hougaard et al., 
2008; Ma-Hock et al., 2009; Halappanavar et al., 2011). Similar inflammogenic response of TiO2NPs was 
also observed in in vitro studies. 
As evidenced by the immunohistochemical staining, there was an enhanced expression of IL-1α, 
a pro-inflammatory cytokine which is known to play a role in resolving infections through the stimulation 
of immune responses via recruitment of inflammatory cells and production of enzymes (Kim et al., 2014). 
In addition to inflammatory responses, there was also an increase in the number of macrophages in rat 
lung. Together, these results are strong indication to support the induction of pulmonary immunity, 





Rattanapinyopituk et al (2013b) reported that translocation of AuNPs to lung tissues caused acute 
inflammation, accompanied by multifocal infiltration of neutrophils, destruction of alveolar wall, 
increased cytokine (IL-6 and TNF-α) and oxidative stress. Exposure to other types of NMs has also been 
reported to cause inflammation in vivo. For example, exposure of TiO2NPs has been reported to induce 
pulmonary airway irritation and inflammation in mice (Leppanen et al., 2014), while single-wall carbon 
nanotubes (SWCNT) cause inflammatory gene expression changes after intratracheal instillation in rats 
(Fujita et al., 2014). The same observation was also made when NiONPs were intratracheally instilled in 
rats, causing inflammation and changes in pulmonary cytokine and chemokine expression (Morimoto et 
al., 2010). 
 
4.5.6 miRNA and inflammation 
The results from the miRNA PCR array provided evidence that AuNP exposure caused alteration in 
miRNA expression in the rat lung. Inflammation-related miRNAs were found to be down-regulated. 
Interestingly, serum protein quantification using the same animals had shown that AuNP exposure up-
regulated serum cytokine expression. These opposite trends are in agreement with the expected role of 
miRNAs, which are negative regulators for transcriptomic and proteomic expression. This finding may 
aid in understanding the inflammatory response involved in damage caused by AuNP exposure in rat lung. 
miR-327, the only miRNA that was observed to be down-regulated in both treatment groups, appears to 
be linked with an induction of inflammatory response. As miR-155 is known to activate NFkB in the 
event of inflammation; it is noteworthy to investigate its expression in future (Izzotti et al., 2009). 
Alteration of miRNA expression after NP exposure has been implicated in inflammation. For 
example, pulmonary toxicity study using TiO2NPs revealed up-regulation of SAA protein, together with 
induction of miR-135b. Similar to the findings in this study, TiO2NPs was found to induce both systemic 
and pulmonary toxicity, accompanied by acute phase and inflammation gene and miRNA expression in 





inflammation following LPS exposure (Lu et al., 2009b); and observed to be down-regulated after 
exposure to synthetic particulate matter in the myocardium of rats (Farraj et al., 2011). miR-183 and let-
7a were observed to be altered in lungs and livers of mice treated with AuNPs (Balansky et al., 2013). 
Recently, Chew et al (2012) performed a blood miRNA profiling in AuNP exposed rats via IV injection 
and found miR-298 up-regulation, an important regulator for Alzheimer's disease. Several miRNAs (Let-
7, miR-10, miR-26, miR-30, miR-34, miR-99 etc) have been implicated in inflammatory lung diseases in 
rats exposed to cigarette smoke (Izzotti et al., 2009); while miR-181b expression was reported to be 
suppressed in the silicosis rat model (Faxuan et al., 2012). Accordingly, the susceptibility of miRNAs 






4.6 Limitations of the present study 
For the in vitro study, 
(a) only one main dose of AuNPs was evaluated for many of the experiments performed. The size of 
AuNPs used was restricted to 20 nm diameter and functionalized only with FBS. 
(b) experiments were performed in only one epithelial and one fibroblastic lung cell line. 
(c) the AuNPs were added into the medium and no experiments were performed by direct exposure using 
the air liquid interface. 
(d) the time points were limited to 24 h-72 h. 
For the in vivo study, 
(a) only single dose injections were performed. 
(b) time points limited to one week, one month and two months. 
(c) bronchoalveolar lavage was not performed in the animals after exposure to AuNPs. 
(d) only male rats were used for the study. 
Although in vitro set up such as the co-culture system has been designed to simulate in vivo 
system, discrepancies still exist. Therefore, a major challenge to surmount is whether the in vitro studies 
can serve as a good surrogate tool to predict in vivo results. Both in vitro and in vivo studies presented 
here have consistently demonstrated the toxicity of AuNPs. Further studies are needed to understand the 







This study has shown that FBS-coated AuNPs induced both cytotoxic and genotoxic effects in the lungs 
upon their entry via RME in vitro. AuNPs exposure suppressed cell proliferation, induced DNA damage 
and oxidative stress in both SAECs and MRC5 cells. These were accompanied by genomic and proteomic 
changes, as well as the involvement of epigenetic mechanisms especially in the MRC5 cells (Fig. 4.2). 
 
 
Figure 4.2: Overview of epigenetic mechanisms which may be possibly involved in regulating gene 






The findings also highlight the difference in response and reaction between SAECs and MRC5 cells. Both 
cell lines are subjected to the same exposure condition; but it appears that the underlying mechanism 
regulating their responses to AuNPs differ from each other. This present the need to use at least two cell 
lines for toxicology due to cell-type specific effects. Differential regulation of the antioxidant MT could 
partially explain the difference in cytotoxicity between AuNP-treated SAECs and MRC5 cells by 
regulation of the levels of oxidative stress in both cell lines. 
In addition to the cell type as a factor of AuNP-induced functional effects, cellular crosstalk and 
microenvironment may play a pivotal role in determining the responses to NPs. Therefore, the co-culture 
system adopted in this study has shed light on the ability of AuNPs to induce bystander effects to the 
neighboring unexposed cells, possibly through cell-cell communication via secretion of soluble factors. 
While the in vitro study has enabled elucidation of the mechanisms involved and signaling 
pathways triggered in response to AuNP exposure, the in vivo study has substantiated some of these 
findings in the organ system. The animal data has verified that AuNP exposure triggered inflammatory 
responses and transient bleeding diathesis in rats, concomitant with alteration in inflammation-related 
miRNA expression in the rat lung. This study has evaluated the cytotoxic and genotoxic effects on AuNPs 
in lung cells in vitro, as well as examined the effects in a co-culture system and in vivo model. The results 
gleaned from this study would contribute to the current understanding of nanotoxicology and also be 






4.8 Future studies 
It would be worthwhile to evaluate the toxicity of different AuNP using multiple sizes with different 
surface modification, such as Au-S peptide conjugation. Given the strong thiol-binding affinity of AuNPs, 
Au-S bonding on one terminal has gained popularity. Stable AuNP-peptide systems prepared through Au-
S bonds is shown to possess reduced toxicity, thereby leading to the safe and efficacious use of AuNPs 
for biological applications. Since AuNP-peptide conjugate requires a centrifugation step during its 
synthesis and preparation, future studies should include the effects of centrifugation on the sedimented 
amount of AuNP-peptide. In addition, whether the AuNP-peptide could induce protein conformational 
changes upon adsorption should be examined, as such conformational changes of the adsorbed proteins 
may cause a reduced functionality of the proteins. 
Since NPs are reported to trigger oxidative stress, stability of AuNP-peptide system upon 
intracellular uptake should be investigated. The effects of Au
1+/3+
 ions release from its peptide conjugate 
system elicited by the acidic pH condition inside lysosomal cellular compartment should be further 
evaluated. Previous reports have demonstrated the ability of AuNPs to disturb the oxido-reductase system 
through the interaction of Au-thiol and Au-S bond, as these bonds are liable to oxidation (Tedesco et al., 
2010b). Moreover, intracellular release of Au ions has been shown to inhibit the activity of enzyme 
thioredoxin reductase through Au-thiol binding (Sabella et al., 2014). Since the stability of AuNP-peptide 
system may potentially affect the amount of Au ions released and thereby cause cellular redox imbalance, 
the stability of the Au-S under acidic condition should be determined. A stable Au-S bond which can 
evade or resist acidic degradation by lysosome would be ideal for subsequent applications. 
Other than RME, other pathways such as diffusion, phagocytosis and micro-pinocytosis are also 
possible mechanisms responsible for the uptake of NPs. Protein corona formation on the surface of NPs 
affects the mode of interaction between NPs and protein receptors, which in turn alter their uptake into the 
cells. Analysis of the components present in the medium may provide clues in understanding the cellular 





Currently, the biological effects of miRNA modulation following AuNP exposure are largely 
unknown. Induction of miRNAs and modulation of the expression of their putative targets are not well 
characterized. Proof of concept studies in relation to miRNA-target biological functionality has to be 
performed. Moreover, the possibility that cellular responses towards AuNPs could be under control of 
miRNA or other epigenetic mechanisms are yet to be demonstrated after AuNP exposure. Recent 
publications have seen a surge in the study of epigenetic effects in the field of nanotoxicology. More in-
depth studies are required with regard to the involvement of the various epigenetic platforms and their 
interactions. 
In silico analysis and molecular modeling could help to predict effects in real life system. Co-IP 
results have identified TLR2-SAA1 protein interactions. The next step to validate that such interactions 
take place, would be to perform a detailed structural modeling so as to confirm their corresponding 
interaction sites. Once the interaction site is identified, mutation of these sites followed by binding assays 
could be employed to confirm if these sites are truly functional. Other than an in silico model, more 
advanced cell culture system using 3D model, simulating the 3D in vivo environment would be even more 
relevant than the current 2D model used for the study of NP toxicity. 
Finally, a detailed screening of all the blood coagulation factors, and evaluation of the effects of 
NPs on anti-oxidant gene and MT expression should be carried out in vivo as they have been observed to 
be significantly affected in the in vitro study. The clearance mechanism of NPs in animal models should 
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